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Abstract 
Albumin is the most abundant protein in blood and plays important homeostatic roles in the 
regulation of oncotic pressure and as a carrier of many small proteins, peptides and hormones. 
Albumin in the circulation can be covalently modified at surface lysine residues and thus the 
circulation contains a mixture of native albumin (i.e. not modified) and modified albumin. A 
significant amount of albumin is lost from the blood each day as a result of the filtration occurring in 
the capillaries of the renal glomeruli. This filtered albumin in the early filtrate is thought to be mostly 
taken up by, and degraded in, the early renal proximal tubular epithelial cells, while a small 
proportion is excreted in the final urine. This degradation of albumin by proximal tubules operates 
via the megalin scavenger receptor and an endocytic pathway.  
 
Experimental measurement of renal albumin re-uptake and excretion remains a 
controversial issue as the test probes used to measure these parameters rely on modified albumin 
probes. These modifications can potentially change the surface charge and tertiary structure of the 
albumin molecule and therefore alter the way albumin is filtered and absorbed by the kidney. 
Hence, there still exists an overall paucity of data in relation to albumin handling and how albumin is 
processed and excreted in the urine.  This is not only a complicating factor for diagnosis, but since 
these probes are often used to study renal function, it also obscures our basic understanding of 
molecular renal physiology and how albumin is processed. A major gap in our knowledge is whether 
the megalin-based albumin uptake is a non-selective process, or whether megalin has a significantly 
different affinity for modified versus native albumin. The latter finding would implicate the megalin 
pathway as a protective mechanism against the toxic effects of modified albumin on cells.  
 
In this project, I sought to develop a uniformly labelled “native” albumin to provide a better 
diagnostic understanding of urinary albumin excretion. The K. Lactis expression system and 14C-
glucose was used to develop the “native” albumin. Using a bioreactor, I examined a wide variety of 
parameters including culture media, bio-physical parameters, biochemical pathways and feeding 
styles to optimise the production of radiolabelled albumin with high specific activity. The purification 
process also underwent considerable optimisation to obtain a high yield and purity of recombinant 
albumin while still maintaining the native structure. The native conformation of this albumin probe 
was confirmed by circular dichroism and compared to that of commercial purified albumin and 
fluorescent-labelled albumin. 
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The project sought to examine how proximal tubules take up native versus modified 
albumin. All previous work in this area has used modified albumin probes. Therefore, to address this 
question, I compared the uptake of commercial fluorescent-labelled albumin with radioactive native 
recombinant human albumin (rHA).  
 
Using a well-established albumin uptake assay in Opossum Kidney (OK) cells, I confirmed 
that standard modified albumin probes (Alexa488-BSA and FITC-BSA) are taken up into OK cells via 
the endocytic pathway. This uptake was inhibited by an excess of modified albumin, whereas an 
excess of rHA had little effect upon the uptake, suggesting a difference in binding affinity. The 
addition of 14C-rHA to OK cells resulted in a very low percentage (3%) of the probe being taken up by 
cells compared to a 30% uptake using Alexa488-BSA. In addition, the uptake of 14C-rHA was not 
saturated in a dose-response assay suggesting non-specific binding. This was confirmed when an 
inhibitor of the endocytic pathway failed to inhibit the uptake of 14C-rHA by OK cells.  
 
Based upon common conserved structural motifs between albumin and known megalin 
ligands, a series of 6 albumin peptides were designed as potential inhibitors of the megalin-albumin 
interaction. One of these peptides (A6) significantly inhibited the uptake of Alexa488-BSA by OK 
cells, thereby identifying a potential binding site between megalin and albumin. The peptide was 
identified as a good tool for future investigation of albumin uptake by megalin in vitro and in vivo. 
 
A common sign of kidney injury is an increase in albumin excretion in the urine 
(albuminuria). This can occur in chronic diseases such as diabetic nephropathy, but it can also occur 
in acute kidney injury such as in patients with bacterial sepsis. Animal models have shown that the 
bacterial cell component, lipopolysaccharide (LPS), can induce albuminuria. However, whether LPS-
induced albuminuria operates via a direct effect on albumin uptake by tubular epithelial cells is not 
known. Therefore, I examined the effect of LPS on OK cells and found this to inhibit the uptake of 
Alexa488-BSA following 2 or 24 hours stimulation. LPS did not affect megalin expression or the 
lysosomal content of cells. However, blockade of LPS induced c-Jun amino terminal kinase (JNK) 
signalling prevented the effect of LPS on albumin uptake, suggesting that this may explain the ability 
of JNK inhibition to prevent LPS-induced albuminuria in mice.  
 
In summary, this thesis presents the first studies to compare the uptake of native and 
modified albumin by tubular epithelial cells. The results indicate that the megalin pathway has a 
much greater affinity for modified compared to native albumin. This may be an important 
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mechanism for the removal of modified albumin from the body as it can exert toxic effects. Further 
studies are warranted to examine how the native albumin probe is handled by the kidney in whole 
animal studies.   
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Chapter 1. Analysis of the uptake of native versus modified 
albumin by renal tubular epithelial cells. 
1.1. Introduction  
The kidney is one of the essential organs in the body which filters the plasma portion of 
blood at a high rate and produces a nearly protein-free filtrate [1]. The constant cycling of the blood 
through the kidneys keeps the blood balanced so that it, in turn, can keep the homeostasis of the 
body. Patients who progress to end-stage renal failure (ESRF) require renal replacement therapy 
consisting of life-long dialysis or kidney transplantation. The latest Australia and New Zealand 
Dialysis and Transplant Registry (ANZDATA) figures indicate that around 19,500 patients were on 
renal replacement therapy in Australia in 2009, with roughly 2,500 new patients beginning dialysis in 
2008 [2]. 
Diabetic nephropathy and glomerulonephritis are the most common causes of ERSF 
requiring renal replacement therapy. Renal replacement therapy places a major socio-economic 
burden on patients and their families. Furthermore, the direct economic costs of ESRF treatment in 
Australia are enormous, and this is increasing rapidly due to the epidemic of type 2 diabetes. The 
clinical signature of diabetic kidney disease and glomerulonephritis is appearance of 
protein/albumin in urine (proteinuria/albuminuria) and a loss of kidney function.  
1.1.1 Kidney 
In humans, the kidneys belong to the urinary system and are bean shaped organs (~ 10 x 6 x 
3 cm) [3]. The renal artery and vein enter and exit the kidney, respectively, at the medial indentation 
known as the renal hilus. Inside the kidney, the renal artery subdivides into many smaller vessels 
known as afferent/efferent arterioles while the renal vein subdivides into small vessels forming 
peritubular capillaries with efferent arterioles. The plasma is conveyed to the kidney through the 
renal artery and exits through the renal vein after filtration [3].  
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The main function of kidney is preserving the constancy of the physiological fluid in the body 
[3]. Through excretion of urine and absorption of different molecules, it helps maintain water 
balance, plasma components and other extracellular fluids (mainly through water and ion balance 
concentration). Physiological pH is also maintained (7.35-7.45) through kidney absorption and 
excretion of H+/HCO3
-. The waste products of metabolism (urea, uric acid, and creatinine) and 
foreign products (drugs, food additives) are also excreted to prevent accumulation. The kidney is 
also the source of some important hormones such as erythropoietin and renin which are responsible 
for blood production and salt conservation, respectively [4, 5]. Vitamin D is also converted into its 
active form in the kidney [6].  
1.1.2 The nephron, filtration unit of kidney  
The nephron is the filtration unit of the kidney which is responsible for filtration of 
unwanted waste and reuptake of necessary molecules. There are approximately one million 
nephrons in kidney [7]. Each nephron is constructed by both a vascular and tubular component.  The 
combination of these two distinct formations in the nephron forms the juxtaglomerular apparatus.  
The vascular components are composed of afferent/efferent arterioles, peritubular 
capillaries and the glomerulus. The vascular components, or specifically the glomerulus, are for 
selective filtration of physiological molecules (Figure 1.1)[8]. The tubular component comprises the 
Bowman’s capsule, renal tubules and the collecting duct. The renal tubules, which are divided into 
three specific regions, proximal convoluted tubule, loop of Henle and distal convoluted tubule are 
responsible for reabsorption and secretion of various solutes such as ions (Na+, Ca2+), carbohydrates 
(glucose) and amino acids. Another part of the tubular component is the collecting duct which is 
mainly responsible for urine excretion [3]. 
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Figure 1.1: Diagram shows filtration process of nephron. The blood enters
glomerular capillaries through an afferent arteriole then undergoes filtration
and reabsorption to have unwanted products excreted as urine. The essential
components are reabsorbed back to blood. There is also secretion of
unwanted molecules (ions) from the peritubular capillaries to renal tubular
lumen. The renal corpuscle, which is composed of the glomerulus and the
Bowman’s capsules, is the initial filtering component of the nephron. The
figure was reproduced from Fox, S. I. 2011.
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Initially, plasma enters the nephron via afferent arterioles leading into the glomerulus (a tuft 
of capillaries), and is then filtered by the glomerular filtration barrier (GFB) which is composed of 
fenestrated endothelium,  glomerular basement membrane and podocytes (Figure 1.1). The filtrate 
enters Bowman’s capsule and subsequently undergoes serial reabsorption/secretion by the tubular 
epithelial cells and is then eliminated from the body in the form of urine. Water and small molecules 
are freely filtered through the GFB but large molecules such as albumin are believed to be virtually 
impermeable to the GFB (a very low glomerular sieving coefficient). The plasma exits the glomerulus 
via the efferent arteriole and then undergoes serial fluid exchange with the tubular components 
through peritubular capillaries [3]. 
In humans, albumin is the most abundant plasma protein at 40 µg/ml, and it accounts for 
55-60% of the measured serum protein (Figure 1.2). In humans, a tremendous workload is put on 
the kidney as close to 180 litres of primary urine is produced each day. Hence, the kidney is exposed 
to around 7 kg of albumin per day. However, in healthy individuals, only minimal amounts of 
albumin (<30 mg/day) are excreted in the urine [3]. 
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Figure 1.2: Albumin structure at physiological and acidic pH. Albumin has a
heart shaped structure at normal physiological pH and cigar shape in
expanded form at acidic pH [9]. Figure is reproduced from Peter, J.T. 1992.
 26 | P a g e  
1.1.3  Albumin 
Albumin is a 585 amino acid protein with molecular weight of ~ 66 kDa. It is synthesized by 
the liver and has a isoelectric point (pI) of about 5.6 (4.87 when carrying fatty acids) [3, 9]. The 
albumin molecule has three specific domains which are comprised of 9 loops that are stabilized by 8 
internal disulfide bonds. An albumin molecule can change from a globular heart shape (crystal form, 
80 x 30 Å) to ellipsoid (liquid form, 40 x 140 Å) depending upon physiological conditions and binding 
of ligands (Figure 1.2) [10].  
This great flexibility in conformation probably contributes to the physiological functions of 
albumin such as being a molecule transporter; maintaining oncotic pressure, acid base buffer 
functions, and antioxidant functions. The concentration of albumin in urine and serum is used as an 
important prognostic indicator in a range of diseases, including diabetic nephropathy and 
glomerulonephritis in which increased urine albumin excretion is an early clinical indication [11]. 
1.2 Kidney pathology 
Diabetes is a chronic illness that requires continuing medical care and patient self-
management. Diabetic nephropathy is a complication of the diabetic state and accounts for 40% of 
patients reaching ESRF. The presence of hyperglycaemia contributes to the kidney damage by 
activating various inflammatory pathways, generating reactive oxygen species, inducing production 
of pro-fibrotic factors such as TGF-1 leading collectively to podocyte injury, albuminuria, 
glomerulosclerosis and progressive loss of renal function. [11].  
Glomerulonephritis is a diverse group of non-diabetic diseases in which glomerular damage 
often leads to progressive tubulointerstitial damage and progression of ESRF. Immune-mediated 
mechanisms are common causes of glomerulonephritis [12]. There are various types of infection 
associated with glomerulonephritis, including bacterial, viral, fungal and protozoal organisms [12]. 
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Lipopolysaccharides (LPS) are known to trigger albuminuria in septic patients in intensive 
care units [13]. LPS also triggers albuminuria and transient kidney damage in mice [14]. LPS 
administration also triggers the production of pro-inflammatory cytokines such as interleukin (IL)-6, 
IL-12 and tumour necrosis factor alpha (TNF-alpha). There is a significant correlation between serum 
and urine TNF-alpha levels and proteinuria in patients with diabetic nephropathy [15]. Serum levels 
of TNF-alpha are 3-4 fold higher in type 2 diabetic patients compared to normal individuals [16-19].  
Defective albumin handling by the kidney is often one of the earliest signs of renal disease, 
making albuminuria (detection of albumin in urine) a hallmark of progressive renal disease. 
Albuminuria can be an hereditary (Pierson’s syndrome, corticosteroid-resistant nephrotic syndrome) 
or acquired condition, such as in diabetic nephropathy [20]. In healthy individuals, less than 30 mg of 
intact albumin is excreted in the urine per day. Microalbuminuria is defined as urinary excretion of 
30 to 300 mg albumin/day, while macroalbuminuria is defined as urinary excretion of >300mg 
albumin/day [21, 22]. However, 50% of patients with diabetic nephropathy will die of cardiovascular 
disease (CVD) before reaching ESRF. Microalbuminuria is also a major independent risk factor for 
cardiovascular events in both diabetic patients and in the general population [21, 23-25]. This well 
established association suggests a common mechanistic link between CVD and renal injury. 
Currently, the most popular theory that endothelial dysfunction is the common mechanism 
underlying both microalbuminuria and CVD is yet to be validated [23]. 
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1.2.1 The traditional view of albumin excretion in health and disease  
There are three major components contributing to the glomerular filtration barrier that 
prevents unbridled albumin flow into the urinary space; glomerular capillary endothelial cells, the 
glomerular basement membrane (GBM) and podocytes (Figure 1.3) [26]. The small amount of 
albumin filtered by the glomerulus is removed from the urinary space by endocytosis in the early 
proximal tubule via the megalin/cubilin scavenger receptor complex [27-29]. The endocytosed 
albumin is subsequently degraded into peptides within lysosomes, allowing only very small amounts 
of intact albumin to be excreted into the urine [30, 31]. There is strong evidence suggest that both 
glomerular injury and impairment of tubular uptake of filtered albumin contribute to the 
development of proteinuria [26, 28, 31-33]. 
Detection of albumin in urine by antibody-based assays combined with micropuncture 
studies in animals report very low albumin levels in the early glomerular filtrate (22.9 g/ml) [34], 
thus indicating a very low glomerular sieving coefficient (GSC) for albumin of 0.00062 [26]. As a 
corollary to this, microalbuminuria may arise through defects in tubular albumin endocytosis, while 
macroalbuminuria in kidney disease is attributed to increased passage of plasma albumin through a 
damaged glomerular filter. These postulates have received substantial support from genetic-based 
studies of human and experimental podocyte injury [30, 35, 36].  
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Figure 1.3: Overall view of the glomerular filtration barrier (GFB). The small
molecules are filtrate from plasma to Bowman’s capsule through GFB with
glomerular filtration rate (GFR) of 125 ml/min. The plasmas flow (Qp) in
nephron is 700 ml/min with albumin (Alb) concentration is hugely different on
both side of the GFB. The urine albumin is 4mg/L while the serum albumin is
40 g/L [18]. Figure is reproduced from Haraldsson, B. 2008
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1.2.1.1 Damaging the glomerular filtration barrier  
The GFB is one of the most complex biological membranes, with properties that allow for 
selective filtration of physiological molecules and waste. It is comprised of fenestrated endothelium, 
the glomerular basement membrane (GBM), and podocyte foot processes (Figure 1.3) [32]. Each of 
these component acts as an important factor in size and charge selectivity of physiological 
molecules. This selective barrier allows filtration of water, ions, and low molecular proteins, but is 
virtually impermeable to plasma albumin (reflecting a fractional clearance of plasma albumin of 
approximate of 0.0006) [26].  
A common first sign of renal injury is glomerular “leakage” of albumin molecules into the 
urine as identified by standard biochemical immunoassays [37]. The classical view of albuminuria 
involves an increasing amount of intact albumin crossing the GFB [32]. It is hypothesized that the 
increase in urinary excretion of intact, immune-reactive albumin that defines micro/ 
macroalbuminuria is due to a breakdown of one or more of the three components of the GFB 
leading to the glomerulus becoming “leaky” for plasma protein. In case of albuminuria, glomerular 
damage results in an increase in the GSC of albumin. Nephrotic syndrome describes a series of 
symptoms which includes urinary excretion of >3 g protein/day. [22].  
Morphological alterations in the structure of the GFB are often associated with the presence 
of proteinuria, suggesting a causal mechanism [26]. Various techniques have been employed to 
support this viewpoint such as micropuncture studies of single nephrons [34], in vivo urinalysis [38, 
39], the isolated perfused kidney or isolated components of the GFB [26]. However, all of techniques 
have their own limitation. For example, in micropuncture studies it is standard practice to exclude 
any high values for albumin concentrations in Bowman’s capsule as being due to contamination [25] 
[40]. Urinalysis in vivo could bypass the extensive reabsorption of nephron with bio-molecules. We 
will discuss further how these techniques interlace with data suggesting cause of albuminuria below.  
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1.2.1.2 The podocyte  
Podocytes are specialized, highly differentiated cells which have a large cell body and long 
cytoplasmic foot processes. These foot processes are separated by filtration slits (25-60nm wide) 
which are exposed to the Bowman’s capsule and primary urine [41] . Using cationic dyes, the 
filtration slit has been shown to contain negatively charged molecules such as glycosaminoglycans 
and sialyzated glycoconjugates [42]. The filtration slit has a pore-like structure which is estimated to 
be 40 x 140 Å [43], corresponding to a slit half-width of 20 Å. High resolution electron-tomographic 
methods suggest that the slit diaphragm contains convoluted strands that cross the midline of the 
filtration slit forming zipper-like sheets, with pores that have a similar diameter to albumin 
molecules located on both sides of the central density [44]. Immuno-electron microscopy and 
electron tomography together support the zipper-like sheets structure as IgG1 and IgG2 motifs of 
the nephron shown to be in the central region of the slit diaphragm [45]. Base on a calculated 
Stokes-Einstein radius, an albumin molecule of 36 Å cannot pass through these filtration slit, except 
in rare case such as “large pores” or shunt pathways [26]. During the last decade, a series of proteins 
have been identified that contribute to the structure of the podocyte slit diaphragm which restricts 
passage of filtered macromolecules. 
Nephrin was the first slit-diaphragm protein to be identified. Nephrin is expressed in brain, 
pancreases and the podocytes of the kidney [43, 45, 46] (Figure 1.4). Inactivation of nephrin gene 
causes the absence of the slit diaphragm, massive proteinuria and neonatal death in mouse [47]. 
Mutation of the nephrin gene causes massive leakage of plasma proteins and severe consequences 
as observed in the congenital nephritic syndrome of the Finnish type [45, 48]. Nephrin has a short 
intracellular domain, a transmembrane domain and eight distal IgG-like motifs in its extracellular 
domain. There is one proximal fibronectin type II-like motif connecting the transmembrane and 
extracellular domain (Figure 1.3) [20, 43, 48].  
The proteins Neph1 and Neph2 are also found throughout the body besides the slit 
diaphragm of podocyte [49-52]. They belong to the filtrin family of transmembrane proteins and are 
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structurally related to nephrin [49-51]. Both Neph1 and Neph2 have 5 extracellular IgG-like motifs 
(Figure 1.3C) and can form heterodimers with nephrin through their extracellular domains but do 
not interact with each other [50]. Neph1 is critical for podocyte function as Neph1 deficient mice 
have proteinuria and die within first eight weeks of life [52]. In addition, Neph2 was also shown to be 
important for podocyte development as knockdown of Neph2 result in loss of slit diaphragm, 
disrupted podocytes ultrastructure with foot process effacement [53]. 
Podocin is a hairpin-shaped integral membrane protein with intracellular N and C terminals 
which is located solely in the slit-diaphragm region [54, 55]. It was first discovered by positional 
cloning of the gene mutated in corticosteroid-resistant congenital nephritic syndrome (NPHS2) [55, 
56]. Podocin forms a complex with nephrin, Neph1 and CD2-associated protein (CD2AP) [52, 57]. It is 
a critical protein for survival, as podocin-knock out mice develop severe proteinuria and die shortly 
after birth [56].  
Initially characterized as the T-lymphocyte CD2 adapter protein, CD2AP-intracellular protein- 
is also found located in the podocyte slit-diaphragm region [58]. CD2AP is involved with endocyosis 
and slit-diaphragm signalling as well as interacting with podocin. Most CD2AP knock-out mice 
develop lethal nephrotic syndrome-like disease and die by 6 to 7 weeks of age [58]. Polymorphisms 
in the human gene are associated with the development of kidney disease (glomerulonephritis and 
glomerulosclerosis) [59] suggesting that dysfunction of CD2AP results in susceptibility to 
glomerulonephritis. 
FAT1 and FAT2 (FAT tumour suppressor homolog 1 and 2 (Drosophila)) are also important 
components of the slit-diaphragm [60]. Both are transmembrane proteins which have 34 
extracellular tandem cadherin-like repeats, 5 epidermal growth factor (EGF)-like repeats and a 
laminin A-G domain [60-62]. In foetal development, FATs are predominantly expressed in epithelial 
cell layers and in the central nervous system and some endothelial and smooth muscle cells. In adult, 
expression of the FATs is most prominent in the kidney, especially in podocytes [61] [62]. Deletion of 
FAT1 and FAT2 in mice causes severe effects. FAT1 knock-out mice display loss of the slit diaphragm 
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leading to proteinuria, it also causes defects in forebrain ocular region and perinatal death [62]. 
Absence of FAT2 in mice causes mild proteinuria [20].  
There are other protein constituents of the slit diaphragm such as ZO-1- intracellular protein 
associated with epithelial tight junction [63], densin and MAGI-1 (Membrane-associated guanylate 
kinase) cadherins, p120 catenin, calcium calmodulin-dependent serine protein kinase (CASK). The 
role of these proteins in the slit diaphragm remains unclear and requires further investigation.  
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Figure 1.4: Nephrin structure and hypothetical homophilic interaction in the slit
diaphragm. Nephrin (A) has a short intracellular domain and transmembrane domain
(TM). Nephrin also has an extracellular domain of proximal fibronectin type III-like
motif (FN) and eights IgG-like motifs. Both Neph1 and neph2 of filtrin family of
transmembrane protein (B) have extracellular membrane domain consisting of 5 IgG-
like motifs. FAT1 and FAT2 (C) have long Cadherin-like motif in extracellular domain
and a short intracellular domain. Podocin (D) is an integral membrane protein which
has only intracellular domain [12]. Figure is reproduced from Haraldsson, B. 2008
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1.2.1.3 Glomerular basement membrane 
The GBM is an acellular matrix that is composed primarily of 2 main proteins; type IV 
collagen (collagen α1, α2 in fetus and α3, α4, α5 in adult) [64-66] and laminin (mainly laminin 11; 
α5βγ1) [64] [66].  Unlike other collagens, collagen IV is only found in basal laminar/basement 
membranes and comprises up to six genetically distinct chains (α1 to α6) [67]. Laminin is a large, 
heterotrimeric protein which is involved in cellular differentiation, adhesion and structural function. 
Other proteins such as nidogen/entactin, proteoglycans (agrin and perlecan) and glycoproteins also 
help in creating the highly fibrous matrix structure [26] which provides tensile strength to the GBM, 
but additional components are required to maintain glomerular permselectivity as in vitro studies 
have shown [68].  
Using electron-microscopy, heparan sulphate and chondroitin sulphate side chains of 
perlecan/agrin have been identified as anionic sites in the GBM which were initially believed to be 
important for filtration as reduction or removal of these sites using glycosaminoglycan-degrading 
enzyme results in proteinuria [68]. However, glycosaminoglycan-degrading enzymes can remove 
glycosaminoglycans from all three layers of the GFB, and so further studies are needed to delineate 
the role of these charged molecules in each component of the GFB. All of these components result in 
a glomerular basement membrane which is much thicker (240 – 370 nm) than basement membranes 
in most other vascular beds (40-80 nm) [69]. 
Alport’s syndrome involves mutations in collagen IV chains and can give rise to severe 
haematuria and mild proteinuria, hence confirming collagen IV as a critical component of the GBM 
[65-67, 70, 71]. Pierson’s syndrome is a lethal form of congenital nephritic syndrome which involves 
mutations in the laminin gene giving rise to proteinuria and neonatal death [64, 72]. Ficoll is a 
neutral, highly branched, hydrophilic polysaccharide which behaves as rigid hydrated sphere [26]. 
Ficoll seems to be closest to the “ideal” solute for the study of glomerular permeability. The ideal 
solute should be solid inert sphere that is not taken up by cells, is not metabolized, has a well- 
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defined net charge, and does not undergo distortion of its 3D structure [26]. Based on Ficoll probes 
(inert and negatively charged), isolated GBM was shown not to be a major component of charge 
selectivity as there is no difference between the sieving curves of negative and neutral Ficolls [73]. 
Despite these finding, the GBM is still an important part of GFB, since it accounts for most of the 
restriction of the fluid flux [74]. 
1.2.1.4 Fenestrated endothelium 
Glomerular endothelial cells appear flattened being 50-150nm in height around capillary 
loops. Capillaries with continuous endothelium are found commonly in skeletal muscle, cardiac 
muscle and skin [69] but only glomerular capillaries have large fenestration constituting 20-50% of 
the entire endothelial surface [75]. Fenestrae are large (~60nm in diameter) so that without a visible 
diaphragm, they do not appear to constitute a significant physical barrier to macromolecules in 
plasma  [76]. Recent evidences suggest fenestrated glomerular endothelium may have a direct role 
in determining protein sieving as the endothelial cell surface layer (ESL) has been proposed to 
contribute to charge selectivity [77, 78]. A highly negatively charged plasma-membrane-bound 
glycocalyx coat is a major component of the ESL which is found on the luminal surface of the 
endothelium, and may contribute to charge selectivity of the GFB [77, 78]. The glycocalyx layer is 
also suggested to act as plugs for the fenestrae [79].  
The glycocalyx is easily destroyed in the standard fixation conditions used for histological 
analysis of tissue samples [77] making it difficult to properly analyse the components/structure of 
the glycocalyx coat. Indeed, specific fixation techniques are required to investigate this structure. 
Primary glomerular endothelial cells are difficult to culture and do not form a complex glycocalyx 
making the study of this structure problematic. There is agreement between studies that the ESL is a 
thick, negative charged structure contributing to the permselectivity of the glomerular filtration 
barrier.  
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1.2.1.5 Other components supporting glomerular filtration 
The mesangium (mesangial cells and extracellular matrix) contributes to the structure and 
function of the glomerular filtration barrier. Due to the contractile properties of mesangial cells, 
their contribution to the permselectivity is probably small and may only involve regulation of 
glomerular distensibility in response to pressure [80-82]. Secreted by mesangial cells, transforming 
growth factor (TGF)-β stimulates proteoglycan synthesis in both podocytes and mesangial cells. The 
mesangial cell can produce matrix proteins which are thought to form a scaffold for glomerular 
capillaries. The mesangial matrix has similar components to those in the GBM including collagen, 
laminin, fibronectin and proteoglycans with both heparan sulphate and chondroitin sulphate chains 
[1] [42, 80, 83, 84].  
1.2.2 Impairment of tubular re-uptake mechanism  
Receptor mediated albumin endocytosis in proximal tubular cells has been an established 
paradigm for the last 40 years [85, 86] (Figure 1.5). This concept is supported by the findings that 
proteinuria may take place independent of which layer of GFB is damaged [87]. As a well-established 
concept, the two mechanism involved in the uptake of filtered albumin by proximal tubular cells in 
the kidney are the nonspecific fluid-phase endocytosis and receptor mediated endocytosis [88]. The 
key components of the multi-ligand receptor complex involved in the tubular uptake of albumin by 
proximal tubular epithelial cells are megalin and cubilin (Figure 1.5) [27, 28, 89-92]. Megalin and 
cubilin mediated uptake of albumin has been demonstrated by in vivo [89] and in vitro [28, 89] 
studies. These receptors are thought to be responsible for the constitutive uptake of the majority of 
filtered plasma proteins and located in the apical membrane of proximal tubular cells. This complex 
structure is internalized by invagination of the plasma membrane [93-95]. The invaginations are 
dissociated from the plasma membrane to form intracellular vesicles which fuse with other newly 
formed vesicles or with an existing pool of larger vesicles. Following fusion of two vesicles, the 
acidification of the intra-vesicular lumen and the dissociation of ligands from the receptor occurs 
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[96]. The ligand may be conveyed into lysosomes for storage or degradation, or into the cytosol for 
further processing/transport. Dense apical tubules containing vacuolar apparatus are involved in 
endocytosis, and the receptor is recycled back to luminal membranes [96]. 
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Figure 1.5: The structure of megalin and cubilin. The cubilin is a protein made
up mostly by CUB domain while megalin is transmembrane protein consisted
of different domain such as complement-type and EGF-type repeat, YWTD
and cytosolic motif of NPXY and VENGNY. The amnionless is transmembrane
protein. A complex of amnionless and cubilin forms the cubam receptor [26-
28]. Figure is reproduced from Christensen, E.I. 2009.
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1.2.2.1 Megalin 
First discovered as an antigen in Heymann nephritis (a rat model of membranous 
glomerulonephritis) [97], megalin is expressed at high levels in the brush border and the luminal 
endocytic apparatus of the kidney proximal tubule as well as in other extra-renal absorptive epithelia 
such as the ileum and the rodent yolk sac [90, 98]. Electron microscopic immunogold double 
labelling of rat yolk sac and renal proximal tubules show subcellular localization of albumin with the 
endocytic receptor megalin [27]. Lysosomal structures also display small amounts of megalin based 
on immunohistochemistry studies [99]. Megalin is a large multifunctional, multi-ligand endocytic 
receptor (4600 amino acid ~ 517 kDa) belonging to the low density lipoprotein receptor family. Most 
ligand binding to megalin is Ca2+ dependent [100]. It has a large extracellular domain (4400 amino 
acids) with the ligand-binding site containing four cysteine-rich clusters of low density lipoprotein 
receptor type A repeats which are each separated and followed by total of 17 epidermal growth 
factor (EGF)-type repeats and eight spacer regions containing YWTD repeats [90, 98, 101]. Megalin 
has a single transmembrane domain consisting of 22 amino acids. The short C-terminal cytoplasmic 
tail (213 amino acids) contain two intracellular motifs such as NPXY domains and one VENQNY 
domain which are responsible for mediating the binding to adaptor proteins and clustering into 
clathrin-coated pits [98].  
Megalin-deficient mice exhibit significant ultrastructural changes in the development of the 
endocytic apparatus in proximal tubules cells.  Megalin-deficient proximal tubule cells have a 
decrease in coated pits, endosomes, dense apical tubules, and lysosomes [91]. Interestingly, 
megalin-deficient mice display no significant changes in transport of water, electrolytes, glucose or 
amino acids but exhibit mild proteinuria featuring several low-molecular weight serums protein [28, 
91]. Dent’s disease, caused by a mutation in renal chloride channels CIC-5, leads to a decrease in 
renal megalin expression and severe proteinuria [102]. 
 42 | P a g e  
1.2.2.2 Cubilin 
Cubilin is also known as intrinsic factor vitamin B12 receptor (IF-B12) or high-density 
lipoprotein (HDL) and Apo lipoprotein A-I. Cubilin is a large multi-ligand, endocytic receptor (3600 
amino acid; 460 kDa) expressed in the renal proximal tubule brush-border and forms a part of the 
endocytic apparatus. Cubilin is also detected in lysosomes by immunohistochemistry [103]. Cubilin 
has a distinct structure compared to other known endocytic receptors [31].  Anchoring to the 
membrane is cubilin’s first domain (110 amino acids) then eight EFG-like repeats and 27 
complement subcomponents Clr/Cls, Uegf and bone morphogenic protein-1 (CUB) domains. The 
ability of cubilin to bind to a variety of ligands such as IF-B12 and receptor-associated protein (RAP) 
is mediated by the intracellular CUB domains [104]. Cubilin also binds to megalin through the N-
terminal region CUB domain 1 and 2 [105]. The albumin binding site is located in the EGF-type 
repeats (113 amino acids) [106]. Cubilin is released from renal cortical membranes by non-enzymatic 
and non-solubilising procedures, consistent with the observation that cubilin does not have a 
transmembrane domain [104, 107, 108]. 
The protein amnionless (AMN) is a middle-sized transmembrane protein (45kDa). AMN and 
cubilin are co-localized in the kidney proximal tubule [29]. The AMN protein is not only needed for 
cubilin expression but is also required for normal translocation of the cubilin-AMN complex from the 
ER to the plasma membrane and for subsequent endocytosis [108, 109]. Dysfunction of the AMN 
gene result in defective apical expression of cubilin, leading to a decrease of tubular endocytosis of 
albumin and an increase of urinary albumin excretion [29, 109].  Cubilin or AMN deficient animal 
models show obvious signs of proteinuria [110]. Inhibition of albumin uptake in possum kidney (OK) 
cells can be achieved by introduction of intrinsic factor (IF)-B12 and anti-cubilin antibodies [89]. The 
inhibitory constant for IF-B12 is consistent with finding that both IF-B12 and albumin may bind to the 
same 113 residue amino terminus of cubilin. However, in humans a nucleotide deletion in the AMN 
gene produces an immature AMN protein which leads to proteinuria suggesting the role of cubilin in 
renal tubular protein reabsorption [111, 112]. 
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1.2.2.3 The endocytic complex 
Binding between cubilin to megalin has been demonstrated using chromatography methods 
[107, 113]. In addition, uptake of cubilin ligands transferrin, Clara cell secretory protein and Apo 
lipoprotein A-I/ high-density lipoprotein is inhibited by anti-megalin antibodies [114-116] or megalin 
antisense oligonucleotides [117]. These findings suggest megalin may facilitate the endocytosis and 
intracellular trafficking of cubilin [89]. The endocytic complexes transfer albumin to lysosomes 
resulting in proteolytic degradation [89, 118] (Figure 1.6). 
Endocytosis of albumin is not just regulated by the megalin/cubilin complex but also by 
other membrane proteins. Animal models and human studies show that the Na+-H+ exchanger 
isoform 3 (NHE3), the chloride channel CIC-5 and the vacuolar hydrogen ATPase (V-H+-ATPase) are 
also involved in the albumin endocytic complex [102, 119, 120]. NHE3-deficient proximal tubule cells 
show reduced albumin uptake [121]. NHE3 knockout mice develop proteinuria [119]. NHE3 is 
proposed to initiate early endosomal acidification [121]. Albumin uptake can be reduced by silencing 
Na+-H+ exchange regulatory factors (NHERF2) which bind to C-terminus of CIC-5 to anchor NHE3 in 
the microvillus membrane [120]. Initially, CIC-5 was found to act as an endosomal anion shunt to 
neutralize the movement of protons during vesicle acidification but, more recently, it has been 
identified as a Cl--H+ anti-porter rather than an ion channel [102, 119, 122]. Hence, role of CIC-5 as 
anion shunt should be investigated further. V-H+-ATPase is identified as scaffolding protein recruiting 
small GTPases to the endosome in an acidification-dependent process which may play a key role in 
protein trafficking in the proximal tubule degradation pathway.  
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Figure 1.6: Uptake of albumin by the megalin/cubilin complex.  Initially, the 
albumin was filtered through glomerulus into renal lumen containing proximal 
tubular cells. Then megalin/cubilin/amnionless  receptor complex binds to 
albumin and undergone  endocytic invaginations to  transfer the albumin into 
cytoplasm of tubular proximal cells.  The amino acid and fragments from 
degradation of albumin by lysosome was either transferred back to renal tubule 
to be excreted or reabsorbed back into blood stream. The dense apical tubules 
was responsible for the excretion of albumin fragments into renal tubule [26-
30,95]. Figure is reproduced from Birn, H. 2006.
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1.3 Development of new technology in detection of albuminuria leads to 
new point of view of albuminuria mechanism 
The glomerular sieving coefficient of albumin – the ratio of  concentration of albumin in 
Bowman’s space and systemic plasma [33] - is still a controversial issue as substantially different 
values have been reported using a range of invasive and non-invasive techniques to measure the 
GSC of albumin in vivo and in vitro.  
The classical view of glomerular albumin filtration is based on a very low GSC which has been 
reported using several different methods. Micropuncture studies in rats report a GSC of 0.0006 for 
albumin [34], finding that the albumin concentration in the ultra-filtrate ranges between 1-50 µg/ml 
which is equivalent to 0.17 – 9 g/24h of filtered albumin to which tubules are exposed to in healthy 
humans. However, micropuncture is a very challenging technique and the issue of the justification 
for deleting all high readings of albumin concentrations in Bowman’s space remains a point of 
contention [34]. In addition, this technique does not account the reabsorption of proximal tubular 
cells.  
Standard biochemical assays indicate that only small amounts (>30mg) of albumin are 
excreted in normal human urine per day. These assays rely upon antibody-based detection methods 
(ELISA, RIA, immunonephelometry, immunoturbidity) which only detect the intact albumin molecule 
[123]. Therefore, the presence of any small albumin peptide fragments would not be identified by 
these widely used assays. Even some standard dye-based protein assays are relatively inefficient in 
detecting small peptides (e.g. benzethonium chloride, Coomassie blue assays) [124]. Thus, different 
approaches are needed for investigation of degraded forms of albumin in urine in order to measure 
total urinary albumin excretion rather than just excretion of intact albumin.  
The use of radio and fluorescent labelled albumin molecules has challenged the convention 
view of glomerular albumin filtration [125]. The use of radiolabelled albumin probes found that 
much larger amounts of total albumin are excreted in the urine of normal rats, mice and humans 
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than previously thought. This was attributed to the presence of significant amounts of very small 
peptides (<750 Da) derived from tubular lysosomal degradation of filtered albumin [9-13]. These 
small albumin-derived peptides are not detected by conventional assays and are routinely removed 
before urinary proteomic analysis. In diabetes, this degradation process is partially impaired so that 
urinary excretion of higher molecular weight albumin peptides occurs, and this is apparent before an 
increase in excretion of intact, immuno-reactive albumin is seen [9, 14], thereby presenting an 
opportunity for earlier diagnosis.  
One apparent anomaly in the classical albuminuria model is that synthetic molecules of the 
same hydrodynamic radius as albumin (36Å) have much higher GSC of 0.02 to 0.1 in humans and 
rodents respectively [126-129]. Indeed, there is good agreement between different labs as to the 
GSC of albumin sized synthetic probes [126-129]. The synthetic molecule is filtered by glomeruli and 
excreted in the urine at much higher levels than albumin. This approximately 100-fold difference in 
GSC has been accounted for by the theory of “charge selectivity”. This theory is based on the 
surface-negative charge of the albumin protein being repelled by negatively charged 
glycosaminogylcans on the surface of glomerular endothelial cells and within the GBM [22, 130, 
131]. 
1.3.1 Is albumin excreted in normal urine in an intact or degraded form? 
It is widely accepted that proximal tubular cells endocytose filtered albumin via the 
megalin/cubilin scavenger receptor complex with resultant lysosomal degradation of albumin [27, 
28, 89]. In study using cultures of intact rabbit nephrons, it was found that tubular degradation of 
albumin results in the release of amino acids to the basolateral side, presumably for recovery to the 
circulation [132]. The polarised proximal tubular cells also secrete heavily degraded albumin 
fragments via both luminal and basolateral surfaces in polarized proximal tubular cells a ratio of 1:2, 
respectively [133]. This suggests the tubular albumin degradation can potentially result in urinary 
excretion of small peptides and amino acids into the urine. 
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 The question of whether the majority of albumin is excreted in the urine as small peptides 
following proteolytic degradation in the proximal tubule raises several important issues. If the 
assumption is true, this would need a re-assessment of total albumin excretion with major 
implications for estimating what proportion of plasma albumin is filtered by the glomerulus. 
Secondly, the measurement of the relative proportion of intact 67 kDa albumin versus albumin 
peptide fragments may provide significant insights into pathogenic mechanisms of albuminuria. 
1.3.1.1 Evidence in support of albumin degradation during renal passage 
As clinical assays of urinary albumin do not measure albumin fragments, the measurement 
has been a subject for debates by researchers around the world. A series of studies have identified 
the presence of small albumin peptides (300-500 Da) in normal urine in mice, rats and humans [134]. 
In addition, proteolytic degradation of albumin probes during renal passage has been shown in the 
ex vivo setting of the isolated perfused kidney in which extra-renal albumin degradation can be 
eliminated [135]. Furthermore, use of the Biuret chromagen assay to detect peptide bonds identifies 
a large amount of low molecular weight material in normal urine [124]. This is consistent with the 
proposed excretion of substantial amounts of heavily degraded albumin peptides [124]. 
The data argue that most of the albumin in normal urine is excreted as small peptides 
generated by the proteolytic degradation of glomerular filtered albumin. The implication of these 
findings is that a much larger amount of albumin is excreted in normal urine than that identified 
using standard antibody-based assays, with total urinary albumin in healthy humans measured as 1-
2 g/day on this basis.  
This albumin degradation could occur at any point in the nephron after the glomerular 
capillary wall. Although podocytes can endocytose albumin (via the histocompatibility complex-
related Fc receptor - FcRn) and potentially degrade albumin, it is logical to consider that uptake and 
degradation of glomerular filtered albumin primarily occurs in the early proximal tubule which have 
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the megalin/cubilin scavenger receptor complex that can bind and endocytose albumin rapidly and 
with high affinity [28, 89, 91, 114, 136, 137]. 
These studies have in large part relied upon the use of post-translational radiolabelled 
albumin probes, with small radiolabelled peptide fragments detected in urine. As controls, these 
studies used size exclusion chromatography to ensure removal of unbound label from the albumin 
probe, and established that these small fragments in urine were peptides based upon their change in 
size upon degradation by the protease trypsin [134]. No extra-renal albumin degradation was 
detected in these studies, except for when the albumin probes were denatured during the labelling 
procedure, and in this setting albumin fragments were readily detectable in blood and very high 
fractional clearance of the albumin probe was evident [138]. This identifies a major limitation in the 
use of albumin probes with very high degrees of chemical labelling (i.e. where a large number of the 
surface lysine residues are conjugated). 
An interesting observation is that the urinary albumin excretion profile changes from being 
that of a predominantly degraded form in normal urine to being largely intact in animal models with 
heavy proteinuria [123, 135]. Thus, in the setting of heavy albuminuria, estimates of total urinary 
albumin excretion using radiolabelled albumin probes become closer to the values obtained with 
antibody-based assays detecting intact urinary albumin. This finding has several implications. First, it 
argues that the increase in total urinary albumin excretion in kidney disease is 10-12 fold, compared 
to the 1000-fold increase seen when relying upon antibody-based albumin assays. Second, it argues 
that the biggest change in urinary albumin excretion relates to albumin proteolytic degradation 
during renal passage rather than the absolute amounts excreted. This suggests alternative 
mechanisms other than an increase in the passage of albumin through the damaged glomerular 
capillary wall make a substantial contribution to the albuminuria observed clinically. Third, the lack 
of albumin degradation products in the urine of animals with different types of experimental kidney 
disease argues that extra-renal degradation is unlikely to account for the albumin degradation 
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fragments seen in normal urine since this would not be expected to be altered in organ specific 
models of kidney disease.  
1.3.1.2 Evidence against albumin degradation during renal passage 
The data on urinary excretion of small albumin peptides have been challenged on a number 
of fronts. Mass spectroscopy analysis found that the major form of albumin excreted in urine is the 
full length protein, with 22 mg/day excretion of total urinary peptides of 750 to 10,000 Da [139]. The 
analysis of fractions with molecular weight smaller than 750 Da failed to detect sequences 
corresponding to plasma proteins [139]. This study also failed to show any marked increase in 
urinary albumin excretion in patients with Fanconi syndrome in which reuptake of filtered proteins 
by the proximal tubule is impaired [139].  
A recent study by Christensen’s group has also challenged the concept that filtered albumin 
is degraded into small peptides by proximal tubular cells that are then excreted into the urine [140]. 
They used a mouse model in which conditional knock-out of megalin and/or cubilin in proximal 
tubular cells avoided problems of neonatal lethality in global gene KO mice. Using a dye-quenched 
albumin probe (DQ-albumin), they showed that proximal tubular cells lacking megalin and cubilin do 
not exhibit albumin degradation which is readily visualised in proximal tubules in normal mice. In the 
same study, a very high specific activity 125I-albumin probe was injected into normal mice; 
subsequently a very large amount of low molecular weight material was seen in the urine. However, 
this result was unchanged in mice lacking megalin/cubilin in proximal tubular cell. But there was a 
reduction in the uptake of labelled albumin within the kidney. This suggests that degradation of the 
albumin probe occurs outside of the kidney, and a very small amount of low molecular weight 
labelled material was detected in the plasma of these mice [140].  
In addition, the specificity of the Biuret assay for peptide bonds has been questioned. There 
are data indicating that other small molecules may also be detected such as single amino acids; urea 
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and creatinine which is argued to account for the large amount of low molecular weight material in 
normal urine detected using the Biuret assay [141].  
These results provide a strong argument that the low molecular weight albumin fragments 
found in urine are derived from extra-renal albumin degradation, with these albumins fragments 
being readily filtered by the glomerulus. The data are clearly at odds with the evidence supporting 
the albumin degradation during renal passage using radiolabelled albumin. This suggests that either 
the small urinary albumin peptides identified using radiolabelled albumin probes is not reflective of 
normal physiology (i.e. the labelled probe is handled differently to normal albumin, possibly by 
extra-renal degradation), or these very small albumin peptides (300-500 Da) are modified by the 
urine environment making them difficult to identify. However, the potential confounding issue in 
Christensen’s study also needs to be addressed – whether there was significant denaturation of the 
high specific activity 125I-albumin probe which could account for this result [138]. 
1.3.1.3 Visualisation of proximal tubule uptake and degradation of fluorescent-labelled 
albumin probes  
An exciting new area is the use of fluorescent-labelled albumin (DQ albumin, Texas red 
albumin) together with advances in fluorescent microscopy imaging techniques, allowing the direct 
visualise of albumin uptake and degradation by proximal tubular cells [142]. Fluorescent-labelled 
albumin given by intravenous injection is rapidly taken up by proximal tubular cells in what appear to 
be lysosomes [142]. The very fact that this uptake is so readily detectable is surprising if there is very 
limited glomerular filtration of plasma albumin. In addition, the injection of DQ-albumin that only 
fluoresces after proteolytic degradation can be used to visualise albumin degradation within 
proximal tubular cells, as illustrated in Figure 1.7 [142]. 
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Figure 1.7: Degradation of DQRed-BSA within proximal tubular cells. The
degradation remove auto-quenching thus emitting bright red colour under
microscope. The fluorescence of DQRed-albumin was predominantly at the
basolateral domain of the proximal tubules [141]. Figure is reproduced from
Slattery, C. 2008.
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1.3.1.4 What is the glomerular sieving coefficient for albumin?  
A second related question is what proportion of plasma albumin that circulates through the 
glomerular capillaries is actually filtered to enter Bowman’s space. The textbook description of this 
process is provided by micropuncture studies of Munich-Wistar rats which have surface glomeruli 
and provides a GSC of 0.0006 [34]. Other estimates in humans have a GSC for albumin of 0.0001 
[143]. However, new techniques have questioned this value. 
1.3.1.4.1 2-photon microscopy studies in support of a high albumin GSC  
A provocative study was published in 2007 by Russo in which real time imaging using 2-
photon microscopy measured the GSC of albumin as 0.02 to 0.04, which is around 50 times higher 
than that measured by micropuncture studies [34, 125]. This led to heated debates in the literature 
and at scientific meetings. These findings not only conflicted with the conventional view of albumin 
filtration, but these data required some form of retrieval of glomerular filtered albumin back to the 
blood to prevent nephrotic levels of urinary albumin excretion [125, 144-146]. This paper provided 
both fluorescent microscopy and electron microscopy images to support such a retrieval pathway, 
which has been postulated from previous studies with radiolabelled probes – although this postulate 
receives overwhelming criticism in the field [87]. 
There are several possible mechanisms for albumin transcytosis across the proximal tubular 
cells which do not involve the megalin/cubilin scavenger receptor complex and lysosomal-base 
degradation. The concept of albumin transcytosis by epithelial cells is not unique to the kidney. 
Similar mechanisms have been described in the lung in which intact albumin can undergo 
transcytosis through the epithelial layer to be returned to the circulation [147]. However, the 
molecular mechanisms of this process remain to be fully elucidated. In addition, bidirectional 
transcytosis of intact IgG via the neonatal FcRn in a vesicular compartment has been described in 
proximal tubular cells [148]. Furthermore, fluid phase pinocytosis has also been described in 
proximal tubular cells in a luminal to basolateral direction involving endocytic vesicles [149].  
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In a second study, Russo et al [150] examined rat diabetic nephropathy using both 2-photon 
microscopy and conventional radiolabelled albumin probes. These distinct methods gave good 
agreement on the accepted GSC of 0.025 for 69 kDa dextran. The use of posttranslational 
radiolabelled 14C-albumin identified an increased in urinary excretion of highly degraded albumin in 
diabetes without any change in the albumin or dextran GSC as measured by 2-photon microscopy 
[150]. 
One potential limitation of this methodology is that the 2-photon imaging technique does 
not identify the molecular weight of the fluorescent signal [125, 151, 152]. As discussed above, it is 
possible that fluorescent-labelled albumin could undergo extra-renal degradation prior to rapid 
glomerular filtration. It cannot be known for certain that the large majority of the fluorescent signal 
in Bowman’s space is due to intact albumin [27, 28, 89]. Hence the intact/degraded nature of the 
fluorescent albumin probe cannot easily be distinguished by this technique. However, since the 
megalin/cubilin complex binds intact rather than highly degraded albumin [27, 28, 117], then the 
large amount of fluorescent-labelled albumin observed to be rapidly taken up by proximal tubular 
cells indicates that there is substantial filtration of intact albumin. Finally, the finding that diabetic 
rats show a 2-fold increase in urinary excretion of heavily degraded fragments of 14C-albumin 
without any change in the albumin GSC supports the proposition that fluorescent-albumin is filtered 
in an intact form [153].  
1.3.1.4.2 2-photon microscopy studies with the opposite findings of a low albumin GSC  
A flurry of letters argued that the Russo et al study [125] must be flawed [151, 152, 154]. 
Using the same source of Munchin-Wistar rats as the Russo paper, Tanner and colleagues identified 
a GSC for albumin of 0.004 in an independent 2-photon imaging study [125, 152]. They suggested 
that technical issues such as low glomerular filtration rate, out-of-focus fluorescent, and high laser 
output may have contributed to the high GSC found by Russo et al [125, 152]. In addition, a study by 
Peti-Peterdi found the GSC for 70 kDa dextran to be lower than 0.004 using 2-photon microscopy, 
which also questioned the Russo et al data [125, 151]. However, it should be pointed out that the 
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GSC for albumin-sized radiolabelled dextran probes is well accepted to be 0.02 to 0.1 based upon 
radiolabelled dextran probes [155]. 
Molitoris and colleagues have recently published a study in which they have systemically 
addressed these criticisms of their 2-photon microscopy technique [154]. This study used two 
different rat strains, Simonsen Munich Wistar (SMW) rats and Frömter Munich Wistar (FMW). Their 
systematic analysis identified that the depth of field, fluorophore selection, and detector sensitivity 
affected the ability to correctly quantify glomerular albumin permeability. In addition, red blood cell 
crowding, out-of-focus fluorescent and having a normal glomerular filtration rate were shown not to 
be a factor in the measurement of the albumin GSC [154]. Notable findings were the 3.5-fold 
difference in albumin GSC between the two rat strains, and that a fasted state reduced the albumin 
GSC in both rat strains. Perhaps most importantly, and controversially, this study provides more 
imaging-based data to support transcytosis of albumin across proximal tubular cells with a presumed 
return to the circulation.  
Currently, there is no obvious alternative to using fluorescent-labelled probes to visualise 
glomerular albuminuria sieving. However, it would be reassuring to compare these fluorescent 
probes to a radiolabelled native albumin probe to establish that they have equivalent plasma half-
lives, and similar urinary excretion profiles of intact and degraded forms – and how this changes in 
proteinuric disease.  
1.4 Rationale for the work in this thesis 
1.4.1 A pressing need for well validated native albumin probes 
What is evident from reading the literature in this field is that the nature of probes used to 
study albumin filtration and handling is problematic. All albumin probes used in animals and human 
studies over the past 40 years have relied upon chemical modification of charged amino acid side-
chains with fluorescent or radioactive probes, and the use of labelled synthetic materials such as 
Ficoll and dextran [32]. Most albumin probes are labelled by chemical modification of surface lysine 
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residues, resulting in around 6 to 12 labels per albumin molecule. This low labelling efficiency 
significantly restricts the number of albumin breakdown peptides that will contain a label [32]. 
Furthermore, the question arises as to whether albumin probes with covalent modification 
still behave as normal albumin. Theoretically, the modified albumin molecule can exhibit discrete 
changes in surface charge and tertiary structure which may, in turn, have subtle effects on the 
hydrodynamic radius, interactions with charged carbohydrates, cell surface albumin receptors and 
recognition by specific proteases [26]. 
In addition, the denaturation of modified albumin leads to its rapid extra-renal degradation 
and urine excretion of peptides [138]. We are now very aware of how glycation can result in the 
uptake and degradation of a wide range of proteins by receptors for advanced glycation end-
products (AGE) [156]. Are labelled albumin probes likewise recognised by scavenger receptors – 
both within the kidney (megalin/cubilin) - and without? Indeed, it is well described that increasing 
the degree of glycation of proteins such as albumin results in a decreased circulating half-life, 
suggesting increased recognition and degradation by scavenger receptors [157]. 
Although these effects may not be significant in terms of some of the parameters measured 
by these probes, the current debates around renal albumin handling rely very much on issues of 
shape, size, surface charge and binding to receptors and other proteins [78, 158-160]. As such, a 
definitive statement on any changes in the biophysical properties of labelled albumin and the 
development of alternative probes to eliminate these potential issues is a priority in this area of 
research. Since labelling is required to follow the fate of any injected albumin preparation, 
researchers do not have much choice. Therefore, better probes need to be developing to fully 
analyse how the nephron processes albumin and the cause of albuminuria. 
This field needs a different approach; one in which the albumin probe is labelled but retains 
native structure. This can be done by using yeast expression systems to synthesize recombinant 
albumin in the presence of radiolabelled precursor molecules (i.e. radiolabelled amino acids, 
radiolabelled carbon source). Techniques such as circular dichroism, native PAGE, reversed-phase 
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high performance liquid chromatography, could be employed to determine whether the synthesized 
albumin retains native albumin structure. Such a native albumin probe would likely have more 
uniform labelling which will enable analysis of a wide spectrum of albumin-derived peptides, rather 
than being limited to analysis of lysine containing peptides as in current probes. A comparison of the 
plasma half-life and urinary excretion profile (intact versus degraded) of a native labelled albumin 
probe compared to those produced by varying degrees of covalent modification of lysine residues in 
studies of normal and proteinuric animals may provide definitive answers to these questions. 
1.4.2 Summary 
Much of the controversy in measurements of the albumin GSC and whether albumin is 
excreted in an intact or degraded form in the urine appears to revolve around the nature of the 
albumin probes themselves. As long as uncertainly exists regarding whether a particular albumin 
probe is susceptible to rapid degradation and clearance, parameters that are often assumed but not 
measured, then this will continue to be a cause for differences in experimental results. It is 
incumbent on those researchers trying to change the conventional view of renal albumin handling to 
provide greater detail on the receptors and molecular mechanisms of albumin exocytosis and 
albumin degradation, and subsequent excretion into the urinary space. I suggest that one way 
forward to clarify these issues is to use endogenously labelled native albumin probes and compare 
their renal handling with albumin covalently labelled with fluorophores. 
1.5 Overall Goal of the Thesis  
The overall goal of my project is to produce radiolabelled recombinant albumin to use as a 
native albumin probe to measure how the kidney and proximal tubular epithelial cells handle native 
albumin. This would provide a new “gold standard” for the study of how the kidney and proximal 
tubular epithelial cells handle native albumin and provide a measure against which to determine 
whether modified albumin probes are handled in the same way, or if modified albumin probes fail to 
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replicate the handling of native albumin. The outcomes of these studies could have a major impact 
upon our understanding of renal physiology and how future studies of albumin handling by the 
kidney should be performed.   
1.6 Specific Aims of the Thesis  
1. The synthesis and physiochemical characterization of [14C]-radiolabelled recombinant native 
albumin using a yeast expression system. 
2. Investigate the mechanism by which megalin uptakes fluorescent labelled albumin in proximal 
tubular epithelial cells, including development of peptide-based inhibitors of albumin/megalin 
binding. 
3. Determine whether the uptake of native versus modified albumin is equivalent or different in 
proximal tubular epithelial cells. 
4. Investigate the mechanisms by which inflammatory stimuli (LPS and TNF-) modify albumin 
uptake and degradation by proximal tubular epithelial cells.  
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2 Chapter 2. Materials and Methods 
2.1 Materials 
2.1.1 General materials 
All the laboratory reagents of analytical grade were obtained from Sigma-Aldrich (Missouri,  
USA), Merck Chemicals (New York, USA), Astral Scientific (Melbourne, Australia), Perkin Elmer 
(Massachusetts, USA) and Ajax Finechem (Australia) unless stated otherwise. Bis-Acrylamide, 
molecular weight markers (MWM), plastic cassette, gel pouring glass kits were purchased from Bio-
rad (California, USA), Perkin Elmer (Massachusetts, USA) and Invitrogen (California, USA). All buffers 
and culture media were prepared using distilled water. For cell culture work specifically, all buffers 
were made from cell culture grade chemicals, filtered and autoclaved before use. 
2.1.2 Yeast strain 
The Kluyveromyces lactis /GAL4/rHA was a gift from New England Biolab (NEB, UK) [161]. K. 
lactis (NEB) was imported from overseas in glycerol/YTD. Acetamide was used as selection marker.  
2.1.3 Cell lines  
2.1.3.1 Opossum kidney cell line expressing megalin 
Opossum proximal tubular kidney cell was a gift from Professor Daniel Markovic (University 
of Queensland, Australia). The cell line was named OK KL for project identification. The cells were 
used between passages 25 and 35. The OK KL cell was grown until reaching confluence and 
transferred to 10 ml of 10% FBS (Fetal bovine serum)/DMEM (Dulbecco's modified Eagle's 
medium)/F12 in a 75 cm2 flask. After three to four days, the OK KL cells were harvested for 
experimentation or passage.  
2.1.3.2 Opossum kidney cell line lacking megalin expression 
An opossum kidney cell line was obtained from American Type Culture Collection (ATCC). 
This cell line did not express the megalin receptor. The cell line was named OK DNP for project 
identification. This cell line was revived from frozen stocks kept in liquid nitrogen. The frozen stock 
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media was DMEM/F12 DMSO. The cell line was grown and passaged in the same manner as for OK 
KL cells.  
2.1.4 Antibodies 
All the antibodies were titrated to identify optimal dilution before use. Detailed information 
for these antibodies is given in the table below. 
Species  Target Antigen Conjugate Company/Catalogue number Dilution 
Rabbit Megalin (P20)  Santa Cruz (16478) 1:10000 
Mouse Lamp-1  Santa Cruz (8098)  1:1000 
Mouse alpha Tubulin  Rockland  (600401880) 1:1000 
Goat Mouse IgG IR-Dye 800 Rockland (610-132-121) 1:1000 
Rabbit Mouse IgG IR-Dye 700 Rockland (610-430-002S) 1:1000 
Sheep Albumin  Abcam (ab8940) 1:1000 
Donkey Sheep IgG Alexa 488 Life Technologies (A-11015) 1:5000 
Mouse p38 MAPK  Cell Signalling (9212) 1:1000 
Mouse c-Jun   Cell Signalling (9261) 1:1000 
Table 2.1 List of antibodies used in this thesis. 
2.2 Methods 
Standard methods were performed as described in molecular biotechnology textbooks [162-
164] or according to manufacturer’s instructions. While the materials and methods are set out in 
detail in this chapter, a brief outline of the methods is also given at the start of each results chapter.  
2.2.1 Sterilization  
Glassware and other equipment were washed with 0.2 M NaOH to remove endotoxin and 
then rinsed using normal tap water followed by double-distilled water. Equipment was left to air-dry 
at room temperature or autoclaved and kept in a clean cabinet. For the yeast culture, culture flasks 
were soaked in 0.2 M NaOH overnight and washed 3 times by distilled water and then autoclaved 
before experiments.  
Separate autoclave cycles were used for liquids and porous materials. The liquid cycle was 
121o C for 30 minutes at 1 atm pressure. The porous cycle was done at 121o C for 20 minutes at 1 
atm then dried at 121o C for 20 minutes.  
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The oxygen and temperature probes were sterilised by spraying with 0.1 M NaOH and then 
70% ethanol, followed by rinsing with autoclaved water and dried with clean tissues. The work-
bench was also sterilised by spraying with 0.1 M NaOH and then 70% ethanol. The surface of 
chemical containers (bottles, flasks) were also sprayed and wiped dry before being opened near a 
Bunsen flame.   
2.2.2 Yeast culture  
All standard procedures for yeast culture work were performed according to protocols 
described in molecular biotechnology textbooks [162-164] and described below.  
2.2.2.1 Yeast selection 
From frozen glycerol stocks, yeast was streaked onto pre-made selection plates using an 
inoculation loop. The components of the plate were varied according to the selection agent for each 
yeast strain. The plate was then incubated for 3-5 days at 30 0C. Yeast colonies were scraped for 
inoculation of liquid cultures. Media plates contained nutrients for yeast growth under stress from 
the selection agent. For K. lactis (NEB strain), the nutrient was nitrogen-free medium containing 
acetamide [161, 165]. These plates were prepared one day before use.  
2.2.2.2 Yeast growth in different vessels 
Yeast colonies of diameter ≥ 2 mm were chosen for culture in either Erlenmeyer flasks or the 
bio- reactor. Supernatant samples and cell pellets were collected by centrifugation at 10,000 g for 10 
minutes at 40 C. Different conditions (OD600, pH, media components) were tested for expression of 
recombinant human albumin (rHA). The samples were either analysed immediately or stored at -800 
C for further analysis.  
50ml falcon tubes were used for small volume cultures, either as trial runs or as seed 
cultures for larger culture volumes. The ratio of Erlenmeyer flask or falcon tube volume/media 
volume was 5, ie 10 ml culture in a 50 ml Falcon tube. The bio-reactor was modified from a spinner 
vessel (Bellco) with volume of 1 Liter. Two metal air spargers (0.25 µm pore) were added to increase 
the oxygen supply. Tubes connecting the air sparger and media input were inserted through the 
two-sided cap. pH and oxygen probes were used to measure culture conditions through access ports 
on the two-sided cap.  
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2.2.3 Measurement of bio-physical parameter  
2.2.3.1 Measurement of optical density  
The UV spectrophotometer (Labkit) was turned on 20 minutes prior to OD600 measurement 
to ensure reading stability. The 600 nm wavelength was used to measure yeast growth while the 280 
nm wavelength measured protein concentration. Fresh media was used as the background value and 
subtracted in calculations. Samples were diluted by a ratio of 1/20 or 1/40 to give an absorbance 
between 0 .0 and 2.0. Samples were either discarded according to OHS regulations or retained for 
further analysis.  
A Nanodrop2000 was used to measure the protein concentration in a 2 l sample at 280 nm 
(Thermoscientific). The protein was resuspended in the selected buffer with minimal UV 
interference. 
2.2.3.2 Measurement of pH, temperature and oxygen  
Measurements of yeast cultures (Erlenmeyer flask or bio-reactor) were done next to a 
Bunsen burner to prevent any contamination from the environment. After each measurement, the 
pH and temperature probe (Hanna instrument) was washed in autoclaved tap water and re-sterilised 
as described in sterilization step. This action prevented cross contamination between cultures.  
The media was adjusted to a particular pH value by acid (0.1 M or 1 M HCl for volume <10 ml 
and >100 ml accordingly) or base 0.1 M NaOH. The acid and base were slowly added by 1 ml syringe. 
Sterile media was introduced either by a suitable syringe or by a peristaltic pump for longer periods. 
The temperature probe was dipped in the culture solution for 1 minute to allow time for the 
temperature reading to stabilize.  
The oxygen probe was calibrated each fortnight. Oxygen measurement was done according 
to guidelines from the manufacturer. The probe was also dipped in culture solution for 30 sec, 
allowing time to stabilize the oxygen reading. Oxygen regulation, to maintain a specified value, was 
done by either increasing or decreasing the flow rate of pure oxygen into the solution through the 
filtered sparger. After measurements, all the probes were stored in the appropriate buffer as 
recommended by the manufacturer.  
2.2.3.3  Measurement of galactose and glucose concentration  
Culture samples were collected for immediate measurement or frozen for later 
measurement. Stored samples were thawed at 4 0C. The galactose concentration was measured 
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using an Abcam assay kit (ab83382), according to the manufacturer’s instructions. The glucose 
concentration was measured using YSI 2300 assay kit, according to the manufacturer’s instructions.  
2.2.4 Protein extraction from culture samples 
In this project, three methods were used to extract protein from the supernatant of yeast 
cultures. The first way used ammonium sulphate, alone or with t-butanol (triple point precipitation). 
The second method used a centrifugal filter unit with a molecular weight cut-off of 30 kDa (Amicon) 
to filter samples. This would concentrate larger proteins and eliminate proteins with molecular 
weight under 30 kDa. The last method was chromatography (affinity, ion exchange), employing 
Bioscale High Q Bio-rad, Hitrap Q XL GE and HiTrap Blue columns. 
2.2.4.1 Sample collection 
There were two types of sample collections depending on the size of the culture media. 
Samples of 1 ml were taken from Erlenmeyer flask or bio-reactor culture (>20 ml) while 100 µl 
sample was collected in falcon tube culture (5-10 ml). Samples were centrifuged in 1.5 ml or 0.7 ml 
tubes at 40 C 10,000 g for 10 minutes. For the final time point, the culture solution was collected by 
50 ml falcon tube 7300 g 20 mins. The supernatant was transferred to another labelled autoclaved 
tube for storage at -800 C. 
For proper disposal, the tube containing the cell pellet was subjected to the porous 
autoclave protocol in a closed sterilized bag, which was then submerged in 10% bleach solution 
overnight. The whole solution was emptied next day in lab sink. The hard waste (tubes, bags) was 
discarded in biological bin. In case of radioactive work, the waste was kept in designated containers 
which were provided by RMIT University. The radioactive waste was disposed according to 
regulation from The Australian Radiation Protection and Nuclear Safety Agency (ARPANSA). 
2.2.4.2 Ammonium sulfate precipitation (ASP) 
Protein in supernatant samples was precipitated by adding ammonium sulfate. Different 
amounts of crude ammonium sulfate were added to sample solutions to achieve particular 
ammonium sulfate concentrations, based on the Encorbio calculator [166]. 2 M NaOH or 1 M HCl 
was added to sample and mixed for 30 minutes to adjust sample pH. After pH change, the sample 
was centrifuged (20000 g for small size sample (>2 ml) or 7500 g for big size sample (10 ml<) to 
collect pellet. 
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2.2.4.3 Triple point precipitation (TPP) 
The collected filtered supernatant was adjusted to the required pH value. Then t-butanol 
(ml) and ammonium sulfate (g) was added to samples to achieve the desired ratio and then vortexed 
well. The solution was then either left at room temperature for settling of protein pellet or 
centrifuge for 10 minutes at 500 g. Different layers were transferred to different tube for further 
analysis. 
2.2.5 Protein separation 
2.2.5.1 Sample preparation  
For all types of chromatography, the samples were either filtered (0.25 µl) or centrifuged at 
10,000 g for 10 minutes at 23o C. The sample was then diluted with running buffer to meet the 
loading capacity of the column as suggestion by the column manufacturer (Agilent and Bio-rad). The 
buffers for running phase were filtered and degassed. All columns were equilibrated by running 
through at least 2 column volumes of buffer before the injection of each sample. 
Dialysis membranes (Snakeskin – 10 kDa cut-off – Thermo scientific), PD-10 desalting 
columns and Amicon ultra centrifugal filtration units (30 kDa cut-off) were used to exchange buffer 
and salts in samples. The membrane and multiple concentrators were used for large sample 
volumes, while PD-10 was used for small sample volumes. All three approaches were trialled 
according to the manufacturer’s instructions, before proceeding to application. The Snakeskin 
dialysis was carried out for two hours at room temperature and then overnight at 4oC. The Amicon 
ultra was centrifuged at room temperature for 3 x 15 mins at 3000 g. The PD-10 column was 
centrifuged at 1000 g for 2 minutes at room temperature. 
2.2.5.2 Buffer preparation 
The pH of chromatography buffers was adjusted using NaOH or HCl before filtration through 
a 0.2 µm membrane, degassing under vacuum, and sonication for 10 minutes. The buffer container 
was submerged in the sonicator bath during the filter/degassing procedure. The chromatography 
system and columns were flushed extensively (2 times volumes of column at required flow rate, 
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Methods Buffer 
Running buffer Elution buffer 
Reversed-Phase 
High Performance Liquid 
Chromatography 
Gradient 2%, 0.01% 
(Trifluoroacetic acid TFA) 
Acetonitrile 
80%, 0.01% TFA 
Acetonitrile 
Isocratic 40%, 0.01% TFA 
Acetonitrile 
 
Size exclusion FPLC and HPLC 150 mM KCl pH 7  
Affinity 50 mM KH2PO4, pH 7.0 50 mM KH2PO4, 1.5 M 
KCl, pH 7.0 
Ion exchange 150 mM KCl pH 1.5 150 mM KCl pH 7.0 
Table 2.2 List of buffers used in this thesis. The chemicals were analytical grade and 
prepared using ddH2O. 
 
The following HPLC techniques were used for purification of rHA from yeast culture 
supernatant: reverse-phase, size exclusion, ion exchange and affinity chromatography. All the 
columns used are described in Table 2.3  
 
Column Company Chromatography Loading range Components 
HiPrep 16/60 (cm) GE Size exclusion FPLC 5 ml  Sephacryl HR-200  
HiPrep 26/60 (cm) GE Size exclusion FPLC 
5 × 103 – 2.5 × 105 
kDa 
13 ml Sephacryl HR-200 
BioSec-3 150A Agilent Size exclusion HPLC 
500-150 kDa 
100 µg/peak 3um silica particles coated 
with a proprietary hydrophilic 
layer 
Bio-Scale Macro -
Prep High Q (5ml 
1.6 x 2.5 cm ) 
Bio-rad Ion exchange ≥37 mg BSA -N+(CH3)3 
HiTrap Blue HP 
(1ml 0.7x2.5cm) 
Invitrogen Affinity 20 mg HSA / ml 
medium 
Cibacron Blue F3G-A, ligand, is 
covalently attached to the 6% 
agarose medium 
Zorbax C18 SB300 Agilent RP-HPLC 100 µg/peak Diisobutyl n-octadecylsilane 
Table 2.3 List of chromatography columns used in this thesis. 
2.2.5.3 Lyophilisation of yeast culture samples  
Samples were kept at -800 C for 2 hours or overnight depending on sample volume.  Then 
the sample was lyophilised at room temp with pressure of 1 atm until completely all water was 
removed and a dry powder form remained. Lyophilised samples were stored for further analysis. 
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2.2.6  Quality control of yeast culture and protein expression 
2.2.6.1 Endotoxin assay  
The final purified proteins were checked for endotoxin before in vitro experiments. The LAL 
test for endotoxin (QCL-1000™ Endpoint Chromogenic LAL Assays (Lonza, Basel, Switzerland)) was 
used to check for the endotoxin according to the manufacturer’s protocol. 
2.2.6.2 Gram stain test  
Gram stain was used to check whether the yeast culture or protein samples were infected 
with bacteria. During experimentation, collected samples were routinely tested using the Gram 
stain. All chemicals used were made by microbiological lab staffs for their routine work. 
2.2.7 Protein characterization 
2.2.7.1 SDS PAGE and Western blot 
SDS-PAGE and Western blot were performed using apparatus from Invitrogen and Bio-rad. 
The running (MOPS) and transfer buffer were purchased from Invitrogen as a 20X stock. The running 
(Tris/glycine/SDS) and transfer buffer used for Bio-rad system was made in the laboratory, according 
to the Bio-rad manual. The 1X buffer was diluted from stock using double distilled water. 
The required amount of samples was mixed with NuPAGE® LDS Sample Buffer and DTT in 
700 µl Eppendorf tubes. The mixture was vortexed and heated at 950 C for 10 minutes. The mixture 
was then centrifuged at 500 g for 2 mins to pellet any precipitates.  
Gels were either purchased or made fresh on the day. 30% Bis-Acrylamide solution was used 
to make stacking gel of 4% and resolving gel of 10 or 12%. Pre-cast 4-20% Bis-Acrylamide gradient 
gels were purchased from Invitrogen and Bio-rad.  
Samples (10 l), including radioactive molecular weight markers (NEC811001UC-Perkin 
Elmer) or normal markers (161-0374 - Bio-rad), were loaded onto the gel and electrophoresed at 100 
V for first 10 minutes then 120 V for 2 hours.  The gel was removed and rinsed in PBS and then 
transfer buffer for 5 minutes each. The gel was subjected to either Western blot technique or 
staining by Coomassie blue. 
 For Western blotting, the gel was placed against nitrocellulose or polyvinylidene difluoride 
(PVDF) membrane and sandwiched between fibre sponges and blotting paper. Transfer buffer was 
pre-chilled to 4oC and the membrane, sponges and blotting paper were all pre-wetted in transfer 
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buffer before assembly with the gel. The transfer voltage was 45 V for 75 minutes for Invitrogen 
apparatus and 100 V for 2 hours for Bio-rad apparatus.  
For Coomassie staining, the gel was incubated for 45 minutes in staining solution (0.1% 
Coomassie Blue R250, 10% acetic acid, 50% methanol) and de-stained overnight in methanol/acetic 
acid (40-40%) solution to visualise protein bands. 
2.2.7.2 Gel densitometry – Gel analyser 2000 
The densitometry of the Western blot membrane and Coomassie gel was routinely 
measured and quantified by using Gel Analyser 2000 [167], according to the software manual. The 
required lane on the membrane or gel was chosen and calculated using the density of the defined 
control lane and subtracting the background. Images of the Western blot membranes and 
Coomassie gels were captured by the Alpha Innotech FluorChem or the Odyssey infrared imaging 
station. For the Western blot membrane, the wavelength was chosen based on the fluorochrome 
conjugate. Each gel was standardized with an internal protein (albumin or tubulin) control. 
2.2.7.3 Circular dichroism (CD) analysis 
The secondary structure of albumin preparations was measured using circular dichroism. For 
circular dichroism measurements, protein samples in either solid or liquid form were resuspended or 
dialyzed against HEPES buffer pH 7.45, respectively, to a final concentration of 1 mg/ml. A sample 
volume of 150 µl was transferred to 20/O cell cuvette (Starna) with a path length of 1mm. CD 
spectra were measured using a Jasco J-1500, at a temperature of 23o C unless state otherwise. Data 
were analysed using the Dichroweb service (http://dichroweb.cryst.bbk.ac.uk/). For analysis of 
peptide sequence, K2D method was employed. In addition, analysis of protein sequence, CDSSTR 
software was used to analyse the CD data with reference data set 7 [168-171].  
 
2.2.7.4 Analysis of potential albumin peptides that bind to megalin  
The following approach was used to identify potential albumin peptides that could bind to 
megalin. First, multiple alignments across different species of albumin were performed using the 
ClustalW 2.0 program [172] .Proteins known to bind to megalin were analysed by Blastp (National 
Center for Biotechnology Informaton). Details of the analyses are provided in section 4.4.5.1. 
Peptides were custom manufactured by ChinaPeptides (Shanghai, China). 
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2.2.7.5 Protein labelling  
rHA was labelled with the Texas red probe using a Texas Red®-X Protein Labeling Kit (T-
10244 – Molecular Probe) accordingly to the manufacturer’s instructions. Briefly, 0.5 mL of 2mg/ml 
rHA in PBS was mixed with 50 µL of 1M of sodium bicarbonate and 10 µL of reactive dye in DMSO. 
The whole mixture was inverted two times and stirred at room temperature for 1 hour and then 
purified using kit provided. Labelling of TR-rHA was calculated as a TR:rHA ratio as described in the 
manual. 
AGE-BSA was a gift from Dr Greg tesch (Monash University). AGE-BSA was prepared by 
incubating BSA (10 mg/ml) at 37°C for 6 weeks with D-glucose (90 g/l) (Sigma Chemical Co.) in a 0.4-
M phosphate buffer containing azide. CML-BSA was produced by incubating 2 mM BSA with 0.15 M 
glyoxylic acid and 0.45 M sodium cyanoborohydride in phosphate buffer (pH 7.8) for 24 h at 37°C. 
Preparations of CML-BSA and AGE-BSA were dialysed extensively against phosphate-buffered saline 
(PBS) and sterilely filtered (0.2 µm). Both substances were determined to have insignificant levels of 
endotoxin (<0.1 ng/mg) by limulus amebocyte lysate assay (E-toxate, Sigma).  The extent of lysine 
modification was up to 34% for CML-BSA preparations and 77% for AGE-modified proteins [173, 
174]. 
2.2.8 Radioactivity work 
2.2.8.1 Liquid scintillation counting 
Radioactivity of samples was measured using a Tri-Carb 2910TR Liquid Scintillation Analyzer 
(PerkinElmer). The sample was measured in liquid form. However, the radioactivity of protein bands 
on nitrocellulose membranes from Western blotting was also measured by cutting a piece of 
membrane having protein bands and mixing with scintillation cocktail. All samples were mixed with 3 
ml of ultimate Gold XR in compatible scintillation vial and mix well by vortexing for 1 minute. Then 
samples were measured for disintegration per minute/count per minute (DPM/CPM). The reading 
parameter was set according to the manufacturer’s manual [175].  
2.2.8.2 Photo-stimulated luminescence  
Radioactively labelled proteins were separated by SDS-PAGE and transferred to 
nitrocellulose membrane by Western blotting as described above. The nitrocellulose membrane was 
sealed in a thin layer of 100% polyethylene sheet and exposed to MultiSensitive Phosphor screen for 
a period of 1-2 weeks, enclosed in a lightproof cassette at room temperature. After incubation, the 
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phosphor image was recorded at high resolution by a Cyclone Plus Phospho Imager (Perkin Elmer) 
for analysis. Then antibodies were applied to detect rHA. The Western blot image and phosphor 
image were overlapped to identify radioactive rHA. Finally, a piece of membrane containing rHA was 
cut out and dissolved in ultimate Gold XR cocktail and measured by liquid scintillation counter. 
Before any measurement, the phosphor screen was blanked by exposed to white light for 30 
minutes. The radioactive membrane was disposed in designated radioactive safe container supplied 
by RMIT University.  
2.2.9 Preparation for cell culture work 
All the cell culture techniques were performed according to standard protocols in 
biotechnology textbooks [162-164]. 
2.2.9.1 Reviving cells from frozen stocks  
Reviving cells from frozen stocks was performed according to American Type Culture 
Collection organization (ATCC) guidelines [176]. Cells were frozen in 1 ml of DMSO DMEM/F12 (DDF) 
in 2 ml cryostat tube (Life technologies). The cells were thawed at room temp for 10 minutes and 
then aseptically resuspended in 5 ml of 10% fetal bovine serum DMEM/F12 medium (10-FDF). The 6 
ml solution was then grown in 25 cm2 culture grade flasks at 37o C, 5% CO2 for 6-8 hours before the 
media was replaced by 5 ml of 10-FDF medium. The 6-8 hours incubation was sufficient for the cells 
to settle on the surface of the flask. The cell were grown until reaching 80% confluence and then 
passaged to 75 cm2 flasks for further experiments.  
2.2.9.2 Passaging and seeding cells 
Cells were routinely harvested and passaged before reaching 80% confluence. The culture 
media was removed and cells washed with sterile EDTA/PBS (Ethylenediaminetetraacetic acid 
/Phosphate buffered saline). Then 0.25% trypsin/PBS was added and incubated for 3 minutes and 
7ml of 10-FDF added to stop the trypsin reaction. The cells were harvested by centrifugation at 50 g 
for 5 minutes. With supernatant was discarded, the cell pellet was resuspended in 10% FBS 
DMEM/F12. Then cells were transferred into an appropriate flask for the experiment. All experiment 
with OK KL cells were performed within 10 passages of cells being thawed (from passage 25 to 35).  
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2.2.9.3 Trypsinization 
Using 96 well plates, 2.5 µg of the required fluorescent probe was mixed in 0.125% trypsin-
EDTA of 100 µl Hepes pH 7.45. The mixture was pipetted thoroughly. The plate was then incubated 
at 370 C for 45 minutes and then measured using plate reader (BMG, Flexstar or Envision).  If the 
trypsinized fluorescent albumin was used for cell uptake assay, the trypsin inhibitor was added with 
weight ratio 1:1 to trypsin for 15 minutes. 
2.2.9.4 Cell counting 
Two methods were routinely used for counting mammalian cells – a manual 
haemocytometer and the Scepter automated cell counter (Millipore). For the haemocytometer, cells 
were resuspend cells in 0.4% tryphan blue in saline solution and viable cells counted. The Sceptor 2.0 
counter (Millipore) was also used to count cells according to the standard guide and manual [162-
164, 177].  
2.2.10 Cell uptake assay  
Cells were seeded in NUNC plates and grown in 10% FBS DMEM/F12 with/without 50 unit 
antibiotic (penicillin/ streptomycin). When cells reached confluence, the media was replaced and 
incubated for 48 hours with DMEM/F12 minimal glucose prior to uptake experiment. Cells then were 
incubated with various labelled albumin preparations 2 hours at 370 C degrees to allow cell uptake. 
Next, the cell media was removed and cells washed three times with ice-cold sterile HEPES buffer pH 
6 to remove surface bound albumin. 
Various chemicals were tested for their effect upon albumin uptake by OK KL cells, including;  
bacterial endotoxin (lipopolysaccharide, Sigma-Aldrich), a disrupter of actin filaments that inhibits 
endocytosis (Latrunculin A, Sigma-Aldrich), a selective JNK inhibitor (CC-930, a gift from Celgene, San 
Diego, CA, USA), or TNF-alpha (Peprotech, Rocky Hill, NJ, USA). Depending on the experiment, cells 
were incubated with these various compounds for 30 min before the addition of labelled albumin In 
addition, in some experiments unlabelled albumin was added for competition assays.  
At the end of the assay, cells were lysed using a buffer containing 0.1% Triton X-100 10 
mmol/L MOPS (M1254 Sigma Aldrich) at 370 C or lysed using 6 M urea lysis buffer at 40 C (1 mM 
EDTA, 5 mM NaF, 6 M Urea in PBS, 20 mM Na Pyrophospho, 0.05% Tween20, 0.5% TritonX100, 100 
mM PMSF). The supernatant was collected by centrifugation (2000 g for 20 minutes at 40 C) and 
measured for fluorescent activity or radioactivity using a plate reader (Perkin Elmer, BMG, Envision) 
or liquid scintillation counter, respectively. The protease inhibitor cocktail (I3786-Sigma Aldrich) with 
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addition of Leupeptin, Aprotonin, PMSF, Na Orthovanadate 100mM,  was used with lysis buffer to 
prevent protein degradation. The fluorescent signal was standardized against protein concentrations 
of sample which were measured by either BCA protein assay or Coomassie protein assay (Piercenet).  
 
Fluorescent-labelled albumin Manufacturer 
Fluorescein isothiocyanate labelled bovine 
serum albumin (FITC-BSA) 
Sigma Alrich A9771 
Alexa Fluor® 555 labelled bovine serum albumin 
(A555-BSA) 
Molecular Probes® A34786 
Alexa Fluor® 488 labelled bovine serum albumin 
(A488-BSA)  
Molecular Probes® A13100 
Self-Quenched BODIPY® TR-X Dye labelled 
bovine serum albumin (DQRed-BSA) 
Molecular Probes® D12051 
Texas Red® labelled bovine serum albumin (TR-
BSA)  
Molecular Probes® A23017 
Table 2.4 List of commercial fluorescent-labelled albumin preparations used in this thesis. 
2.2.11 Immunohistochemistry 
Cells were seeded in Nunc microscopic chamber slides which have 4 wells of 1.8 cm2 each. 
Around 104 cells were seeded in each well and grown to confluence. The seeded media was 10% 
vol/vol of fetal bovine serum (FBS) in DMEM/F12 (Gibco-Lifetechnologies). The growth rate of both 
OK KL and OK DNP was 30% slower than growing in flask. After two days, the media was replaced by 
0.5 ml 10% FBS DMEM/F12 and cultured until reaching confluence.  
The confluent cells were washed in Tris buffered saline (0.01% Triton X100) (TBS-T) and then 
fixed in either -200 C acetone or methanol for 10 minutes. After fixation, the cells were washed 3 
times with TBS-T then incubated with appropriate antibodies. Typically, primary antibodies were 
incubated at 4o C overnight while the secondary antibodies were incubated for 2 hours at room 
temperature. Details of antibodies were listed in Table 2.1. The slides were washed 3 times with TBS-
T for 3 minutes each between antibody incubations. 
The plastic chamber and adhesive gel were removed before mounting in fluorescent 
mounting medium (Dako). The slides were analysed by fluorescent or confocal microscopy. In each 
experiment, all of the captured images had the same focus, contrast and laser intensity for the 
purpose of data analysis. The fluorescent signal in immunohistochemistry images was quantified 
using ImageSpot software.   
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2.2.12 Biotechnology work 
 All the biotechnological work was completed based on references from Pubmed/Expasys. 
The protein, DNA, mRNA sequences were obtained from NCBI and Genebank database [178-180]. 
The alignment of albumin from different species was done by CLUSTWAL Omega (Figure A8.4). 
 
Species and Abbreviation Databank 




Albumin [Mus musculus] MSA GenBank: AAH49971.1 
 
Albumin [Rattus norvegicus] RSA GenBank: AAH85359.1 
 
Serum albumin precursor [Ovis aries] SSA 
 
NCBI Reference Sequence: NP_001009376.1 




Table 2.5: Albumin sequences analysed in this thesis. The table includes Genebank, NCBI 
number and the Latin name for each species. 
2.2.12.1. Analysis of megalin for potential albumin binding sites  
Common/conserved motifs in protein sequences of ligands known to bind to the megalin 
and cubilin-AMN complex, including albumin, vitamin D binding protein (DBP) Apolipoprotein A-I 
(Apo A-1) Clara Cell Protein (CC16) transferrin (TF), were analysed to identify potential albumin-
megalin binding sites using BLASTP, ClustalW Omega [178-180]. The preliminary data was shown in 
appendix section (Figure A8.5.).  
 
Megalin ligands  Databank information 
Homo sapiens albumin (cDNA clone MGC:32888 IMAGE:4766983), 
complete cds, GenBank: BC041789.1 
Homo sapiens group-specific component (vitamin D 
binding protein)  
(cDNA clone MGC:61910 IMAGE:4767205), 
complete cds, GenBank: BC057228.1 
Homo sapiens transferrin mRNA cDNA DKFZp686O0685 (from clone 
DKFZp686O0685) GenBank entry:BX648533.1 
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Rattus norvegicus apolipoprotein A-I (Apoa1), mRNA  NCBI Reference Sequence: NM_012738. 
Homo sapiens secretoglobin, family 1A, member 1 
(uteroglobin) (SCGB1A1) Or CC16 
NCBI Reference Accession:P11684.1 
 
Table 2.6 Sequences of megalin ligands investigated in this thesis. 
2.2.12.2 Bio-informatics software 
Basic local alignment search tool (BLASTP) was performed using the national centre for 
biotechnology information server (NBCI) [178-180]. The protein sequences of vitamin D binding 
protein, Apolipoprotein A-I, Clara Cell Protein and transferrin were aligned against human serum 
albumin (NCBI:AOPO6) using BLASTP to look for any homology in the protein sequence. 
Multiple alignments were performed using ClustalW Omega, (EBI server) multiple sequence 
alignments were generated using amino acid sequences of these ligands in BLASTP. The global 
alignment was manually analysed for constant regions in all the ligands (Appendix). The motif-like 
and similarity was examined in these constant regions. 
Global alignment of various albumin species was achieved using CLustalW Omega. The 
mRNA and amino acid sequence of albumin from human (Homo sapiens), cow (Bos Taurus), mouse 
(Mus musculus), rat (Rattus norvegicus) and sheep (Ovis aies) were analysed. The multiple 
alignments of ligands were then manually chosen for conserve motif across sequence (Appendix). 
These peptides were checked to see if the motif was on the surface of albumin by using Cn3D [181-
184].  
2.2.13 Statistical methods 
Data is presented as the mean ± 1 standard deviation. Cell culture experiments were 
performed at least 3 times with replicates of at least 3. Data from experiments with 2 groups were 
examined using the student’s t-test, while data from experiments with 3 or more groups was 
analysed by one way ANOVA with an appropriate post-hoc multiple comparisons test such as Tukey's 
test for parametric data. Statistical analysis was performed using GraphPad Prism 6.0.  
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3 Chapter 3. Expression, radiolabelling, purification and 
characterisation of rHA 
3.1 Introduction 
3.1.1  Controversial issues in kidney and diabetes research 
There has been a great deal of research on kidney disease and diabetes utilizing modified 
albumin or synthetic molecules that mimic the properties of albumin. The addition of a fluorescent 
probe (e.g. FITC) or radioactive group (e.g. I125) to the albumin molecule allows us to trace that 
albumin molecule in both in vivo and in vitro experiments. Labelled synthetic molecules of a similar 
molecular weight have been used to mimic albumin, such as Ficoll and dextran. However, all of these 
probes and synthetic molecules have their own inherent limitations that can lead to complications 
with the interpretation of both in vitro and in vivo studies. For example, measurement of the 
glomerular sieving coefficient for albumin has produced widely varying results depending upon the 
method and type of albumin probe used [185-190]. Furthermore, while conventional detection of 
albumin using antibody-based methods identifies only 10 to 30 mg albumin/day in normal human 
urine, the use of radiolabelled albumin coupled with HPLC detection has identified significantly 
higher amounts of albumin fragments excreted in rat and human urine [133, 139, 191-194]. 
However, this controversial finding is difficult to replicate since these small albumin fragments 
cannot be detected by conventional antibody-based albumin assays. 
3.1.2  Problems with modified probes for research 
3.1.2.1 Fluorescent probes 
As shown in Table 3.1, the fluorescent molecules used for labelling albumin have a wide 
range of molecular weight and net charge. The addition of a fluorescent molecule/moiety to albumin 
will increase its molecular weight as well as alter its secondary structure and net charge. These 
alterations to albumin may cause significant changes in the behaviour of albumin in physiological 
conditions, and the greater the number of molecules/moieties that are added, the greater the 
likelihood of changing the physiochemical properties of the albumin molecule. Albumin is known to 
change shape as the pH changes, from a heart-shaped structure at neutral pH to a cigar-shaped 
structure at pH <3. In addition, the shape of albumin is considered to be important in urinary 
clearance [138].  
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3.1.2.2  Synthetic molecules  
Dextran has been used extensively for transport studies in kidney over the past 30 years 
[195]. It is an α-D-1,6-glucose-linked polymer with few short side branches. However, data obtained 
using neutral dextran to calculate glomerular pore dimensions have been re-assessed based upon 
consideration that the flexibility of dextran may have caused an over-estimation of neutral dextran 
sieving data [26, 196].  
Ficoll is a neutral, heavily cross-linked, sucrose-epichlorohydrin copolymer that behaves as 
rigid hydrated spheres. However, studies using Ficoll with an equivalent radius to that of albumin 
(36Å) consistently give a much higher glomerular sieving coefficient (0.04) compared to that of 
albumin (0.0004) [26, 196]. This has traditionally been attributed to albumin filtration being 
massively inhibited due to charge selectivity, although negatively charged Ficoll has an increased 
sieving coefficient compared to neutral Ficoll [26, 196, 197]. One explanation for these apparent 
contradictions is that both Ficoll and dextran are readily compressible and undergo major structural 
changes in vivo and therefore fail to mimic albumin [26, 196]. 
The uncertainties and contradictory findings in the study of albumin filtration and excretion 
indicate a major need to develop a probe that accurately mimics albumin itself. The only way that 
this can be done without introducing significant modifications to albumin structure and avoiding the 
use of synthetic probes, is to use recombinant albumin which is labelled with a radiotracer during 
synthesis – thus producing native albumin which can be traced both in vitro and in vivo. The aim of 
this chapter is to produce labelled albumin in its native form in order to study renal handling of 
albumin. The possible approaches to producing labelled native albumin are considered below. I 
decided to focus on making recombinant human albumin with the view to performing studies in 
human cells and potentially in human subjects. In addition, human albumin is handled in the same 
way in cells isolated from mice, rats or cows (bovine serum albumin is the most widely used form of 
albumin in kidney studies in human, mice and rats) with no significant differences reported. 
3.1.3  Factors influencing the choice of protein expression system 
Achieving the desired goal of a native-like, unmodified but radiolabelled albumin requires 
recombinant expression of albumin. The first step was to identify the most appropriate protein 
expression system. There are important factors that determine the choice of expression system. The 
first factor is whether the host producing the recombinant albumin has the appropriate machinery 
to carry out proper folding and post translation modification of the expressed protein. 
The second factor is being able to express recombinant albumin in a low endotoxin 
environment to avoid problems of triggering inflammatory responses when using the albumin for in 
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vivo and in vitro experiments. E. coli is commonly used for protein expression but it is also difficult to 
avoid endotoxin contamination during purification of recombinant proteins. Other problems that 
makes E. coli unsuitable for making recombinant albumin is that it lacks proper protein folding 
functions, and inclusion bodies are a common problem for purification of expressed proteins. 
 
3.1.4 Advantages of yeast expression systems 
The required conditions for making recombinant human albumin (rHA) can be met by using 
a yeast expression system. Yeast is widely used in research and industry due to its utility as an 
economical heterologous protein expression system that also includes eukaryotic post-translational 
processing (e.g. folding, glycosylation).  
Whether the rHA gene remains within a vector or becomes completely integrated into the 
host genome can affect the levels of protein expression [198, 199]. As yeast is an unicellular 
organism, its genetic manipulation is relatively simple. The integration of rHA gene into the yeast 
genome ensures the stable presence of the rHA gene for protein induction. However, a possible 
limitation of genomic integration is that the gene would be limited to one or two copies, whereas 
vectors may be present in multiple copies and thereby amplify protein expression.  
Under optimal conditions, yeast can grow to high density (OD600 >20) in culture media from a 
small colony within 30 hours of incubation with a doubling-time of 2.5 to 3 hours [198, 199]. Given 
an appropriate inducer and optimal media, this can result in maximal protein expression. Thus media 
conditions are a key factor to define.  
3.1.5  Kluyveromyces lactis  
Yeast strains such as Kluyveromyces lactis (K. lactis) have a long history in terms of 
laboratory and industrial applications [198-204]. K. lactis is also known as “dairy yeast” or “milk 
yeast” due to its unique property to utilize lactose as a sole carbon source by breaking it down with 
the enzyme lactase (β-galactosidase) [205]. Enzymes produced in K. lactis have been granted 
"Generally Regarded As Safe" (GRAS) status. Thus it is used in commercial production of numerous 
proteins, such as milk clotting enzyme bovine chymosin and recombinant human albumin for 
commercial and research purposes [203, 206-208].  
Thus a K. lactis expression system was employed to produce rHA. New England Biolabs 
kindly provided us with a K. lactis strain with the rHA gene integrated into the genome under the 
control of the strong inducible pLAC4 promoter which could be induced up to 100-fold by galactose 
[161, 165, 209, 210]. 
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3.2 Aims of chapter 3 
This chapter will focus on the methods for expressing, radiolabelling and purifying rHA from 
K. lactis. The specific aims of this chapter are to: 
1. Optimise conditions for expression of rHA in K. lactis. 
2. Evaluate variables to maximise 14C labelling of rHA. 
3. Develop methods for crude extraction of expressed rHA. 
4. Optimise purification of extracted rHA 
3.3 Methods 
All the materials and methods are described in detail in Chapter Two. To maintain 
continuity, a brief summary of the methods used is given below.  
Culture growth and induction was performed using fresh yeast colonies. A 
spectrophotometer was used to measure the optical density of cultures. The measurements of pH 
and oxygen were performed using pH and oxygen probes (Hannah 201). Galactose and glucose 
concentration were analysed by using YSI 2000 and Abcam assays.  
Liquid chromatography, ammonium sulfate precipitation (ASP), three-phase partition 
precipitation (TPP) were used to isolate proteins. His-tagged protein purification was performed as 
per the Bioline manual. The Gram stain test, endotoxin assay was used to check if there was any 
contamination of the purified protein.  
SDS-PAGE and Coomassie staining plus Western blotting were used to separate and identify 
purified proteins. The antibodies used in Western blotting are listed in Chapter Two. Gel densities 
were performed with “Gel Analyser 2000” software to estimate protein quantities. A photo-
stimulated luminescence Cyclone Plus Phospho Imager was used to measure the integration of 
radioactive materials into proteins from K. lactis. Liquid scintillation quantification of radioactivity 
was done using Tri-Carb counters.  
CD analysis, trypsinization and liquid scintillation counting were used to investigate the 
biochemical properties of albumin probes. Statistical analysis was performed by either t-test (2 
groups) or one way ANOVA with Tukey’s multiple comparison tests.   
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3.4 Results 
3.4.1  Expression of rHA by K. lactis 
The K. lactis strain used for producing rHA was a gift from New England Biolab (NEB). The 
transformed K. lactis was selected by an antibiotic-free method, using acetamide as the sole 
nitrogen source in defined medium. The acetamidase gene (amdS) expressed from pKLAC2 permits 
transformed cells to survive on acetamide as the sole nitrogen source.  
3.4.1.1 Galactose as an inducer/carbon source for K. lactis 
Expression of rHA was initially tested using published conditions for K. lactis induction with 
galactose in conventional media containing 1% yeast extract, 2% tryptone and 2% galactose 
(YTGal2%). The rHA expressed by K. lactis was shown to have a molecular weight similar to that of 
purified human serum albumin (Figure 3.1A). 
The galactose concentration and time of harvest that gave the best yield of rHA was 
determined. For three different concentrations of galactose (1%, 2% and 4%) in conventional media, 
maximal expression was obtained 48 hours after induction (Figure 3.1B). The rHA expression level 
was not significantly different between the galactose concentrations of 2% and 4%. The rHA 
expression reached a maximal point at 48 hours in both 2% and 4% Gal and decreased thereafter. 
The 1% galactose culture had rHA expression that was roughly half that of the 2 and 4% galactose 
cultures at 48 hours incubation but was relatively stable over 24 to 72 hours. In conclusion, the 2% 
galactose induction, harvested at 48 hours gave the best rHA expression. 
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Figure 3.1: Time course of rHA expression in K. lactis
A. Western blot of YTGal4% culture at three different time courses.
B. K. lactis was grown in YTGlu2% to an OD600 of 30 and then transferred to YTGal1%,
YTGal2% or YTGal4% for induction. Supernatant samples were collected at time
points of 24, 48 and 72 hours post-induction. rHA expression was measured by
Western blot using a fluorescence based technique.
These data were from 3 independent experiments. The one-way ANOVA with Tukey’s
multiple comparison test was done to statistically analyse the difference between
groups. The error bars are shown as standard deviation (SD).
Antibodies used for Western blot are sheep polyclonal to human serum albumin
(1:1000) (Abcam) and secondary antibody is donkey anti-sheep Alexa Fluor 488
(1:1000) (Molecular Probes).
*: p<0.05 between YTGal2%, YTGal4% and YTGal1%
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3.4.1.2 Comparison of conventional and commercial media for growth of K. lactis 
Conventional YT media, made from yeast extract and tryptone, was compared with 
commercial complex media (Silantes) for optimal growth of K. lactis, using three different carbon 
sources: 2% galactose (Gal2%), 2% glucose (Glu2%) or 3% glycerol (Gly3%). For both conventional 
and commercial media, there was no difference in growth between the different carbon sources 
(Figure 3.2). Likewise, there was no difference in growth rate between Silantes commercial media 
and YT conventional media over the time course of 72 hours in which culture OD600 was 57.3 ± 6.2 
and 55.1 ± 2.7 absorbance units (AU), respectively (Figure 3.2). 
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Figure 3.2: Growth of K. lactis in different media. K. lactis cultures were
started from a fresh colony on a plate and then diluted to 0.01 OD600 in each
medium. Optimized commercial media (Silantes) and conventional media
(yeast extract, tryptone, YT) were used with different carbon sources at
specified concentrations (galactose or glucose, glycerol).
These data were from 3 independent experiments. The one-way ANOVA with
Tukey’s multiple comparison test was done to statistically analyse the
difference between groups. The error bars are shown as standard deviation.
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3.4.1.3 Effect of the carbon source on rHA expression  
Different carbon sources with commercial and conventional media were also investigated 
for their effect on rHA expression. K. lactis was incubated in either Silantes or YT growth media 
supplemented with different carbon sources, then pelleted by centrifugation and resuspended in the 
same base media (Silantes or YT) containing 2% galactose as carbon source and inducer of rHA 
expression. Expressed rHA was measured at 48 hours post-induction (Figure 3.3). The straight Gal2% 
culture was treated slightly differently, as after 48 hours growth in Silantes galactose 2%, fresh 
galactose was added to 2% mass/volume, without pelleting and re-suspension in new media.  
This experiment was done to test the idea that transferring yeast from growth to induction 
media could remove inhibitory metabolites or secreted proteases and enhance rHA expression. 
Indeed, there was significantly less rHA in the straight Gal2% than in the fresh induced Silantes Gal 
2% culture (29 ± 5 and 39 ± 2 mg/L, respectively), indicating that media replacement increases rHA 
expression. 
Glucose as the carbon source gave the highest rHA expression in both Silantes and YT media 
(approximately 53 mg/L rHA in both, Figure 3.3). Relative to 2% glucose in growth media, the use of 
2% galactose in both growth and inducing media gave significantly lower rHA expression in Silantes 
media (~39 mg/L) and even lower rHA expression in conventional media (~9 mg/L). Using 3% glycerol 
for growth instead of 2% glucose in YT media reduced rHA expression but the difference was not 
significant. 
In conclusion, of the different carbon sources tested, glucose gave the highest level of rHA 
expression. K. lactis required fresh media at induction for optimal induction of rHA expression. The 
optimal condition for rHA expression in K. lactis involved growing in YTGlu2% and then inducing in 
fresh YTGal2%. The maximal level of rHA expression in YT media was 53 ± 4 mg/L after 48 hours 
incubation (Figure 3.3). 
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Figure 3.3: Expression of rHA by K. lactis in different media and carbon
sources.
K. lactis was grown in either Silantes (S) or YT for both growth and induction
phases but the carbon source was changed. Glu2% and Gal2% means the
usage of glucose 2% or galactose 2%. All the expressed rHA was standardized
for volume of culture and measured by Western blot. The glucose is shown as
the best carbon source for albumin expression but not galactose.
These data were from 3 independent experiments. The one-way ANOVA with
Tukey’s multiple comparison test was done to statistically analyse the
difference between groups. The error bars are shown as Standard Deviation
(SD).
Antibodies used for Western blot are sheep polyclonal to human serum
albumin (1:1000) (Abcam) and secondary antibody is Donkey anti-Sheep Alexa
Fluor 488 (1:1000) (Molecular Probes).
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3.4.1.4 Use of minimal media for the incorporation of 14C into rHA  
I selected to use 14C as the preferred method for labelling rHA. This was based upon 
considerations that 14C can be readily detected, is safe to handle, can be uniformly incorporated in 
proteins, and the cost involved makes the approach practical.  
An important question to address was which media to use for the growth of K. lactis to 
optimise 14C incorporation into rHA? Complex media is optimal for yeast growth and induction of 
recombinant protein expression [199, 209, 211, 212]. Complex media contains various components 
that could be utilized by K. lactis for protein production [211]. However, this could affect the 
homogeneity of incorporation of radioactive isotopes into rHA. On the other hand, minimal media 
has a limited carbon and nitrogen source that can be controlled to enhance 14C incorporation in rHA 
even though rHA production would be reduced. Hence, the effect of complex and minimal media on 
rHA expression and 14C incorporation into rHA was investigated. 
Due to the specificity of the K. lactis (NEB) strain, galactose is both carbon source and 
inducer. However, the cost of 14C-galactose was impractical for the project (21 times the cost of 14C-
glucose). Thus, I explored the alternative approach of using 14C-glucose as a carbon source with a low 
level of galactose for induction of expression to minimise the incorporation of unlabelled carbon into 
the synthesis of rHA.  
Reducing the galactose concentration to 0.2% in complex media produced a substantial yield 
of rHA (30 ± 3 mg/L) (Figure 3.4A). However, the incorporation of 14C (from 14C-glucose) into rHA was 
extremely low, being barely detectable by phosphor image film (Figure 3.4B). Based on liquid 
scintillation counting, the rHA expressed under these conditions had a specific activity of ~35,000 
CPM/mg which was too low for in vivo and in vitro experiments. Consequently, minimal media was 
investigated as an alternative induction media for the expression and radioactive labelling of rHA. 
The effect of additional media components such as L-amino acids and pyruvate were studied 
for their effect on yeast growth and rHA expression. In minimal media, K. lactis had a prolonged and 
unstable doubling time, thus conventional YTGlu2% was used for growth media unless stated 
otherwise. K. Latis was grown in YTGlu2% to OD600 of 15, and then transferred to fresh inducing 
minimal media. 
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Figure 3.4: Expression and radioactivity of rHA with addition of 14C-glucose.
Panels A,B and C show Western blot, phosphor image and quantification
respectively of rHA expression from induced complex media (1% yeast extract,
2% tryptone and 0.2% galactose and 2mCi/L of 14C-glucose ) for three time
points (12, 24 and 48 hours) of two different cultures.
The Western blot membrane was exposed to phosphor film for 2 weeks in
lightproof cassette at room temperature. The [Methyl-14C] molecular weight
markers was used as control for specific radioactivity.
These data were from 3 independent experiments. The one-way ANOVA with
Tukey’s multiple comparison test was done to statistically analyse the
difference between groups. The error bars are shown as standard deviation.
HSA
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3.4.1.5  Optimising parameters in minimal media for rHA expression 
In changing from cultivation to induction media, a low density culture of K. lactis could 
potentially divert the resource into cell growth instead of rHA expression and a low density would 
also mean fewer cells to express rHA [198, 199, 209]. On the other hand, starting induction with a 
high density culture could potentially deplete media resources. Thus the effect of starting culture 
density (OD600) on rHA expression was tested in K. lactis being induced in minimal media. 
As shown in Figure 3.5, a starting OD600 of 15 before induction in minimal media containing 
0.2% galactose gave a greater yield of rHA compared to using higher starting culture densities, 
although the level of rHA expression was still only about half of that seen when using conventional 
media in a similar induction protocol.  
Published studies have shown that pH is an important factor for expression of rHA [198, 199, 
209]. I found that the highest level of rHA expression was obtained from cultures with a controlled 
pH of 6.5 (Figure 3.6). A pH of 7.5 gave a similar yield of rHA to a pH of 6.5 but the expression was 
not stable between experiments (see large error bar in Fig 3.6). Outside the pH range of 6.5-7.5, the 
expression level of rHA reduced significantly.  
Oxygen is an important factor in yeast physiology [198, 199, 209]. As shown in Figure 3.7, 
the expression of rHA in complex media was relatively independent of an additional oxygen supply. 
Oxygen supply did, however, significantly increase the expression of rHA in minimal media to 
approximately five times that in control minimal media. 
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Figure 3.5: Effect of starting OD600 on expression of rHA in minimal media.
The OD600 of 15, 30 and 60 was chosen as starter OD600 for inducing minimal
culture (48 hours incubation). The Western blot was used to check the
expression level of rHA after 48 hours incubation in minimal media.
These data were from 3 independent experiments. The one-way ANOVA with
Tukey’s multiple comparison test was done to statistically analyse the
difference between groups. The error bars are shown as standard deviation.
AU - absorbance unit
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Figure 3.6: Effect of pH on rHA expression in minimal media. Each of three
different colonies was diluted to OD600 of 0.01 and grew in YTGlu2% then
induced in minimal media of different pH. The expression culture pH was kept
constant at 5 point (3.5, 5.5, 6.5, 7.5, and 9.5) for 48 hours. The sample was
collected after 48 hours incubation.
The rHA was detected using Western blot. These data were from 3
independent experiments. The one-way ANOVA with Tukey’s multiple
comparison test was done to statistically analyse the difference between
groups. The error bars are shown as Standard Deviation (SD).
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A
B
Figure 3.7: Effect of oxygen with rHA expression in both complex (a) and
minimal (B) media. The Erlenmeyer flask culture was employed in all
experiments.
The oxygen flow rate is 1 ml/min for 4 ml of media culture. Under aseptic
condition, the oxygen was supplied to culture using metal sparger (0.25 µm).
The rHA was measured by Western blot. These data were from 3 independent
experiments. The t-test was done to statistically analyse the difference
between groups. The error bar are shown as Standard Deviation (SD).
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3.4.1.6 Optimising the nitrogen source for rHA expression in minimal media 
The nitrogen source is an important factor for the capacity of protein expression systems as 
nitrogen is required for the production of amino acids [198, 199, 209]. Beside the conventional 
nitrogen source of ammonium sulphate, urea was chosen for testing as an alternative nitrogen 
source since, in contrast to ammonium sulphate, no H+ is released during utilization of urea 
(equation 1) [213], thus having less effect upon culture pH compared to (NH4)2SO4. However, the 
consumption of urea as the nitrogen source releases more carbon dioxide, which could potentially 
affect the homeostasis of the culture.  
As I showed previously, pH 6.5 is optimal for rHA expression, with a higher or lower pH being 
suboptimal (Figure 3.6). Hence, using urea in place of ammonium sulfate in a culture of pH 6.5 could 
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Equation 1: These two equations show the consumption of urea or ammonium sulphate as 
the sole nitrogen source to produce biomass by K. lactis. The total produced biomass of yeast was 
100 g [213].  
 
As shown in Figure 3.8, with same inducer concentration (Gal 2%), the use of urea as a 
nitrogen source did not increase the expression of rHA. The lowest concentration of urea (0.5 g/L) 
gave the highest rHA expression. On the other hand, using 7.5 g/L of ammonium sulfate induced 
higher expression of rHA than using 0.5 g/L urea. Interestingly, increasing concentration of either 
ammonium sulfate or urea did not increase rHA expression. 
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Figure 3.8: Effect of nitrogen source on the expression of rHA. The yeast grow
to optimal OD600 of 15 in YTGlu2% and transferred to minimal media with
Gal2% as inducer and different nitrogen source (ammonium sulfate and urea)
with different concentration and constant media pH of 6.5. The ammonium
sulfate gave the best rHA yield but not urea.
The rHA was detected using Western blot. These data were from 3
independent experiments. The one-way ANOVA with Tukey’s multiple
comparison test was done to statistically analyse the difference between
groups. The error bars are shown as Standard Deviation (SD).
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3.4.2 Modulating biochemical pathways to optimise 14C incorporation into rHA 
I examined whether modification of the tricarboxylic acid cycle (TCA cycle) in yeast could be 
utilised to increase 14C incorporation during the synthesis of rHA. Glucose, converted to pyruvate via 
glycolysis, can enter the TCA cycle for maximal energy output [214, 215]. Amino acids are made from 
the intermediates of the citric acid cycle [216]. When there is an abundance of pyruvate and amino 
acids, glucose may be converted into amino acids via diversion into the pentose-phosphate pathway 
or from intermediates in glycolysis and the TCA cycle (Figure 3.9 (1)). This idea was employed to 
increase the incorporation of 14C glucose into amino acids for rHA expression.  
3.4.2.1  Metabolite addition to enhance yield and labelling of rHA  
The addition of amino acids and pyruvate to induction media could potentially indirectly 
increase the incorporation of 14C into rHA by diverting the labelled glucose into amino acid synthesis 
(Figure 3.9 (1) and (2)). Hence L-Met, L-Glu and pyruvate were investigated for their effect on the 
incorporation of 14C-glucose into expressed rHA. All the cultures (5 ml) were supplemented with 10 
µCi 14C-glucose.  
Cultivation in control induction media (0.2 % galactose, YNB, pH 6.5) gave a high yield of rHA 
(~20 mg/L) with specific radioactivity of 6.9x104 cpm/mg (Figure 3.10A and B). The addition of 
pyruvate (0.22 M) and L-amino acids, methionine (20 mg/L) and glutamic acid (100 mg/L) did not 
affect rHA expression but significantly increased the specific radiolabelling of rHA to 13.5x104 
cpm/mg (Figure 3.10B), approximately double that of control. 
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Krebs cycle
Figure 3.9: The TCA cycle was adapted to show the conversion of glucose to L-
Methionine, L-Cysteine and L-Glycine from glutamate (1). The glucose could
also go through pentophosphate pathway to create aromatic amino acid (3).
The conversion from glucose to phosphoenolpyruvate was reversible hence an
abundance of pyruvate could potentially direct the glucose into synthesis of
amino acid. The abundance of pyruvate also increases the chance to synthesis
L-Leu, L-Val and L-Ile with incorporation of L-Glu (2). [37-39]
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3.4.2.2 Effect of induction method on 14C-glucose integration 
The possibility was tested that culturing K. lactis in minimal media in the growth phase as 
well as the induction phase may improve rHA expression and labelling. In this alternative induction 
technique, termed “old induction”, K. lactis was incubated in minimal media with L-amino acids and 
pyruvate added for the growth phase, instead of YTGlu2%, until an OD600 of 15 was reached. Then 
concentrated induction minimal media with 14C glucose, galactose, L-amino acids and pyruvate was 
added to a final 1x concentration. The added volume was insignificant relative to the total volume. 
The old induction method produced labelled rHA with a specific activity of 16.15 x 104 cpm/mg, 
which was not significantly different to the control fresh induction (Figure 3.11C). However, the old 
induction method produced only half the total rHA expression of the fresh induction method (12 and 
23.4 mg/L, respectively).   
The conversion of 14C-glucose to amino acid was investigated using radiometric imaging of 
Western blots of supernatant samples. The Western blot and phosphor image shows that rHA was 
the major radioactive protein in the supernatant (Figure 3.11C). The expressed rHA in both fresh and 
old induction culture had more radioactivity than the control.  
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A
B
Figure 3.10: Effect of pyruvate, L-amino acid additions on the expression and
radioactivity of rHA.
A. The amount of rHA expressed, measured by Western blot
B. The radioactivity of expressed rHA measured by liquid scintillation method
The minimal media – control consisted of 0.2% galactose, 7.5 g/L YNB, pH 6.5.
The fresh induction have extra 0.22 M pyruvate, 0.1 g/L L-Glu, 0.02 g/L L-Met.
The addition of amino acid and pyruvate help increase the radioactivity of rHA
but not the yield of rHA.
These data were from 3 independent experiments. The t-test was performed
to compare the difference between 2 groups. The error bar are shown as
Standard Deviation (SD).
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Figure 3.11: Effect of induction method with expression and radioactivity of
rHA by K. lactis
A. The expression of rHA in both induction methods
B. The radioactivity of expressed rHA in both induction methods
C. The phosphor image of Western blot membrane of samples taken from
supernatant from no addition of pyruvate and L-amino acids (N), control
(C) and old (O) induction culture.
Fresh induction only increased the rHA expression but not radioactivity.
PI: phosphor image, L-aa, Pyru: addition of L-Met, L-Glu and Pyruvate. With
old induction, the yeast was cultivated in minimal media with addition of
amino acids and pyruvate while the yeast was cultivated in complex media.
When induction began, old induction was supplied with concentrated inducing
media to culture. With fresh induction, old media was discarded and supplied
fresh media.
These data were from 3 independent experiments. The t-test was performed
to compare between 2 groups. The error bars are shown as Standard
Deviation (SD).
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3.4.3 Extraction of rHA from yeast culture supernatant 
The next consideration was extraction and purification of rHA from the culture medium. To 
optimise these processes, all samples were collected from the same culture YTGal2% (72 hours 
incubation) and investigated for purification efficiency. The combination of centrifugation (7300 g 
for 10 minutes at 4° C) /sterile vacuum filtration (0.2 µm - nitrocellulose membrane) was used for 
separation of yeast, cell debris and culture supernatant.  
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Table 3.1: Fluorescent probes used in both in vivo and in vitro studies. The
fluorescent probes were coupled to protein for experiments. All the probe
charge was based on physiological pH 7.45. The commercial probe data was
obtained from the manufacturer’s websites (Invitrogen and Sigma-Aldrich).
 
 100 | P a g e  
Name MW 
(Da) 
Net charge Structure 
Texas red 625.15 - 
 
BODIPY TR 634.5 0 
 
Alexa 488 643 - 
FITC 389.38 non 
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Figure 3.12: The structures of synthetic molecules used to investigate the
filtration of protein in the kidney.
(A) Ficoll has molecular weight of 70 kDa and Stokes radius of 50 Å
(B) The basic unit of Dextran sulfate could be linked to each other forming
large molecular weight molecule (3-2000 kDa)
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3.4.3.1  Ammonium sulfate precipitation  
Ammonium sulfate precipitation (ASP) was employed for protein precipitation from the 
culture supernatant. As the isoelectric point of rHA is 4.7, the pH for ASP was investigated over a 
range of 3.5-8.  
The ammonium sulfate precipitation of rHA was pH dependent (Figure 3.13). For acidic pH 
<5, significant rHA precipitation was evident at 35% ammonium sulfate but precipitation was not 
complete until the ammonium sulphate level reach 80%. With higher pH levels, there was minimal 
rHA precipitation in 35% ammonium sulfate, while pH 6.5 and 8 gave efficient precipitation in 80% 
ammonium sulfate. At a constant pH of 7.8, precipitation of rHA begins from the concentration of 
20% ammonium sulfate (Figure 3.14). Then, raising ammonium sulfate to 40% or higher gave 
essentially complete precipitation of rHA.  




kDA 3.5    5    6.5    8   (pH) 3.5    5    6.5    8    (pH)
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A B
C
Figure 3.13: The Western blot show the rHA availability in pellet and
supernatant collected from ammonium sulphate precipitation method with
different sample pH (3.5, 5, 6.5 and 8). The ammonium sulphate concentration
is 35% (A) and 80% (B). The figure (C) shows the Western blot of sample
supernatant after ammonium sulfate precipitation of 80% saturation. The
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A) Pellet B) Supernatant
Figure 3.14: The Western blot show the rHA availability in pellet (A) and
supernatant (B) after ASP with different concentration of ammonium sulfate
(20, 40, 60, and 80%). The concentration of 40% AS is enough for albumin
precipitation.
The entire sample has the same volume of the same culture. These samples
have pH of 7.8 .
HSA
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3.4.3.2  Three-phase partition precipitation 
As an alternative to direct ASP, three-phase partition precipitation (TPP) was tested. The pH 
of samples were either changed before or after the addition of ammonium sulfate and TPP. The 
samples were mixed with ammonium sulfate and t-butanol. After two hours incubation at room 
temperature, the proteins precipitate and form a layer (Figure 3.15).  
With centrifugation, the protein layer forms a floating disc. For changing pH before addition 
of ammonium sulfate and TPP, acidic pH of 3.5 – 5.0 was found to give better precipitation of rHA 
using TTP than neutral pH of 6.5 – 8 (Figure 3.16A). Although precipitation occurs with all tested pH, 
the complete precipiataion of rHA did not happen at pH 6.5 and 8 (Figure 3.16B).  
For changing pH after addition of both ammonium sulfate and TPP, a very acidic pH of 1 
precipitated essentially all the rHA. After TPP extraction of sample of pH 1, stained SDS-PAGE gel 
shows rHA is the major component in the pellet (Figure 3.16C). With pH 8, rHA did not fully 
precipitate and there were many bands other than rHA in the pellet (Figure 3.16D). 
The concentration of ammonium sulfate also affects protein precipitation in TPP. Figure 3.17 
shows the effect of different concentrations of ammonium sulfate in TPP, with a constant ratio of 
sample to t-butanol of 3:2. At a low concentration of ammonium sulfate (0.25 and 0.5 g per 3 ml 
sample), there was much less precipitation of rHA compared to 0.75 g of ammonium sulfate per 3 ml 
sample - which is equivalent to 25.5% ammonium sulfate in the ASP method.  





A.  Time=0hr B. Time=2hrs
Figure 3.15: Use of the TPP method to precipitate protein from yeast 
supernatant. The t-butanol, sample and ammonium sulfate was mixed with 
SBA ratio of 3:2:0.75 and vortexed and left at room temperature (A). After two 
hours incubation, the protein disc was precipitated (B). 
SBA ratio is the ratio between these components. The sample and t-butanol
unit are in ml when the ammonium sulfate unit is g. 
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Figure 3.16: Western blot showing the effect of pH on the rHA precipitation in 
pellet (A) and supernatant (B) after TPP extraction. The sample was adjust to 
pH of 3.5,5,6.5 and 8 before addition of t-butanol and ammonium sulfate. 
Final SBA ratio is 3:2:1.
The figure (C) and (D) show the Coomassie staining of SDS-PAGE gels and 
Western blot of TPP samples (pellet and supernatant). These samples had pH 
adjusted to pH of 1 and 8 after addition of t-butanol and ammonium sulfate. 
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Figure 3.17: Western blot showing rHA expression in pellet and sample after
TPP with pH 3.5 with different ammonium sulfate concentration.
The volume ratio between sample and t-butanol is 3:2 (ml/ml). The
ammonium sulfate was 0.25, 0.5 and 0.75.(g) S: supernatant after TPP, P:
collected pellet.
HSA
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3.4.4 Liquid chromatography for purification of rHA  
After extraction of the supernatant, liquid chromatography was employed to separate 
proteins from other materials in supernatant. A number of different chromatography techniques 
were investigated to optimize purification of rHA.   
3.4.4.1 Affinity chromatography 
As a first step in the purification of rHA from the proteins precipitated from the yeast culture 
media, I employed a HiTrap Blue column (Invitrogen) based on the ability of the column media (Blue 
Sepharose 6B-CL) to bind albumin with high affinity. Pellets collected from both ASP and TPP 
methods were applied to the affinity column. High salt conditions (1.5 M KCl pH 7.0) were used to 
elute rHA.  
As shown in Figure 3.18, elution of proteins bound to the HiTrap Blue column gave only one 
peak of A280 (absorbance at 280 nm). SDS-PAGE followed by Coomassie staining (Figure 3.18B) and 
Western blot (Figure 3.18C) showed that this peak contained predominantly rHA with some level of 
impurities. However, a higher yield of rHA was obtained from TTP based precipitation compared to 
the ASP method. 
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A
Figure 3.18: The chromatography (A) of samples from ASP (2) and TPP (1)
pellet that apply to HiTrap Blue column. The Coomassie staining of collected
fraction was shown in figure B. The figure C shows the availability of rHA in
collected fractions. The 1O and 2O were collected fractions of other proteins
peaks.
The sample was dialysed against buffer 50 mM KH2PO4 pH 7 before applied to
column which was also stabilised by 50 mM KH2PO4 pH 7 for five times
column volume. Non-binding protein would elute out of the column. The 1.5
M KCl and 50 mM KH2PO4 pH 7 was used to elute the rHA out of column. The
concentration of protein in sample was measured using Nanadrop2000 and
diluted to meet specific requirement for usage of HiTrap Blue column.
HSA
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3.4.4.2 Ion exchange chromatography  
Utilising the acidic isoelectric point of rHA, I tested ion exchange chromatography as a 
purification step for rHA isolation using the strong anion exchange resin Bioscale Macro-Prep High Q 
(Bio-rad) in which a quaternary ammonium group (-N+(CH3)
3 binds to negatively charged proteins. 
The isoelectric point of rHA was estimated to be 4.7. Therefore, I used a pH 7 buffer for rHA binding 
to the column and a pH gradient (7 to 1.5) to elute rHA from the column (Figure 3.19A).  
Samples from 5 different crude extraction methods underwent ion exchange 
chromatography using the High Q column. The media supernatant from fresh culture was collected 
by centrifuge/filtration and applied to the High Q column without further purification. Resuspended 
TPP and ASP pellets with/without centrifugal ultra-filtration with cut-off molecular weight of 30kDa 
(Amicon) were also tested  
Figure 3.19B shows rHA in control (C) media supernatant sample before being applied to 
High Q column and the collected fractions of the eluted peak (shown in A) for different the samples. 
The High Q column recovered 84% and 89% of rHA from ASP and TPP precipitated samples, 
respectively. Ultra-filtration of TPP and ASP samples prior to High Q column dramatically reduced 
the recovery rate of rHA (10% and 20% for ASP and TPP, respectively). The recovery rate of the 
directly applied supernatant was 81%. 
 
  













Figure 3.19: Ion exchange chromatography using the BioScale High Q (Biorad)
column (A) with samples collected from different protein extraction methods.
Western Blot (B) of collected fractions from different samples.
There were 5 samples was eluted and have fraction collected. The media
supernatant was collected after separation from yeast in culture then
undergone different purification step before applying to the ion exchange
column.
The supernatant of different samples was diluted in buffer to meet protein
loading capacity of column. Then the supernatant pH was adjusted to 7 and
applied directly to BioScale High Q - 5ml column. The gradient pH (7-1.5) was
used to elute sample.
C: control – crude yeast supernatant. TPP, ASP: collected samples from
TPP,ASP method. TPP-Amicon, ASP-Amicon: collected sample from TPP and
ASP and then undergone centrifugal dialysis with cut off molecular weight of
30kDa.
HSA
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3.4.4.3 Size exclusion FPLC  
Using a Sephacryl HR-200 16/60 column, 4 main peaks were identified by size exclusion 
chromatography of the yeast supernatant (Figure 3.20B). Coomassie staining identified an albumin-
sized band as the main protein in the third protein fraction (Figure 3.20C), and this was confirmed as 
rHA by Western blotting (Figure 3.20D).  
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A B C
D
Figure 3.20: Coomassie staining of yeast supernatant samples before (A) and
after (C) purification by FPLC. FPLC chromatography (B) shows the separation
of protein in supernatant by Sephacryl HR-200 column. The Western blot
confirms the availability of rHA in the collected fraction using FPLC method
(D).
The collected fraction was diluted 5 times due to the size of collected volume.
The running buffer is 150 mM KH2PO4 pH 7. The flow rate is 2 ml/min. Sample
injection size was 2 ml. Std HSA is serum human albumin at concentration of 1
mg/ml. K-lac sample was supernatant sample. Alb peak – supposed HSA peak
in chromatograph.
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3.4.4.4 Reversed-phase HPLC  
Purification of rHA based on hydrophobic interactions was investigated using reversed 
phase-HPLC. The reversed-phase chromatogram showed multiple peaks eluting from both the TPP 
and ASP pellet samples (Figure 3.21A). Both of the collected fractions from the 2 samples showed a 
single band of rHA by Western blot (Figure 3.21B and C). However, a potential limitation of the RP-
HPLC method is the use of TFA which can denature proteins and requires an extra step for removal 
before the rHA could be used in experiments.  
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Figure 3.21: RP-HPLC analysis of samples prepared by TPP and ASP.
The TPP, ASP pellet was diluted and applied to Zorbax 300SB column. The 
running buffer is Acetonitrile: ddH2O (40:60) with TFA 0.01%. Figure A shows 
the chromatography of eluted TPP and ASP pellet. Figure B and C show the 
Coomassie staining and Western blot detecting rHA of collected fraction from 
RP-HPLC methods of both pellets.  
Time(mins)
HSA
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3.4.4.5 Comparing TPP versus ASP precipitation samples for size exclusion HPLC  
More impurities were detected in the ASP pellet compared to the TPP pellet based on both 
size exclusion and reverse phase chromatography (Figures 3.21 and 3.22). In comparing the two 
methods, the size exclusion HPLC method appeared to give a higher degree of purification of rHA 
(Figure 3.22C).  
 120 | P a g e  
Figure 3.22: The Coomassie staining of SDS-PAGE gels show the pellet
components before (A) and after (C) which ANP and TPP pellet was separated
by the size exclusion HPLC method. The Western blot (D) show rHA availability
in these pellets after size exclusion HPLC methods. The size-exclusion (HPLC)
chromatograph (B) of both ANS and TPP pellet was shown.
Both ANS and TPP pellet were dialysis against 150 mM KH2PO4 pH 7 buffers
before injection to column. The column was BioSec-3 with flow rate of 1
ml/min using running buffer 150 mM KH2PO4 pH 7. AP, TP – ASP and TPP
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3.4.5 Protein analysis 
3.4.5.1 Characterisation of purified rHA  
An endotoxin assay (Lonza) was performed to exclude contaminated samples. If the 
endotoxin level was higher than 1 EU/ml, the culture supernatant was discarded and the protocol 
was checked for cause of contamination. Using optimized culture conditions for 14C-rHA expression, 
the culture media exhibited a minimal endotoxin level (0.037 EU/ml). Purified non-radiolabelled rHA 
also exhibited a minimal endotoxin level (0.024 EU/ml) (Figure 3.23). These endotoxin levels were 
well below that which induces inflammatory responses and therefore these preparations were 
deemed suitable for further studies [217, 218]. 
The purified rHA has less than 0.5% of impurities based on size exclusion HPLC analysis 
(Figure 3.24). Western blotting confirmed that the collected fraction contained rHA. The specific 
radioactivity activity of 14C rHA was 161,000 cpm/mg, indicating an average of one 14C per seven rHA 
molecules. This specific activity is sufficient for studies in cultured cells, but too low for in vivo 
studies in mice.  
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Figure 3.23: The endotoxin assay was performed with samples taken from the
culture supernatant and final purified rHA.
Due to the detection range limitation of endotoxin test kit, the supernatant
sample was concentrated for 5 times using freeze-dry before any endotoxin
test. The final concentration of purified rHA is 5 mg/ml for endotoxin test. The
figure above was endotoxin result of normal culture conditions and 1 mg/ml
rHA.
These data were from 3 independent experiments.
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Figure 3.24: Final purified rHA was checked for purity by using Size exclusion-
HPLC (A). The Western blot (B) shows the single peak in chromatograph (A) is
rHA.
The samples were dialysed against 150 mM KH2PO4 pH 7 buffers before
injection to column. The column was BioSec 3 with flow rate of 1 ml/min. The
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3.4.5.2 Analysis of albumin secondary structure by circular dichroism  
The secondary structure of rHA and of various commercial preparations of purified albumin 
and fluorescent labelled albumin was analysed by circular dichroism (CD). Analysis showed that rHA 
contains 57% -helix and 7% -sheet. This is comparable to the analysis of HSA and BSA and is 
consistent with previous studies of the secondary structure of purified albumin (Figure 3.25) [171, 
219, 220].  
Most of the commercial fluorescent labelled BSA preparations showed an increase in the 
degree of -helix formation, being significantly increased in DQRed-BSA compared to non-labelled 
rHA, HAS and BSA and to TR-rHA (Figure 3.25). -strand makes up only a small component of the 
secondary structure of albumin and this was not significantly different between the various labelled 
and unlabelled albumin preparations, including rHA (Figure 3.25).  
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Figure 3.25: Analysis of the secondary structure of different albumin 
preparations by circular dichroism (CD). The percentage of alpha helix and 
beta strands were determined in rHA and commercially purified BSA and HSA, 
with/without fluorescent labelling.
CDSSTR software was used to analyse the CD data with reference data set 7 
[210, 212]. Data are from three independent experiments and shown as mean 
± Standard Deviation (SD). Differences between groups was analysed by one-
way ANOVA with Tukey’s multiple comparison test. ns = not significant.
Original CD data is presented in the Appendix 8.3.
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3.4.5.3 Investigation of quenching in fluorescent labelled albumin 
Quenching, the loss of fluorescent signal, is a potential limitation in use of albumin 
conjugated with fluorescent molecules. If there is significant quenching due to close proximity of 
fluorescent molecules covalently bound to surface lysine residues in the albumin protein, then there 
will be an apparent increase in the fluorescent signal when the albumin protein is degraded into 
peptides and the fluorescent molecules are separated and quenching is removed. Indeed, this is the 
principle by which the DQ-albumin probes operate in that albumin is densely labelled with 15 
fluorescent molecules per albumin molecule so that quenching abrogates the fluorescent signal. 
However, upon degradation in the lysosome, the DQ-albumin peptides fluoresce strongly.  
I investigated the degree of quenching in a range of albumin conjugates by comparing the 
fluorescent signal in the intact albumin conjugate and after complete degradation by trypsin. As 
shown in Figure 3.26, there was a minor increase in fluorescent for some albumin conjugates (128% 
increase for A555-BSA and 132% increase for A488-BSA), a 165% increase for TR-BSA, and a 
substantial 373% increase for FITC-BSA. As a positive control, I verified a 2,945% increase in the 
fluorescent signal for DQRed-BSA following trypsin digestion (Figure 3.26).  
Using Texas red labelling kit (T-10244 - Molecular Probes®), rHA was labelled with Texas red 
probe (Invitrogen) for in vitro experiments (Figure 3.27). The labelling ratio was 1.23:1 (TR:rHA) 
which resulted no significant quenching (106%), whereas moderate quenching (165%) was evident 
with commercial TR-BSA (165%).    
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Figure 3.26: The auto-quenching effect of different fluorescence probe. The
trypsin was applied to different probes and measured for the auto-quenching
or increase of fluorescence signal in the sample. DQRed-BSA has the greatest
auto-quenching effect then FITC-BSA.
These data were from 3 independent experiments. The entire fluorescence
albumin were used at the same concentration 50 µg/ml (50 µl) per 1 µg
trypsin of 1 mg/ml. The mixture was incubated at 370 C for 45 minutes before
measurement.
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Figure 3.27: The TR-rHA and commercial TR-BSA was subjected to
trypsinization for 45 minutes at 370C.
These data were from 3 independent experiments. The trypsin was used with
ratio 1:50. The trypsinized and normal TR-rHA, TR-BSA was separated on SDS-
PAGE gel (4-12%). The gel was then exposed to laser of Ex585/Em620 (A). The
fluorescence absorbance of these sample was also measured (B).
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3.5 Discussion 
This chapter describes the optimisation of protocols for the production and purification of 
recombinant human albumin in a yeast expression system. A major challenge was to synthesize 14C-
rHA on a limited budget which required considerable manipulation of the expression system.  
3.5.1 Production and purification of rHA in K. lactis 
The optimal induction of rHA expression in K. lactis involved growth in conventional media 
containing yeast extract, tryptone and glucose (YTG), followed by induction using 2% galactose for 
48 hours. This gave yields of approximately 50 mg rHA/L.  
 
Of the three common carbon sources (glucose, galactose and glycerol), glucose was superior 
for growth of K. lactis. Galactose gave sub-optimal growth of K. lactis which is easily explained by the 
fact that galactose induces HA expression and thus would divert metabolic energy from cell growth 
to expression of an “irrelevant” protein. As a non-fermentable carbon source, glycerol does not 
provide sufficient energy for optimal growth due to modification of K. lactis metabolism. Therefore, 
glucose (which does not induce HA expression) was the optimal carbon source for the growth of K. 
lactis. 
 
The final purification protocol for rHA employed: i) centrifugation of culture media to obtain 
the supernatant; ii) precipitation of the rHA containing protein fraction using the TTP method; iii) ion 
exchange chromatography to remove most impurities, and; iv) RP-HPLC for the final purification 
step. This purification protocol was selected on the basis of the highest yield of rHA, as well as on 
minimising the time involved in each step (e.g. TTP is quicker than ASP and avoids the need for an 
overnight incubation) and the potential for denaturation of the recombinant protein. The final rHA 
preparation had negligible levels of endotoxin contamination making it suitable for in vitro and in 
vivo use. In addition, analysis of secondary structure by circular dichroism confirmed that rHA was 
correctly folded and had not undergone denaturation during synthesis or purification. 
 
Analysis of native albumin compared to various albumin probes using standard laboratory 
equipment to measure circular dichroism found a significant difference in secondary structure 
between DQ-red albumin and other albumin preparations. However, variation in the measurements 
meant that I was unable to definitively determine that other fluorescent albumin probes have a 
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different secondary structure compared to native albumin, despite clear trends (Fig 3.25).  This is 
consistent with with unpublished work by my supervisor, Prof Poronnik, in which clear differences in 
secondary structure between FITC-BSA and native BSA were identified by circular dichroism analysis 
using a synchrotron beam source. 
3.5.2 Production of 14C-rHA 
A major challenge in my thesis was to synthesize radiolabelled albumin with a native 
conformation on a limited budget. It was essential to incorporate the radiolabel during the protein 
synthesis step to ensure the resultant radiolabelled rHA would behave in a manner identical to that 
of non-radiolabelled rHA, so as to avoid the major limitation of all current albumin probes which are 
covalently modified at surface lysine residues. 14C was selected as the radioisotope of choice since it 
can be readily detected in samples by liquid scintillation counting, but is relatively safe to handle and 
for potential use in animal studies. On comparing the costs of various 14C containing precursor 
molecules, including glucose, galactose and several amino acids, it was evident that 14C-glucose was 
the most cost-effective strategy.  
 
To ensure uptake of 14C atoms from 14C-glucose into rHA, it was important to optimise 
several aspects of protein expression. First, non-radiolabelled carbon sources which could be 
incorporated into the rHA had to be minimised to ensure the highest possible up-take of 14C into 
rHA. For this, I utilised complex media to grow K. lactis to a high density culture which was then 
changed to minimal media containing 14C-glucose for induction of recombinant protein synthesis. 
Conditions for induction of protein synthesis in minimal media were optimised in terms of pH, 
oxygen supply and glucose content. 
 
Second, the minimal media was optimised to drive the metabolism of 14C-glucose into amino 
acid synthesis for protein production. As shown in Figure 3.9, one molecule of glucose can be 
metabolised via the TCA to produce two molecule of pyruvate. Therefore, 0.22 M of pyruvate can 
theoretically substitute for 0.11 M (2%) glucose in media. Hence, I added pyruvate to the minimal 
media as an energy source for cell metabolism and which would increase the conversion of 14C-
glucose to L-amino acid synthesis (Figure 3.9 (1) and (3)). Glucose can be converted to 3-
phosphoglycerate which is a precursor for the synthesis of amino acids cysteine, methionine, glycine 
and serine. This step requires phosphoserine transaminase (SER1) and L-glutamate (Figure 3.9 
(1))[221]. The serine produced by this reaction can also be utilised as a precursor for the biosynthesis 
of glycine, cysteine and tryptophan. The addition of L-glutamate to media can increase the 
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production of L-tyrosine and L-phenylalanine. Finally, the synthesis of L-methionine from 
homocysteine involves greater energy consumption than the synthesis of serine [222]. An excess of 
methionine promotes the synthesis of cysteine and consequently that of serine. Therefore, L-
methionine and L-glutamate were added to the minimal media to increase the conversion of limiting 
amounts of 14C-glucose into amino acids for rHA synthesis. 
The purified rHA had a similar secondary structure to that of HSA. On the other hand, the 
highly labelled DQRed-BSA was shown to have an altered secondary structure compared to native 
albumin. These changes in secondary structure could readily affect how receptors bind to albumin 
and thus modify their filtration/uptake by kidney.   
3.5.3 Specific activity of 14C-rHA 
The 14C-albumin preparations used in animal studies to measure albumin clearance and 
degradation have a specific activity in the range of 2 to 8 x 106 dpm/mg [136, 223]. Such 
preparations involve modification of surface lysine residues through chemical reactions. A crucial 
issue is whether such chemically labelled albumin preparations maintain normal structure. It has 
been shown that denatured preparations of chemically labelled albumin behave in an anomalous 
fashion, producing detectable amounts of radiolabelled peptides in plasma and having a much 
higher apparent renal clearance due to the filtration of these circulating albumin peptides [138]. 
Therefore, not only are chemically labelled albumin probes limited on the basis that only surface 
lysine residues are modified, but too high a degree of labelling, or excessive pH changes during the 
labelling reaction, can result in partial denaturation of the albumin and cause it to be handled in a 
fashion quite different from normal albumin.  
 
The 14C-rHA prepared in my studies had a specific activity of 16.1 x 104 cpm/mg. This means 
that on average one 14C atom is incorporated per 7 albumin molecules. Unfortunately, this was too 
low a specific activity to enable the use of my 14C-rHA probe in mouse studies to measure albumin 
clearance rates and degradation fragments in urine. However, this was still sufficient to perform 
studies of albumin uptake by cultured proximal tubular cells. The subsequent two chapters compare 
the uptake of 14C-rHA and fluorescent labelled albumin probes in cultured proximal tubular epithelial 
cells.    
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3.5.4 Quenching in fluorescent labelled albumin probes 
Quenching is an important issue for the interpretation of data when using fluorescent 
labelled probes. My studies identified that the degree of quenching of the fluorescent signal in 
labelled albumin probes increased in proportion to the number of fluorophore molecules conjugated 
per albumin molecule. While this is a deliberate feature in the use of DQ-albumin probes (a 15:1 
ratio of labels per albumin molecule) such that they do not fluoresce until they undergo proteolytic 
cleavage, it is an issue that is often overlooked in studies of fluorescent albumin probes such as the 
commonly used FITC-BSA which increases it fluorescent signal by over 3-fold following proteolytic 
cleavage [121, 159, 224]. FITC-BSA has approximately 7 molecules of FITC per molecule of albumin, 
leading to significant quenching. In contrast, A488-BSA and A555-BSA have lower degrees of 
labelling and a minimal quenching effect. Therefore, most studies on the uptake of fluorescent 
labelled albumin utilised A488-BSA and A555-BSA.    
 
3.5.5 Conclusion. 
In this chapter, I have described a method for the synthesis and purification of recombinant 
human albumin from K. lactis. The normal structure of the rHA, its purity and lack of endotoxin 
contamination were confirmed. This method was modified to allow the production of 14C-rHA within 
a limited budget in order to investigate how the kidney (proximal tubular epithelial cells) handles 
native albumin in comparison to covalently modified albumin probes.  In addition, I also showed 
there was difference in secondary structure between rHA and fluorescence albumin. The auto-
quenching effect of these fluorescence albumin also state the need for the development of native 
radioactive recombinant albumin. 
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4 Chapter 4. The role of megalin in the uptake of fluorescent 
albumin in tubular proximal cells 
4.1 Introduction 
4.1.1 Megalin in the uptake of albumin by opossum kidney cells 
Many different approaches have been utilised to investigate how the kidney deals with 
filtered plasma albumin, such as the isolated perfused kidney, dissected nephrons in culture and 
cultured proximal tubular epithelial cells. The opossum kidney (OK) cell line has been used 
extensively to research the uptake of albumin by proximal tubular epithelial cells [225, 226]. These 
cells display a typical epithelial morphology and upon reaching confluence in culture, have a 
cobblestone appearance and form domes. When confluent, OK cells strongly express megalin/cubilin 
receptors which play a major role in the endocytosis of albumin [89]. 
Megalin is a well-known scavenger receptor that is part of a larger macromolecular complex. 
Megalin was first discovered as the major antigen in the rat model of Heymann’s nephritis [90, 97, 
227] . It is a large transmembrane protein (517 kDa) that belongs to the family of LDL-receptors. It 
can also act as a calcium sensor in the parathyroid [100, 101]. As a scavenger receptor one of its 
main physiological roles is to bind albumin [117]. Megalin is highly expressed by renal proximal 
tubular cells where it has a major role in the reabsorption of filtered proteins [92]. 
Megalin forms a complex with cubilin, which is also known for its role in the reabsorption of 
multiple nutrient-carrying proteins from the glomerular filtrate, such as; albumin, intrinsic factor-
cobalamin (IF-B12), transferrin, vitamin D binding protein and apolipoprotein A-1 [28, 89, 91]. 
Megalin and cubilin are co-localised in the luminal surface of proximal tubule cells.  Cubilin also binds 
to the transmembrane protein Amnionless (AMN) to form a complex (CUBAM). This complex is 
required for the translocation of both proteins to the plasma membrane and their subsequent 
involvement in the endocytosic process. Although CUBAM can function at a reduced rate without 
megalin, it appears that megalin plays a prominent role in the internalization of cubilin-ligand 
complexes.  
4.1.2 Role of megalin in Dent’s disease 
Dent’s disease is a hereditary renal tubular disorder. It is characterized by low molecular 
weight proteinuria, hypercalciuria and nephrolithiasis [102, 228]. The disease is caused by a 
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mutation of chloride channel-5 (ClC-5) which is a member of the family of voltage-gated chloride 
channels [229]. In addition, Dent’s disease is associated with a reduction in renal megalin expression 
resulting in defective re-uptake of filtered protein. ClC-5 co-localizes with the megalin/cubilin 
complex on the brush border of proximal tubule cells and is known to be part of the megalin 
macromolecular complex. However, in Dent’s disease, the  megalin/cubilin complex is largely absent 
from the microvilli of renal proximal tubules, further indicating the role that ClC-5 plays in 
maintaining albumin uptake [230]. 
4.1.3 Toxicity of modified albumin  
Advanced glycated-end products (AGE), such as AGE-albumin, are formed by non-enzymatic 
glycation and oxidation (glycoxidation) reactions. The high levels of AGE present in diabetes have 
been implicated as an important pathogenic factor in the development of diabetic complications 
[231]. In addition, AGEs can induce inflammatory and fibrotic responses in human proximal tubular 
epithelial cells [232]. Modifications of albumin, such as carboxyl methylation of lysine residues (CML-
albumin), is known to increase oxidative stress associated with uraemia in haemodialysis patients 
[233]. Plasma CML-albumin is also several times higher in haemodialysis patients compared to 
normal subjects and non-uraemic diabetic patients. However, it is not known whether modified 
albumin is handled differently to normal (native) albumin by proximal tubular epithelial cells. 
4.2 Aims of Chapter 4 
The studies in this chapter investigated the role of megalin in the uptake of fluorescent-
labelled albumin in opossum kidney (OK) proximal tubular cells. The role of meglain in this process 
was examined by using two different OK cell lines; one expressing megalin (OK KL cells) and one not 
expressing megalin (OK DNP cells). In addition, I designed albumin peptides on the basis of their 
predicted involvement in the binding of albumin to megalin to investigate the uptake of fluorescent 
albumin by OK cells. 
4.3 Materials and methods 
All of the materials and methods are described in detail in Chapter 2. To maintain continuity, 
a brief summary of methods is discussed. Two opossum kidney (OK) cell lines were chosen for 
experiments in this chapter: the normal opossum kidney cell line with megalin expression (OK KL) 
and a sub-clone OK cell line lacking megalin expression (OK DNP). The morphology of each cell line 
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was investigated using inverted phase contrast microscopy. Megalin expression was assessed by 
fluorescent confocal immunomicroscopy and Western Blotting. The degree of uptake of different 
fluorescent-labelled albumin molecules by OK cells was determined using an uptake assay. The 
source of the cell lines and the chemicals utilised are described in detail in chapter 2. Statistical 
analysis was performed by either t-test or one way ANOVA with Tukey’s multiple comparison tests.   
4.4 Results 
4.4.1 Characterisation of the uptake of modified-albumin by OK KL cells  
In order to confirm a positive control for the uptake assay, the OK KL cell line was 
characterised on the basis of morphology, megalin expression and the uptake of modified albumin.  
4.4.1.1 OK KL cell morphology 
OK KL cells showed the morphology and distinctive features characteristic of OK cells (Figure 
4.1A). Confluent OK KL cells displayed cobblestone morphology and the characteristic dome 
formation of OK cells. 24 hours after reaching confluence, cell density was 63 x 104 cells /cm2. 
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Figure 4.1: Morphology of different opossum kidney cell clones (OK KL and OK
DNP). Photograph of confluent OK KL (A) and OK DNP (B) cells.
For OK KL, the cells exhibit a cobblestone morphology and areas of dome
formation (red circles) appear after cells reach confluence. For OK DNP, the
cells exhibit a predominant cobblestone morphology, but lack dome
formation. Image (x100 magnification).
A. OK KL
B. OK DNP
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4.4.1.2 Megalin in OK KL cells  
As shown in Figure 4.2, megalin was detected on the brush border of proximal tubular cells 
by immunofluorescent staining of normal mouse kidney. Western blotting of megalin in normal rat 
kidney lysates (Figure 4.2) identified strong bands running at 250 kDa and higher molecular weights 
which are presumably intact and cleaved fragments of the megalin protein which is susceptible to 
proteolytic cleavage. Megalin was detected in OK KL cell lysates as bands running at approximately 
250 kDa (Figure 4.2), which is consistent with the findings in rat kidney. It appears that megalin 
underwent limited degradation in the lysate buffer despite the presence of protease inhibitors 
(Chapter 2- 2.2.10).  
Cubulin cooperates with megalin in the binding and endocytosis of albumin in proximal 
tubular epithelial cells. However, I was unable to verify cubulin expression in OK KL cells due to a lack 
of a suitable commercial antibody to detect cubulin in the opossum.  
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A. Megalin immunostaining in 
normal mouse kidney. 
B. Negative control for megalin 
immunostaining in mouse kidney.
Figure 4.2: Immunofluorescent staining of megalin in OK cells.
(A) Normal mouse kidney shows immunostaining for megalin (blue) on the
luminal surface of proximal tubules.
(B) Negative control omitting the primary antibody shows no staining.
(C) Western blot detection of megalin in cell and tissue lysates. Lane 1,
megalin was detected as 2 bands at approximately 250 kDa in OK KL cell
lysate. Lane 2, molecular weight markers (sizes shown on the side in kDa).
Lane 3, a 1 in 5 dilution of normal rat kidney lysates showing a strong band
around 250 kDa. Lane 4, normal rat kidney lysate. Lane 5 OK DNP cell lysate
in which no megalin band was detected. Tubulin was also detected in all
samples (green band).
C. Western blot 
detection of megalin 
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4.4.1.3 Uptake of fluorescent bovine serum albumin by OK KL cells  
After a two hour incubation period, OK KL cells showed significant uptake of both FITC-BSA 
and A488-BSA (Figure 4.3). The cell lysate showed a greater fluorescent signal with uptake of A488-
BSA compared to FITC-BSA, even though the cells were incubated with the same volume and 
concentration of labelled BSA. Whether this apparent difference is due to the efficiency of detection 
of the respective fluorophores or differences in degradation of the BSA preparations is not clear.   
Confocal imaging showed the uptake of A488-BSA in cytoplasmic vesicles within OK KL cells 
(Figure 4.4). At this time, megalin was largely present around the cell surface of the cells, suggesting 
dissociation of megalin from albumin at this time point. This may reflect A488-BSA moving into 
lysosomes whereas megalin is recycled to the cell surface.  
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Figure 4.3: Graph shows uptake of FITC-BSA and A488-BSA by OK KL cells in
comparison to the background control. Significant uptake of both forms of
modified albumin was detected.
The data were from at least 3 independent experiments. The one-way ANOVA
with Tukey’s multiple comparison test was done to statistically analyse the
difference between groups. The error bars are shown as Standard Deviation (SD).
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4.4.2 Characterisation of the uptake of modified-albumin by OK DNP cells 
One approach to investigating the role of megalin in the uptake of fluorescent-labelled 
albumin in OK KL cells is to use a subclone of OK cells that lacks megalin expression. For this purpose 
I examined OK DNP cells.   
4.4.2.1 OK DNP cell morphology 
Confluent OK DNP cells showed a largely cobble stone morphology (Figure 4.1B), although 
this was not as distinct as that seen in OK KL cells. However, confluent OK DNP cells lacked the 
characteristic dome formation. Cell density 24 hours after reaching confluence was slightly lower 
than OK KL cells (41x104 cells /cm2) 
4.4.2.2 Lack of megalin expression in OK DNP cells 
Western blotting showed a lack of megalin expression in OK DNP cells in comparison to the 
positive control of rat kidney and megalin expression in OK KL cells (Figure 4.2C). The tubulin control 
was detected in OK DNP cells verifying correct loading of the cell lysate.  
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A. Megalin staining
C. Combined image of megalin and A488-BSA
B. Uptake of A488-BSA
Figure 4.4: Confocal microscopy visualisation of A488-BSA uptake by OK KL
cells. OK KL cells were incubated for 2 hrs with A488-BSA and then examined
by confocal microscopy.
(A) Shows immunostaining for megalin (blue).
(B) Shows uptake of A488-BSA (green).
(C) Combined images of megalin and A488-BSA.
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4.4.2.3 Lack of uptake of fluorescent albumin by OK KL cells 
Compared to blank cells, no uptake of A488-BSA or FITC-BSA at 50 µg/ml or 200 µg/ml was 
observed in OK DNP cells (Figure 4.5). Given the lack of uptake of fluorescent albumin by OK DNP 
cells, the remaining studies in this Chapter were performed using OK KL cells.  
4.4.3 Uptake of modified albumin by OK KL cells operates via endocytosis  
Latrunculin A disrupts actin filaments of the cytoskeleton and thus inhibits the endocytic 
pathway. As shown in Figure 4.6, Latrunculin A caused a dose-dependent inhibition of the uptake of 
A488-BSA by OK KL cells, reaching a maximal 78% inhibition of A488-BSA uptake at 1 µM. Toxicity 
was only evident at the highest concentration (2 µM) of Latrunculin A. Further experiments used 
Latrunculin A at the 1 µM concentration. 
Latrunculin A also inhibited the uptake of FITC-BSA by OK KL cells (Figure 4.7). The uptake of 
FITC-BSA by OK KL cells appeared to be saturated at 50 µg/ml, since increasing the concentration of 
FITC-BSA did not result in an increase in uptake. The uptake of FITC-BSA at all concentrations tested 
was significantly reduced by Latrunculin A.  
The uptake of A488-BSA by OK KL cells was imaged by confocal microscopy together with 
megalin expression (Figure 4.8A). Pre-treatment of cells with Latrunculin A dramatically inhibited the 
uptake of A488-BSA and caused a partial reduction in megalin expression (Figure 4.8B). These data 
confirm that the uptake of both A488-BSA and FITC-BSA by OK KL cells is actin dependent. 
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Figure 4.5: The uptake of fluorescent albumin by OK DNP. There were no
uptake of A488-BSA (A) and FITC-BSA (B) by OK DNP cells. The fluorescent
signal between uptake of 50 µg/ml and 200 µg/ml of A488-BSA and Hepes
buffer was not significant different if not virtually no change in fluorescent
signal.
The data were from at least 3 independent experiments. The one-way ANOVA
with Tukey’s multiple comparison test was done to statistically analyse the
difference between groups. The error bars are shown as Standard Deviation
(SD).




















Figure 4.6: Effect of Latrunculin with uptake of A488-BSA by OK KL. OK KL cells
were pre-incubated with varying concentrations of Latrunculin A for 45 min
prior to performing an assay to measure the uptake of 50 µg/ml A488-BSA.
A significant reduction in A488-BSA uptake was evident at all concentrations
of Latrunculin A, reaching a maximal effect at 1 µM. At 2 µM of Latrunculin A,
OK KL cells exhibited drug toxicity with some cells beginning to detach from
plastic surface of the well.
The data were from at least 3 independent experiments. The one-way ANOVA
with Tukey’s multiple comparison test was done to statistically analyse the
difference between groups. The error bars are shown as Standard Deviation
(SD).
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Figure 4.7: Effect of Latrunculin with uptake of FITC-BSA by OK KL cells. The OK
KL cells were incubated for 45 mins with 1 µM Latrunculin A (La) prior to an
albumin uptake assay using 50 µg/ml, 100 µg/ml or 200 µg/ml FITC-BSA.
There was no difference in the fluorescent signal for the uptake of FITC-BSA in
the absence of Latrunculin A, and in the presence of Latrunculin A there was
an equivalent degree of inhibition of FITC-BSA uptake for all concentration of
FITC-BSA examined.
The data were from at least 3 independent experiments. The one-way ANOVA
with Tukey’s multiple comparison test was done to statistically analyse the
difference between groups. The error bars are shown as Standard Deviation
(SD).
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A. A488-BSA uptake (green) and megalin (blue) in 
control OK KL cells
B. A488-BSA uptake (green) and megalin (blue) in 
Latrunculin treated cells
Figure 4.8: Confocal analysis of the effect of Latrunculin on the uptake of
A488-BSA and megalin expression by OK KL cells. Combined confocal analysis
of the uptake of A488-BSA (green) and megalin staining (blue) by control cells
(A) and cells pre-treated with 1uM Latrunculin A (B). Note the marked
reduction in A488-BSA uptake following Latrunculin A treatment.
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4.4.4 Competition studies in the uptake of modified albumin by OK KL cells 
Albumin uptake by OK cells operates via megalin-dependent endocytosis. However, it is not 
clear how modification of albumin affects binding to the megalin receptor during endocytotic 
uptake. Therefore, binding assays were performed to assess the ability of standard BSA (minimally 
modified) versus AGE-BSA and CML-BSA (heavily modified) to compete with A488-BSA or FITC-BSA 
uptake by OK KL cells.  
4.4.4.1 Effect of various types of BSA upon the uptake of fluorescent albumin probes by OK 
KL cells 
A 10-fold excess of BSA, but not equimolar BSA, significantly reduced uptake of A488-BSA 
(Figure 4.9A), indicating competition between A488-BSA and BSA for endocytic uptake by OK KL 
cells. However, equimolar AGE-BSA or CML-BSA significantly reduced A488-BSA uptake – an effect 
that was enhanced using a 10-fold molar excess (Figure 4.9A). By contrast, neither equimolar or a 
10-fold molar excess of BSA, AGE-BSA or CML-BSA had any effect upon the uptake of FITC-BSA by OK 
KL cells (Figure 4.9B).   






A488-BSA vs AGE-BSA and CML-BSA










Figure 4.9: Competition studies for uptake of A488-BSA (A) or FITC-BSA (B) by
OK KL cells. Cells were co-incubated with A488-BSA (A) or FITC-BSA (B) in
combination with either an equal concentration of 50 µg/ml (+) or a 10-fold
excess (10+) of BSA, AGE-BSA or CML-BSA.
(A) The uptake of A488-BSA was significantly reduced by 10-fold excess BSA or
by equimolar AGE-BSA or CML-BSA.
(B) In contrast, the addition of BSA , AGE-BSA or CML-BSA did not affect the
uptake of FITC-BSA.
The data were from at least 3 independent experiments. The one-way ANOVA
with Tukey’s multiple comparison test was done to statistically analyse the
difference between groups. The error bars are shown as Standard Deviation
(SD).  




Figure 4.10: OK KL cells were pre-treated (or not) with 1uM Latrunculin A (La)
prior to performing an assay to measure the uptake of: (A) FITC-BSA, (B) TR-
BSA, or (C) A555-BSA.
The data were from at least 3 separated experiments. The t-test was done to
statistically analyse the difference between groups. The error bars are shown
as Standard Error in the Mean (SEM).
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A. A488-BSA uptake (green) and Lamp-1 (red) in control OK KL cells
B. A488-BSA uptake (green) and Lamp-1 (red) in Latrunculin treated cells
Figure 4.11: Confocal analysis of the uptake of A488-BSA (green) and Lamp-1
staining (red) for lysosomes by control cells (A) and cells pre-treated with 1
µM Latrunculin A (B). Note the marked reduction in A488-BSA uptake and the
change in Lamp-1 staining pattern following Latrunculin A treatment.
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4.4.4.2 Effect of Latrunculin A upon uptake of different fluorescent albumin probes  
Latrunculin A markedly inhibited the uptake of TR-BSA and A555-BSA, having a smaller effect 
upon the uptake of FITC-BSA (Figure 4.10). This could be due to different probes have different 
binding affinity to membrane receptors, or that the different probes have varying degrees of auto-
quenching.   
The lysosomes are responsible for most degradation of protein inside the cell. Lysosomal-
associated membrane protein 1 (Lamp-1) is a marker for the lysosomal compartment [234, 235]. 
Therefore, the effect of Latrunculin A on the uptake of A488-BSA and Lamp-1 expression was 
investigated. In normal cells, Lamp-1 is concentrated in vesicles near the outer cell membrane and 
abundant A488-BSA can be visualised inside OK KL cells (Figure 4.11A). By contrast, Latrunculin A 
substantially reduced the uptake of A488-BSA and Lamp-1 staining was also significantly reduced 
(Figure 4.11B).  
In Chapter 3, it was shown that trypsinization of fluorescent albumin probes leads to an 
increase in the fluorescent signal, indicating auto-quenching (Figure 3.27). Auto-quenching was more 
prominent in FITC-BSA compared to TR-BSA (Figure 3.27). The uptake of trypsinized TR-BSA by OK KL 
cells was greater than that of the intact albumin probe (Figure 3.27). The uptake of both intact and 
degraded TR-BSA was significantly reduced by Latrunculin A, although there was still a greater 
uptake of degraded TR-BSA (Figure 4.12A). The uptake of trypsinized FITC-BSA was significantly 
greater than intact FITC-BSA (Figure 4.12B). Latrunculin A caused only a small reduction in the 
uptake of intact or degraded FITC-BSA by OK KL cells (Figure 4.12B). These results suggest that the 
differences in the uptake of A488-BSA and FITC-BSA are not due to an auto-quenching effect.  
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Figure 4.12: Comparison of the uptake of intact FITC-BSA or TR-BSA (50µg/ml)
with the uptake of trypsinized fragmented FITC-BSA or TR-BSA (50 µg/ml).
After auto-quenching effect of TR-BSA and FITC-BSA was taken into account,
there were still huge difference between the uptake of trypsinized fluorescent
and non-trypsinized fluorescent albumin under Latrunculin effects (1uM).
The data were from at least 3 independent experiments. The one-way ANOVA
with Tukey’s multiple comparison test was done to statistically analyse the
difference between groups. The error bars are shown as standard deviation.
La-Latrunculin applied
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4.4.5 Design of peptides to interfere with albumin binding to megalin. 
The aim of this section was to design peptides which could inhibit albumin binding to 
megalin and thereby block albumin uptake by OK KL cells. Such peptides would be useful tools for 
investigating native and modified albumin uptake by OK cells. Since megalin can bind multiple 
ligands, the selection of albumin peptides employed analysis based upon areas of predicted 
conformational similarity between albumin and the other megalin ligands. Several different 
computer modelling programs were used as described below.   
4.4.5.1 Megalin ligands compared to albumin 
Analysis using ClustalW2 showed multiple alignments across different species of albumin 
(human, cow, mouse, rat and sheep) indicating almost identical sequences with a high number of 
positive substitutions (see Appendices 8.4 to 8.6). The multiple alignment score was 31236 which 
suggested an exceptional amount of conserved homology in these albumin proteins. Hence, it would 
be safe to suggest there was a conserved region(s) in the albumin molecule that facilitates binding to 
megalin. 
A number of proteins known to bind to megalin were analysed, including DBP, TF and Apo A-
1. The Blastp alignment showing these megalin ligands indicated that they are not significantly 
similar to HSA (Table 4.1A). The ClustalW2 alignment results of these megalin ligands at the mRNA 
level showed a high level of homology between them. However, this could be due to common 
features of mRNA such as poly-A-tails. The multiple alignments of amino acid sequences of these 
megalin ligands showed a very low score of -454. However, the large difference in alignment score 
between mRNA and amino acid sequences could also be due to varying lengths of the protein 
sequence. 
The pair-based alignment of each megalin ligand with HSA produced 9 different peptide 
motifs. These motifs were manually chosen based on the homology of the global alignment of the 
megalin ligands. As can be seen in Table 4.1B, possible motifs 1, 4, 5, 6 and 9 are composed of 
predominant neutral and non-polar amino acids. Motifs 2 and 8 are mixtures of acidic and basic 
polar residues. Motif 3 is composed of neutral and polar amino acids. Further analysing of albumin 
3D structure eliminated 2 motifs (6, 8) due to the internal location of peptides. The X-ray based 
structure of albumin did not cover the region of the first motif which was then excluded from the 
analysis. 























Table 4.1: Alignment score and Expect value (E- value) of HSA with megalin ligands 
(A). The E-value describes the random background noise in which the smaller the 
value, the better the accuracy of the data. The alignment score is a measure of the 
similarity between two sequences using algorithms. The higher the score also 
indicates the greater the accuracy of the result. The most similar alignment was DPB 
with the score of 136 and E-value of 2E-36. The relevant ClustalW alignment is in 
appendix section. 
The position and side chain properties of possible motifs for albumin peptide binding 
to megalin (B). The colour code for amino acids with polar neutral side chains (black),
amino acids with hydrophobic side chain – aliphatic (green) ,  amino acids with 
hydrophobic side chain – aromatic (green with yellow highlight), amino acids with 
electrically charged side chains – acidic (red) , amino acids with electrically charged 
side chains – basic (blue), unique amino acid (purple).
A 
B
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Table 4.2: Peptides used in albumin binding studies. The origin motif is labelled in red 
while the extra residues added onto the ends of the peptides are labelled in black. 
Their secondary structure and domain location in 3D albumin model is also shown. 
The pI and molecular weight was calculated using tools from Expasys. 
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4.4.5.2 Structure of the selected peptides 
From the motifs identified, 6 peptides were selected for further study (labelled as red in 
Table 4.2). These peptide sequences are shown with extra residues extended on both their N and C 
termini in order to maintain their secondary structure as identified in the albumin molecule. The 
final structures have 2-6 extra residues on either terminus. These extra residues were chosen to 
ensure any present motif will be included such as protruding shape. The peptides were then made 
by Chinapeptide with high purity (>99.5%).  
Peptides A1, A3 and A6 have -helices as their main secondary structure. The coil structure 
contributed more than half secondary structure of A2 and A5. The confirmation of peptide A4 was 
half helices and half coil. Peptides A1, A3 and A5 are located in domain I of albumin, while peptides 
A2 and A4 expand from domain I to II.  Peptide A6 was the only peptide located within domain III 
(Figure 4.13). Based on the theoretical pI of these peptides, their overall charge is expected to 
positive at pH 7.45 as used in the albumin uptake assays in OPK cells. All of the peptides A1 to A6 
had 100% identity alignment to human serum albumin protein (Pdb number - 1AO6). 
Analysis by circular dichroism indicated the structural features of the selected peptides in 
Hepes buffer pH 7.45 (Figure 4.14). Analysis of CD data from Dichroweb using the K2D method 
shows A1 had random coil structure. The peptide A4 also had random coil as main component (82%) 
then β-sheet (10%).  The peptides A5 and A6 shared similar proportion of secondary structure and 
both had the highest α-helix structure (22% and 28%) between 6 peptides. The peptide A2 had 
random coil structure (61%) as major component and then β-sheet (43%). The peptide A3 had a 
similar ratio of β-sheet (47%) and random coil (46%) structure. 
4.4.5.3 Effect of albumin peptides on the uptake of fluorescent albumin probes by OK KL 
cells  
OK KL cells were pre-incubated with 10µg/ml or 50µg/ml of each peptide before the 
addition of A488-BSA. Compared to the control, only peptide A6 significantly reduced A488-BSA 
uptake (Figure 4.15). A positive control of Latrunculin A to inhibit A488-BSA uptake was included in 
the assay.   
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Figure 4.13: This figure depicts the 3D structure of albumin with location of
the selected peptides(A1-A6). The positions of 6 peptides are located in
different domain of human albumin. The grey/brown colour depict domain 3,
yellow depict domain 2, green depict domain 1. The blue colour depicts
peptides sequence.
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Figure 4.14: Analysis of the 6 peptides by circular dichroism in Hepes buffer pH
7.45 at 1 mg/ml. Structure was analysed using the K2D method (Dichroweb)
based on crude circular dichroism value (Jasco). The table shows the
prediction of secondary structures of peptides. millidegrees (mdeg). high
tension (HT) – V (voltage). The measurement data were from average of 3
separated experiments .








A1 0.00 0.00 1.00
A2 0.05 0.34 0.61
A3 0.06 0.47 0.46
A4 0.07 0.10 0.82
A5 0.22 0.26 0.51
A6 0.28 0.32 0.40
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Figure 4.15: The effect of 10 µg/ml (A) or 50 µg/ml (B) of peptides A1 to A6 on
the uptake of A488-BSA by OK KL cells.
Only the A6 peptide exhibited a significant inhibition of A488-BSA uptake at
both concentrations tested. The other peptides did not inhibit the uptake of
A488-BSA. Latrunculin was used as control for endocytosis.
The data were from at least 3 independent experiments. The one-way ANOVA
with Tukey’s multiple comparison test was done to statistically analyse the
difference between groups. The error bars are shown as Standard Deviation
(SD).
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4.5 Discussion 
The OK KL cell line exhibited the typical features of OK cells with cobblestone morphology 
and dome formation when confluent, expression of megalin and the uptake of fluorescent albumin 
probes. Megalin was localized near outer membrane layer of OK KL cells. However, there was no 
apparent co-localization of megalin and A488-BSA within these cells after the 2 hours incubation. 
This is in agreement with previous studies of the uptake of DQRed-BSA by OK cells [142].  
4.5.1 Uptake of different fluorescent albumin through different pathway 
The ability of Latrunculin A to markedly inhibit the uptake of A488-BSA, A555-BSA and TR-
BSA by OK KL cells is consistent with this uptake occurring via endocytosis. The importance of the 
cytoskeleton for megalin expression was also evident in Latrunculin A treated cells. The increased 
uptake of trypsinized A488-BSA in OK KL cells was unexpected. The increased fluorescent signal 
evident upon trypsinization could have accounted for part of this effect. Whether the A488-BSA 
fragments were taken up by OK KL cells via the megalin receptor was not confirmed, but the ability 
of Latrunculin A to markedly inhibit this uptake indicates a receptor-based endocytic mechanism is 
involved.  
Curiously, Latrunculin A had only a partial inhibitory effect upon the uptake of FITC-BSA by 
OK KL cells. This suggests that some of the uptake could occur independently of the normal 
endocytic machinery. Indeed, Latrunculin A treatment suppressed Lamp-1 expression and by 
implication reduced lysosomal activity, thereby ruling out the loss of auto-quenching as a possible 
explanation. One reason why Latrunculin A could only partially reduce the uptake of FITC-BSA is that 
unlike the other modified BSA probes, FITC-BSA and its trypsinized fragments can bind non-
specifically to the cell surface such that they are not dislodged by the stringent washing procedure in 
the uptake assay. However, if this was the case, it would be expected that non-specific uptake of 
FITC-BSA would have been identified in OK DNP cells. Therefore, a portion of FITC-BSA may be taken 
up into OK KL cells via an unknown selective mechanism which operates independent of 
endocytosis.  
A different uptake mechanism is also proposed by the lack saturation of FITC-BSA uptake at 
50 µg/ml – a relatively low concentration. Indeed, this is supported by previous studies in which only 
extremely high doses of BSA (10 mg/ml) were able to compete for uptake of FITC-BSA by OK cells 
[224]. This could operate via the low efficiency fluid-phase endocytosis in which cells continuously 
takes up solutes from their neighbourhood. The fluid-phase endocytosis does not require specific 
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binding to the plasma membrane or concentration of molecules at special sites [236]. Thus it would 
require extremely high dose to inhibit the uptake of FITC-BSA by OK KL cells. 
4.5.2 Effect of albumin peptide with fluorescent albumin uptake 
The A6 peptide was shown to significantly inhibit the uptake of A488-BSA by OK KL cells. The 
A6 peptide is the only motif tested from domain III of albumin. These results provide an initial 
mapping of a site on the surface of albumin that may directly interact with the megalin receptor. 
Unfortunately, due to time constraints, further work such as mutating amino acids within the 
albumin molecule to assess the impact upon uptake by OK KL cells was not performed. However, the 
A6 peptide represents as an interesting tool for analysing the uptake of native versus modified 
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5 Chapter 5. Characterisation of the uptake of native versus 
modified recombinant albumin by proximal tubule cells. 
5.1 Introduction  
5.1.1 Albuminuria is a marker of diabetic nephropathy and cardiovascular disease. 
Defective albumin handling by the kidney is one of the earliest signs of progressive renal 
disease [237]. The first indication of kidney disease in the diabetic patient is usually the presence of 
microalbuminuria – defined as urinary excretion of 30 to 300 mg albumin/day. Microalbuminuria 
often progresses to macroalbuminuria (>300 mg albumin/day) with a deterioration of renal function 
until reaching end-stage renal failure [23-25]. 
As considered in the literature review, the precise mechanism(s) of albuminuria remain hotly 
debated due to conflicting results from different research groups. Two contrasting mechanisms have 
been proposed to contribute to albuminuria. The conventional view is that damage to the 
glomerular barrier creates leakage of albumin into urine [26, 35, 146]. Alternative hypotheses for the 
cause of albuminuria are the impairment of tubular cell uptake of filtered albumin for degradation 
via the lysosomal pathway, or impairment of the ability of tubular cells to uptake and return filtered 
albumin to the blood stream [36].  
5.1.2 Potential problems with using modified albumin for investigation of albuminuria. 
All published studies of albumin uptake by tubular epithelial cells have been performed 
using modified or non-native forms of albumin. Some issues arise due to biophysical differences 
between chemically-labelled and native albumin. As described in Chapter 3, CD analysis showed 
differences in secondary structure between various types of fluorescent-labelled albumin and native 
albumin. In addition, the migration pattern on SDS-PAGE gels indicates differences in the net charge 
of albumin molecules conjugated with fluorescent probes compared to that of native albumin. 
Furthermore, the auto-quenching effect which is evident upon trypsinization of some fluorescent 
albumin probes complicates interpretation of the results obtained from urine analysis and cell 
uptake assays. To address these concerns, I developed a uniformly labelled radioactive native 
recombinant albumin probe as described in Chapter 3. 
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5.2 Aims of Chapter 5 
This chapter will investigate whether modification of albumin alters its uptake by tubular 
epithelial cells by comparing the uptake of native recombinant versus modified albumin in OK cells. 
In addition, the role of megalin in the uptake of fluorescent and native albumin probes by OK cells 
will be investigated.  
5.3 Materials and methods 
All the materials and methods are described in detail in Chapter 2. To maintain continuity, a 
brief summary of the methods used is given. The cell uptake assay was performed using fluorescent 
albumin and radioactive and non-radioactive native albumin. The ability of albumin peptides to 
inhibit the uptake of radioactive recombinant albumin was also tested using the cell uptake assay. 
Statistical analysis was performed by either t-test or one way ANOVA with Tukey’s multiple 
comparison tests.   
5.4 Results 
5.4.1 Uptake of native recombinant human albumin versus fluorescent albumin by OK 
cells  
5.4.1.1 Non-radioactive recombinant albumin versus fluorescent albumin 
The 14C-rHA was shown not to fluoresce under assay conditions (Appendix 8.2). As we can 
see from Figure 5.1(A & B), a 10-fold molar excess of recombinant human albumin (rHA) had no 
effect upon the uptake of A488-BSA or FITC-BSA by OK KL cells. On the other hand, a 10-fold molar 
excess of either purified human serum albumin (HSA) or bovine serum albumin (BSA) reduced the 
uptake of A488-BSA, but not the uptake of FITC-BSA (Figure 5.1 C-F). Co-incubation with HSA and 
BSA reduced the uptake of 50 µg/ml A488-BSA by 16% and 37%, respectively (Figure 5.1 C & E). 
Interestingly, a 1:1 ratio of DQRed-BSA: A488-BSA significantly reduced the uptake of A488-BSA by 
25% (Figure 5.1 E), while an equimolar ratio of DQRed-BSA reduced the uptake of FITC-BSA by 24% 
(Figure 5.1 F).  
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Figure 5.1: Competition studies on the uptake of fluorescent albumin. OK KL
cells were incubated with 50 µg/ml A488-BSA (A, C, E) or 50 µg/ml FITC-BSA
(B, D, F). The uptake of FITC-BSA was not blocked by a 10-fold molar excess of
rHA, HSA or BSA (B, D, F). However, a 10-fold excess of HSA (500ug/ml)
reduced the uptake of A488-BSA (C), while rHA had no effected on the uptake
of A488-BSA (A). A 1:1 ratio of DQRed-BSA (50 µg/ml) reduced the uptake of
A488-BSA to the same degree as a 10-fold excess of BSA (500 µg/ml) (E). AFU,
Arbitrary Fluorescent Units.
The data were from at least 3 independent experiments. The one-way ANOVA
with Tukey’s multiple comparison test was done to statistically analyse the
difference between groups. The error bars are shown as standard deviation.
 









































 172 | P a g e  
 
5.4.1.2 Radioactive recombinant albumin versus fluorescent albumin 
The addition of 14C-rHA at a 10-fold molar excess over that of A488-BSA or FITC-BSA failed to 
inhibit the uptake of these fluorescent albumin probes by OK KL cells (Figure 5.2). This result 
contrasts with the ability of BSA and HSA to compete with uptake of A488-BSA (Figure 5.1). The 
failure of 14C-rHA to inhibit the uptake of fluorescent albumin is consistent with the lack of effect of 
unlabelled rHA (Figure 5.1 A & B). These results suggest that the uptake of native versus modified 
albumin may operate via different pathways in OK KL cells.  
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Figure 5.2: Competition studies on the uptake of fluorescent albumin and
radioactive albumin. OK KL cells were incubated with or (A) FITC-BSA or (B)
A488-BSA. Co-incubation with 14C-rHA (500 µg/ml) did not affect uptake of
the fluorescent albumin probes. AFU, Arbitrary Fluorescent Units.
The data were from at least 3 independent experiments. The one-way
ANOVA with Tukey’s multiple comparison test was done to statistically
analyse the difference between groups. The error bars are shown as standard
deviation.
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5.4.1.3 Uptake of native 14C-rHA and non-radioactive rHA by OK cells. 
The uptake of 14C-rHA was similar between OK KL and OK DNP cells (Figure 5.3). In addition, 
this uptake could not be saturated, even upon the addition of 500 µg/ml of 14C-rHA (Figure 5.3). 
However, only a very small fraction (approximately 2%) of the 14C-rHA added was actually taken up 
by either OK KL or OK DNP cells (Figure 5.4). In contrast to the uptake of 14C-rHA, OK KL cells showed 
an efficient uptake (approximately 30%) of A488-BSA, whereas OK DNP cells failed to take up A488-
BSA (Figure 5.4). Thus, it can be concluded that the uptake of 14C-rHA by OK cells is not an active 
process since the efficiency was extremely low and non-saturable. 
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A 
B 
Figure 5.3: Uptake of radiolabelled native albumin by OK cell lines. (A) OK KL
cells and (B) OK DNP cells, were incubated with different concentrations of
14C-rHA (50, 200 and 500 µg/ml). (C) OK KL cells were incubated with TR-BSA
and TR-rHA (50 µg/ml). The role of endocytosis in the uptake of TR-rHA was
investigated by pre-incubation with 1 µM Latrunculin. La : the use of
Latrunculin
For the control, both OK KL and OK DNP cells were incubated with Hepes
buffer pH 7.45 (blank sample). The data were from 3 independent
experiments for (A) and (B) and 2 independent experiments for (C).
C 
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Figure 5.4: The percentage of uptake of albumin probes by OK cells. The
percentage of added probe that was actually taken up by OK KL and OK DP
cells was calculated.
The uptake of 14C rHA was very low for both OK DNP cells (3.4 ± 1.1%) and OK
KL cells (2.6 ± 0.75%). By contrast, 31% of added A488-BSA was taken up by
OK KL cells. However, there was virtually no uptake of A488-BSA by OK DNP
cells. The efficiency of A488-BSA uptake was calculated based on the standard
curve of weight versus fluorescence intensity of A488-BSA (Appendix). The
efficiency of 14C-rHA uptake was calculated based on the radioactivity of initial
dosage and the final cell lysate.
The data were from at least 3 independent experiments. The one-way ANOVA
with Tukey’s multiple comparison test was done to statistically analyse the
difference between groups. The error bars are shown as standard deviation.
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5.4.1.4 Latrunculin, native rHA and BSA do not affect the uptake of 14C-rHA by OK KL or OK 
DNP cells. 
High concentrations of rHA or BSA (500 µg/ml) did not inhibit the very low level of uptake of 
14C-rHA in OK KL cells (Figure 5.5A). Latrunculin did not inhibit the uptake of 14C-rHA (500 µg/ml) in 
OK KL or OK DNP cells indicating that uptake of 14C-rHA was not dependent upon the cytoskeleton, 
thus ruling out a role for any receptor-based endocytosis (Figure 5.5B). Curiously, Latrunculin caused 
a small increase in the uptake of 14C-rHA in OK DNP cells, but given the very minimal uptake 
involved, this is likely to have little biological significance. 
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Figure 5.5: Effect of Latrunculin A and albumin competition on the uptake of
14C-rHA by OK cells. (A) OK KL cells were incubated with 14C-rHA (50 µg/ml)
and co-incubated with either rHA or BSA (500 µg/ml). The uptake of 14C-rHA
was not blocked by high concentrations of either rHA or BSA in OK KL cells. (B)
Pre-treatment of OK KL or OK DP cells with Latrunculin with did not inhibit the
uptake of 14C-rHA (500 µg/ml); however, Latrunculin caused a small increase in
the uptake of 14C-rHA by OK DNP cells.
The data were from at least 3 independent experiments. The one-way ANOVA
with Tukey’s multiple comparison test was done to statistically analyse the
difference between groups. The error bars are shown as standard deviation.
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5.4.2 Albumin peptides fail to affect the uptake of 14C-rHA by OK KL cells. 
In Chapter 4, it was demonstrated that peptide A6 significantly inhibited the uptake of A488-
BSA OK KL cells. All the other peptides were also able to inhibit the uptake of FITC-BSA at a 
concentration of 25 µg/ml. However, these peptides had no inhibitory effect upon the extremely low 
levels of 14C-rHA uptake by OK KL cells except A4 (Figure 5.6). The increase in 14C-rHA uptake by OK 
KL cells seen with some albumin peptides is not considered to be biologically significant given the 
very low basal rate of albumin uptake. This is most likely an increase in non-specific binding to the 
cell surface.  
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Figure 5.6: Effect of albumin peptides on the uptake of 14C-rHA by OK KL cells.
OK KL cells were incubated with 14C-rHA (50 µg/ml) plus one of six different
peptides at either: (A) 50 µg/ml, or; (B) 10 µg/ml. None of the peptides
inhibited the uptake of 14C-rHA (50 µg/ml). In contrast, both concentrations of
peptides A1, A3 and A4 promoted the uptake of 14C-rHA by OK KL cells.
The data were from 3 independent experiments. The one-way ANOVA with
Tukey’s multiple comparison test was done to statistically analyse the
difference between groups. The error bars are shown as standard deviation.
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5.5 Discussion  
5.5.1 Megalin is expressed by OK cells and necessary for uptake of modified albumin 
but not native albumin. 
As discussed in Chapter 4, the megalin receptor was necessary for uptake of modified 
albumin by OK KL cells. However, we observed that the uptake of native radioactive recombinant 
albumin by OK KL cells was quite different compare to that of modified fluorescent albumin. The 
uptake efficiency was very different between native 14C-rHA (3-4%) and modified A488-BSA (>30%) 
in OK KL cells. The uptake of radioactive albumin by OK DNP cells occurred at a similar rate to that in 
OK KL cells, indicating that megalin was unlikely to contribute to the uptake of radioactive native 
recombinant albumin. In addition, TR-rHA was taken up by OK KL cells demonstrating that: (i) rHA 
can be taken up by OK KL cells and thus ruling out a trivial species difference between BSA and HA, 
and (ii) that modification of rHA through covalent binding of TR was sufficient to induce uptake by 
OK KL cells implying that it is the modification status of the albumin which is important for uptake. 
 
Furthermore, Latrunculin A did not block the very limited uptake of radioactive native 
albumin by OK KL cells. This suggests that the uptake of 14C-rHA is not through a membrane bound 
receptor. It is unclear why Latrunculin increased the very limited uptake of 14C-rHA by OK DNP cells, 
although this did not result in substantial levels of 14C-rHA uptake. This small difference may be a 
non-specific effect of Latrunculin affecting the charge/composition of the cell surface membrane 
which could increase non-specific binding of 14C-rHA. 
5.5.2 Non-radioactive and radioactive native recombinant human albumin did not 
affect the uptake of modified albumin by OK KL.  
The uptake of fluorescent albumin by OK KL cells was reduced by modified albumin such as 
HSA and BSA but not by native recombinant albumin. This suggests that the uptake of albumin by OK 
KL cells is based on the degree of modification of albumin. The 14C-rHA or rHA did not block the 
uptake of A488-BSA and FITC-BSA. Only BSA and HSA were able to block A488-BSA uptake. The 
capacity of DQRed-BSA to block the uptake of A488-BSA and FITC-BSA was more potent than that of 
BSA, suggesting that the greater the degree of modification of albumin, the greater the binding to 
megalin and uptake by OK KL cells.   
Bovine serum albumin also did not block the uptake of 14C-rHA. However, given that very 
low levels of uptake of 14C-rHA by OK KL cells, it is unlikely that any inhibition of this response would 
 182 | P a g e  
have been possible to observe. Furthermore, the inhibition of fluorescent albumin uptake by BSA 
may due to the low levels of modification seen in commercial bovine serum albumin such that OK KL 
cells recognize BSA as modified albumin but not as native albumin such as rHA. 
It could be argued that the result is due to the different affinity of albumin species, but 
multiple alignments of bovine and human albumin structures show that there is a very high identity 
between the species (Chapter 4).  Thus, the inability of purified rHA to block the uptake of modified 
fluorescent albumin by OK cells is unlikely to be due to a species difference. 
The A6 albumin peptide was shown to block the uptake of fluorescent albumin probes in OK 
cells in Chapter 4, presumably by blocking the binding of albumin with megalin. However, the low 
levels of non-selective 14C-rHA uptake by OK KL cells could not be reduced further by the A6 peptide. 
Indeed, some of the albumin peptides (A1, A3 and A4) caused minor increases in the uptake of 14C-
rHA in OK KL cells, but it is unlikely that this is of biological significance.  
In conclusion, the uptake of albumin by OK KL cells appears to be related to the degree of 
modification of the albumin molecules, with greater uptake seen for the more extensively modified 
forms of albumin. 14C-rHA was not selectively taken up by OK KL or OK DNP cells, while fluorescent 
albumin actively underwent endocytosis only in OK KL cells suggesting that the megalin pathway is 
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6 Chapter 6. Effect of lipopolysaccharide and TNF-alpha on albumin 
uptake and degradation by proximal tubular cells 
6.1 Introduction 
Albuminuria is evident in patients with bacterial sepsis in the intensive care unit [13]. As a 
model of bacterial sepsis, administration of LPS to mice induces systemic inflammation, including 
kidney inflammation and albuminuria [14]. This LPS administration triggers increased serum levels of 
pro-inflammatory cytokines, including interleukin (IL)-6, IL-12 and tumour necrosis factor alpha (TNF-
alpha) which can be produced by many different cell types, such as leukocytes and renal tubular 
epithelial cells [14, 238, 239]. Monocytes/macrophages activated during acute and chronic kidney 
inflammation can directly cause renal injury [240]. 
TNF-alpha, also known as cachexin, is produced by many different cell types including CD4+ 
T lymphocytes, NK cells, and neurons [241, 242]. It is an endogenous pyrogen which induces fever 
and apoptotic cell death; production of TNF-alpha by immune cells during systemic inflammation is 
also regulated by adipokines such as leptin [243]. TNF-alpha stimulates the acute phase reaction by 
activating macrophages. It has a range of potential renal effects such as inducing local glomerular 
insulin resistance, increasing albumin permeability and reducing GFR [244]. 
Patients with diabetic nephropathy showed a significant positive correlation between serum 
and urine TNF-alpha levels and proteinuria [15]. Serum levels of TNF-alpha are 3-4 fold higher in type 
2 diabetic patients than in those without diabetes [16-19]. There is also evidence showing an 
increase in TNF-alpha levels prior to the rise in albuminuria in diabetic rats [245]. 
Macrophages can be activated via a number of intracellular signalling pathways such as the 
c-Jun amino terminal kinase (JNK) and p38 mitogen-activated protein kinase (MAPK) [240]. JNK is 
member of stress-activated protein kinase (SAPK) family and is activated in diabetes and contributes 
to both insulin-resistance and decreased pancreatic islet mass and function [246, 247]. Activation 
(phosphorylation) of p38 MAPK is marked in experimental diabetes and precedes the development 
of proteinuria, while inhibition of p38 MAPK activation by FR167653 has been shown to suppress 
proteinuria [248, 249]. 
A recent conference report indicated that CC-930 treatment (a selective JNK inhibitor [250]), 
suppressed LPS-induced albuminuria in mice (Ho J, Ozols E, Ma FY, Bennett BL, Nikolic-Paterson DJ. 
JNK signalling is required for LPS-induced albuminuria in mice. J Am Soc Nephrol 23:896A, 2012). 
One possible mechanism of LPS-induced proteinuria in this model is via inhibition of albumin uptake 
by proximal tubules, resulting in more of the glomerular filtered albumin being excreted in the urine. 
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This potential mechanism of LPS-induced albuminuria was investigated by examining the effect of 
LPS on albumin uptake by OK cells and whether this could be modified by inhibition of the JNK 
signalling pathway.   
6.2 Aims of Chapter 6 
This chapter investigated the effect of LPS on the uptake of fluorescent albumin by OK KL 
cells. The inhibitor CC-930 was utilised to examine whether effects of LPS on proximal tubular cells 
operate through the JNK pathway.  
6.3 Methods and materials  
All the materials and methods are described in detail in Chapter 2. To maintain continuity, 
brief summaries of methods used are given. SDS-PAGE gel and Coomassie staining and Western 
blotting were used to separate and detect proteins concentration. The antibodies for Western blot 
are listed in Table 2.1. Gel densitometry – Gel analyser 2000 was performed to estimate the protein 
quantities. This chapter utilized the albumin uptake assay described in Chapter 2 using fluorescent-
labelled albumin. Immunohistochemistry was also used for confocal imaging. CC-930 is a selective 
JNK inhibitor [250] and was a gift from Celgene (San Diego, CA, USA). Statistical analysis was 
performed by one way ANOVA with Tukey’s multiple comparison tests. 
6.4 Results 
6.4.1 LPS vs uptake of fluorescent albumin by OK KL 
First, it was determined whether pre-treatment of OK KL cells with LPS affects the uptake of 
fluorescent albumin. This employed a dose response study and different albumin probes.  
6.4.1.1 Dose response effect of LPS on fluorescent albumin uptake 
OK KL cells were stimulated with different doses of LPS either 2 hours (Figure 6.1A) or 24 
hours (Figure 6.1B) before assaying the uptake of FITC-BSA. Acute stimulation (2 hours) with LPS 
caused a clear reduction in the uptake of FITC-BSA uptake in a dose-dependent fashion (Figure 6.1A). 
The 24 hours period of LPS stimulation only reduced the uptake of FITC-BSA at the 100 ng/ml LPS 
dose (Figure 6.1B). However, the 100 ng/ml LPS dose did not cause any detectable loss of cell 
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viability or cell death in the 24 hours study, suggesting that this was a specific effect of LPS-induced 
cell activation. 
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Figure 6.1: Effect of LPS on the uptake of 50 µg/ml FITC-BSA in OK cells.
A. Cells were incubated for 2 hours, with 1 ng/ml, 10 ng/ml, or 100 ng/ml LPS
(L) prior to assaying uptake of FITC-BSA. Control cells had no LPS
stimulation.
B. Cells were incubated for 24 hours, with 1 ng/ml, 10 ng/ml, or 100 ng/ml
LPS (L) prior to assaying uptake of FITC-BSA. Control cells had no LPS
stimulation.
The data were from at least 3 independent experiments. The one-way ANOVA
with Tukey’s multiple comparison test was done to statistically analyse the
difference between groups. The error bars are shown as standard deviation.
A
B
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Figure 6.2: Effect of 100 ng/ml LPS on the uptake of A488-BSA by OK KL cells.
Cells were incubated for 2 hours or 24 hours with 100 ng/ml LPS followed by
an uptake assay using the standard 150 µl culture volume of 50 µg/ml A488-
BSA.
The data were from at least 3 independent experiments. The one-way ANOVA
with Tukey’s multiple comparison test was done to statistically analyse the
difference between groups. The error bars are shown as standard deviation.
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6.4.1.2 Uptake/degradation/secretion of fluorescent albumin under effect of LPS 
Since differences were seen in the uptake of individual fluorescent albumin probes (see 
Chapter Four), the effect of LPS on the uptake of albumin by OK KL cells was also tested using A488-
BSA. Stimulation of cells with 100ng/ml LPS for 2 hours or 24 hours significantly reduced the A488-
BSA (Figure 6.2), which was a more pronounced effect than that seen with FITC-BSA (Figure 6.1).  
Due to its strong auto-quenching effect (Chapter 3), DQRed-BSA was used to detect the 
effect of LPS on degradation/secretion of fluorescent albumin molecules by OK KL cells [142]. The 
lysate fluorescent signal suggests an increase of intracellular degradation of DQRed-BSA with LPS 
stimulation (Figure 6.3A). LPS significantly increased the secretion of DQRed-BSA (mainly fragments) 
into supernatant (Figure 6.3B and C). Intact DQRed-BSA had minimal fluorescent activities as 
expected. In Coomassie staining of supernatant samples, there was an increase of DQRed-BSA 
fragments after 30 minutes of cell assay uptake compared to the control (Figure 6.3D). It should be 
noted that these assays are performed in serum free media, thereby excluding that degradation of 
albumin is occurring within the cell supernatant.  
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Figure 6.3: Effect of LPS on the secretion/degradation of fluorescent albumin
by OK KL cells. For all samples (control vs LPS treated), the Coomassie staining
of SDS-PAGE of supernatant sample collected at different time points
(0,30,60,90 and 120 mins) is shown
A. Fluorescent signal of OK cell lysates under effect of LPS (2 and 24 hours)
after 2 hours incubation with DQRed-BSA
B. Fluorescent signal of supernatant of OK cells under effect of LPS (2 and 24
hours) after 2 hours incubation with DQRed-BSA.
C. The fluorescent detection of supernatant of OK cells under effect of LPS (2
hours) after 2 hours incubation with DQRed-BSA.
D. Coomassie staining of SDS-PAGE gel of supernatant samples under effect
of LPS 2 hours and control for 3 different time points ( 30, 60 and 120
mins)
The data were from at least 3 independent experiments. The one-way ANOVA
with Tukey’s multiple comparison test was done to statistically analyse the
difference between groups. The error bars are shown as standard deviation.
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6.4.2 Megalin vs LPS 
One mechanism by which LPS stimulation inhibited uptake of fluorescent albumin by OK KL 
cells is a reduction in megalin-dependent endocytosis as described in Chapter Four. Therefore, the 
effect of LPS on megalin expression and distribution was examined. 
6.4.2.1 Effect of LPS on megalin expression 
Figure 6.4 shows Western blot detection of megalin in OK cells lysates following 2 or 24 
hours stimulation with 100 ng/ml LPS compared to the control. Multiple bands were detected by the 
anti-megalin antibody despite the use of protease inhibitors in preparing the cell lysates. Three 
bands were identified with molecular weights of approximately 250 kDa, 100 kDa and 35 kDa (Figure 
6.4). Using tubulin expression as a standard, densitometry analysis of these bands showed that 
megalin protein levels were not affected LPS stimulation for 2 hours or 24 hours. 
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Figure 6.4: Effect of LPS stimulation upon megalin protein levels in OK KL cell
lysates.
(A) Western blot of lysates prepared from control cells or cells at 2 hours or 24
hours following stimulation with 100 ng/ml LPS. Red bands indicate
megalin and green band is the tubulin loading control.
(B) Graph showing densitometry analysis of the 250 kDa band of megalin
standardized against the tubulin control. There was no difference of
megalin expression between groups.
The data were from at least 3 independent experiments. The one-way ANOVA
with Tukey’s multiple comparison test was done to statistically analyse the
difference between groups. The error bars are shown as standard deviation.
A
B
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6.4.2.2 Effect of LPS on megalin distribution  
Confocal microscopy was used to examine whether LPS affected the cellular distribution of 
megalin in OK KL cells (Figure 6.5). In control cells, megalin was primarily distributed in a punctate 
pattern at or near the cell surface, consistent localisation at the cell surface membrane and within 
endosomal vesicles. Stimulation with LPS for 2 hours or for 24 hours did not affect the distribution of 
megalin.  
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Control
LPS 2hours LPS 24hours
Figure 6.5: Confocal microscopy of megalin staining (blue) in OK KL cells.
Control cells shows megalin distributed in a punctate pattern at or near the
cell surface. This pattern was unchanged in cell at 2 hours or 24 hours after
stimulation with 100 ng/ml LPS.
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6.4.2.3 Effect of LPS on LAMP-1 expression  
One further mechanism by which LPS may have reduced albumin uptake in OK KL cells is 
through modification of lysosomal activity or distribution. As a marker of lysosomes, LAMP-1 was 
examined in cultured OK KL cells. Serum starved OK cells without added albumin showed low levels 
of LAMP-1 expression (Figure 6.6A). The addition of albumin to cells induced an increase in the 
LAMP-1 signal (Figure 6.6B), suggesting an increased lysosome formation and/or activation. 
Interestingly, LPS caused a pronounced increase in LAMP-1 staining with many lysosomes seen 
throughout the cytoplasm (Figure 6.6C and 6.6D). Thus, the reduction in uptake of A488-BSA does 
not appear to be due to reduced lysosomal activity.  
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Figure 6.6: Localisation of the lysosomal antigen LAMP-1 (red) in OK KL cells by
confocal microscopy.
(A) Serum starved OK cells in the absence of added albumin exhibit low levels
of LAMP-1
(B) The addition of A488-BSA induces an increase in the LAMP-1 signal, with a
punctate staining pattern near the cell surface and in the cytoplasm.
(C) Stimulation of cells with 100 ng/ml LPS for 2 hours (induced strong
punctate LAMP-1 staining throughout the cytoplasm.
(D) Stimulation of cells with 100 ng/ml LPS for 24 hours (D) induced strong
punctate LAMP-1 staining throughout the cytoplasm.
(E) Graph showing the fluorescent signal for LAMP-1 staining in the 4 different
conditions examined.
The data were from at least 3 independent experiments. The one-way ANOVA
with Tukey’s multiple comparison test was done to statistically analyse the
difference between groups. The error bars are shown as standard deviation.
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6.4.3 Role of JNK signalling in LPS-induced effects on albumin uptake by OK cells  
6.4.3.1 Effect of CC-930 on LPS induced JNK activation 
To confirm that CC-930 blocks JNK activation, OK KL cells were incubated with CC-930 15mins 
prior to LPS stimulation. JNK activation can be quantified by phosphorylation of its specific target, 
Serine63 in the amino terminal domain of c-Jun. The LPS was able to significantly increase 
phosphorylation of c-Jun. As shown in Figure 6.7B, a 15 mins LPS stimulation of OK KL cells induced 
phosphorylation of c-Jun and this was inhibited by 1 µM and 5 µM CC-930.  
The effect of CC-930 on the LPS induced suppression of albumin uptake in OK KL cells was 
examined. As shown in Figure 6.8, concentrations of 0.2 to 5 µM completely prevented the LPS 
induced suppression of albumin uptake in OK KL cells.  
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Figure 6.7: CC-930 inhibits LPS-induced JNK activity of OK KL cells.
(A) Western blot showing phosphorylation of c-Jun (red) and the tubulin
loading control (green). Cells were incubated with 1 µM or 5 µM for 1 hour
before a 15 mins stimulation with 100 ng/ml LPS.
(B) Graph showing densitometry analysis of phospho-c-Jun standardized
against the tubulin loading control.
The data were from at least 3 independent experiments. The one-way ANOVA
with Tukey’s multiple comparison test was done to statistically analyse the
difference between groups. The error bars are shown as standard deviation.
Tubulin
Phospho-c-jun
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Figure 6.8: Dose response study showing the effect of the JNK inhibitor, CC-
930, on the LPS-dependent reduction of albumin uptake by OK KL cells.
A. Cells were incubated with varying concentrations of CC-930 for 1 hour
before stimulation with 100 ng/ml LPS for 2 hours before the uptake of
A488-BSA was measured.
B. Cells were incubated with varying concentrations of CC-930 for 1 hour
before stimulation with 100 ng/ml LPS for 24 hours before the uptake of
A488-BSA was measured.
The data were from at least 3 independent experiments. The one-way ANOVA
with Tukey’s multiple comparison test was done to statistically analyse the
difference between groups. The error bars are shown as standard deviation.
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6.4.3.2 The effect of TNF-alpha on albumin uptake by OK cells  
TNF-alpha activates many of the same pro-inflammatory pathways as LPS. Therefore, the 
effect of TNF-alpha on albumin uptake by OK KL cells was examined. As shown in Figure 6.9B, the 
highest concentration of recombinant TNF-alpha induced clear activation of both JNK and p38 
signalling, whereas the lower concentrations had no significant effect.  
Stimulation of OK KL cells for 2 hours or 24 hours with 2 ng/ml to 50 ng/ml TNF-alpha had no 
effect upon albumin uptake (Figure 6.10). Thus, despite clearly activating pro-inflammatory 
signalling pathways in OK KL cells, TNF-alpha failed to suppress albumin uptake.   
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Figure 6.9: Effect of TNF-alpha on activation of signalling pathways in OK KL 
cells. OK KL cells were stimulated for 15 mins with 2 ng/ml, 10 ng/ml or 50 
ng/ml TNF-alpha and then cells lysed for analysis. 
(A) Western blot showing the band for phospho-c-Jun (red) and the tubulin 
loading control (green). Graphs below show densitometry analysis of 
phospho-c-Jun standardized against the tubulin loading control. 
(B) Western blot showing the band for phosphorylated p38 MAPK (red) and 
the tubulin loading control (green). Graphs below show densitometry 
analysis of phospho-p38 MAPK standardized against the tubulin loading 
control. 
The data were from at least 3 independent experiments. The one-way ANOVA
with Tukey’s multiple comparison test was done to statistically analyse the
difference between groups. The error bars are shown as standard deviation.
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Figure 6.10: Diagram showing the effect of TNF-alpha on the uptake of A488-
BSA by OK KL cells. There were 3 different dosages of TNF was used 2 ng/ml,
10 ng/ml and 50 ng/ml.
A. The OK KL cells were incubated with TNF-alpha in DMEM/F12 minimal
glucose for 2 hours prior to uptake experiment
B. The OK KL cells were incubated with TNF-alpha in DMEM/F12 minimal
glucose for 24 hours prior to uptake experiment
The data were from at least 3 independent experiments. The one-way ANOVA
with Tukey’s multiple comparison test was done to statistically analyse the
difference between groups. The error bars are shown as standard deviation.
A
B
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6.5 Discussion  
6.5.1 Effect of LPS on albumin handling by OK KL cells 
This chapter investigated the effect of LPS on albumin uptake by OK cells. Based on cell 
uptake assays, LPS stimulation consistently suppressed the uptake of albumin by OK KL cells (Figure 
6.1 and 6.2). This was shown for both A488-BSA and FITC-BSA, and was evident following both acute 
(2 hours) and longer term (24 hours) LPS stimulation. This inhibition of albumin uptake by OK KL cells 
could be due to 3 reasons: 1) a reduction in the endocytosis of fluorescent albumin; 2) an increase in 
the excretion of fluorescent albumin fragments back into media, and; 3) a reduction in the 
degradation of fluorescent albumin in OK KL cells. 
6.5.1.1 LPS vs Megalin  
Megalin is a well characterised receptor involved in the endocytosis of albumin by OK cells 
as discussed in Chapter 5. However, LPS did not affect total megalin protein expression by OK KL 
cells based on Western blotting (Figure 6.4), nor did LPS affect the distribution of megalin in OK KL 
cells based upon confocal microscopy (Figure 6.5). However, co-immunoprecipitation studies of 
megalin and albumin in cell lysates and high resolution confocal microscopy to co-localise albumin 
and megalin in cultured cells were not performed. Therefore, while LPS appeared not to affect 
megalin function, it remains a possibility that megalin/albumin interactions were affected by LPS 
stimulation of cells. More investigation needs to be done to confirm whether megalin/albumin 
interactions were affected by LPS.   
6.5.1.2 A possible role for autophagy in the uptake/degradation/secretion of fluorescent 
albumin by OK KL cells 
As Figure 6.3D shows, fragmented fluorescent albumin was excreted back into supernatant 
more than to control group under effect of LPS. The LPS-induced degradation/secretion could be 
seen as defence mechanism of OK KL cells against DQRed-BSA. The increased degradation of DQRed-
BSA also agrees with LAMP1 result which suggests the induction of lysosomes activities. LPS had a 
profound impact upon LAMP-1 staining in OK KL cells, being far more impressive than the effect of 
albumin addition (Figure 6.6). Exposing the fluorescent albumin to OK cells would not increase the 
LAMP-1 activities as much as LPS. This may relate to the induction of autophagy by LPS stimulation 
[251]. Under stress stimuli from environment, autophagy is induced and autophagosome are formed 
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[252]. Fusing with lysosome, autophagosomes are capable of degrading its contents. The 
degradation of intracellular organelles in response to major cellular insults requires a marked 
increase in lysosome activity in the formation of autophagosomes [253, 254]. Thus, there is a 
reduction in available lysosomes for albumin degradation. Hence, a re-organisation of lysosomal 
function due to LPS-induced autophagy may explain why the fluorescent signal of albumin uptake 
was reduced in LPS stimulated OK KL cells.  
As shown in Figure 3.26, trypsinization of FITC-BSA or A488-BSA increased their fluorescent 
signal by 372% and 131%, respectively, by removing auto-quenching in the intact fluorescent 
albumin probes. Thus, some of the signal taken in the measurement of albumin uptake by OK KL 
cells may be contributed by the release of albumin auto-quenching through lysosomal degradation 
of the albumin probe. It follows, therefore, that LPS may not have affected albumin uptake into the 
cell (via megalin), but that reduced lysosomal degradation of albumin due to the autophagy 
response would have prevented the fluorescent signal produced upon lysosomal degradation of 
albumin probes to remove their auto-quenching and therefore given the appearance of reduced 
albumin uptake by cells. Future studies are warranted to examine whether blockade of autophagy 
(via Atg7 gene deletion) would prevent the apparent reduction in the albumin of fluorescent 
albumin by LPS stimulated OK KL cells.    
6.5.2 LPS vs TNF-alpha and CC-930 
Some of the pro-inflammatory and pro-apoptotic, autophagy actions of LPS are mediated via 
the JNK signalling pathway, p38 MAPK and TNF-alpha [255]. Since the JNK inhibitor CC-930 has been 
reported to inhibit LPS-induced albuminuria in mice (Ho J, Ozols E, Ma FY, Bennett BL, Nikolic-
Paterson DJ. JNK signalling is required for LPS-induced albuminuria in mice. J Am Soc Nephrol 
23:896A, 2012), this was further examined in cell culture. CC-930 was shown to block LPS-induced 
JNK signalling in OK KL cells and CC-930 efficiently prevented the LPS-induced reduction in albumin 
uptake. Thus, the ability of CC-930 to inhibit LPS-induced albuminuria in mice may be due to a direct 
effect upon the uptake of glomerular filtered albumin by proximal tubular epithelial cells. However, 
other mechanisms, including changes in glomerular permeability could also explain the in vivo 
findings.  
It was unexpected that TNF-alpha, which activates many of the same pro-inflammatory and 
pro-apoptotic pathways as LPS, failed to affect albumin uptake by OK KL cells. This was not due to a 
lack of cross-reactivity of mouse TNF- for opossum cells; since TNF-alpha was shown to activate 
both JNK and p38 pathways in OK KL cells (Figure 6.10). Further studies using pathway specific 
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inhibitors will be needed to dissect the downstream pathways by which LPS/JNK signalling affects 
albumin uptake in OK KL cells.  
 
7 Chapter 7 Discussion 
7.1 Introduction 
As described in Chapter One, the mechanism of albuminuria in kidney disease has been the 
subject of extensive investigation without reaching a scientific consensus. Despite the application of 
new techniques such as real time two photon microscopy, studies are still limited by the nature of 
the modified albumin probes employed [152, 154]. For example, covalent modification of albumin 
with fluorescent molecules results in a protein with which has different biochemical properties 
(molecular weight, secondary structure and charge) compared to native albumin plus inherent 
limitations of auto-quenching effects. Therefore, there is a need to develop a new type of albumin 
probe for studying renal function in health and disease. Thus, the aim of this thesis was to develop a 
native albumin probe in order to determine whether the many studies using modified albumin 
probes truly reflect the way in the which the kidney, and in particular, the proximal tubule handles 
albumin in health and disease. 
7.2 Production of a native albumin probe 
K. Lactis has multiple advantages for the production of recombinant proteins over that of 
prokaryotic systems. In my studies, the most critical advantage of K. lactis was being able to express 
albumin in the correctly folded native conformation [198]. In addition, my studies confirmed that 
K.Lactis is a suitable system in which to synthesize bulk quantities of recombinant albumin which can 
be purified to homogeneity without loss of native structure.  
 
A considerable challenge was the production of radioactive recombinant albumin with high 
specific activity and a native conformation. The first problem to solve was achieving homogeneity of 
14C incorporation into recombinant albumin. This was overcome by the manipulation of yeast 
biochemical pathways. Growing yeast in minimal media with the addition of amino acids induced the 
utilisation of 14C glucose in the synthesis of amino acids during the production of rHA. This avoided 
the more general utilisation of 14C glucose in yeast growth when used in rich media [256]. In 
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addition, a number of purification strategies were tested to optimise the yield of 14C-rHA while 
maintaining native conformation. However, once the conditions for synthesis and purification had 
been optimised it became clear that the dollar cost of making sufficient quantities of high specific 
activity 14C-rHA for in vivo studies in mice was simply not feasible within the limited budget for my 
project.  While this was very frustrating that the major constraint in my project was financial rather 
than methodological, I was still able to produce a sufficient quantity of native 14C-rHA to perform 
novel studies using cultured proximal tubular cells.    
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Figure 7.1. Proposed mechanisms for the uptake of modified and normal albumin 
by proximal tubular cells. 
(A) In the normal kidney the FcRn (and possibly other receptors) takes up filtered 
normal albumin from the tubular lumen and returns it back to peri-tubular 
capillaries (the transcytosis pathway). Whether the FcRn can bind and transcytose
modified albumin is unknown. This process limits loss of albumin in the final urine. 
(B) In the normal kidney, megalin is responsible for the uptake of filtered modified 
albumin leading to its degradation in the lysosomal compartment with presumed 
secretion of amino acids into the peri-tubular capillaries. 
(C) In disease, an increase in urine excretion of normal albumin may occur if the 
capacity of the FcRn transcytosis pathway is overwhelmed by an increase in 
glomerular albumin filtration (glomerular leakage). Albuminuria could also occur 
by inhibition of the transcytosis pathway even without a change in glomerular
albumin filtration.
(D) In disease, a reduction in megalin expression will prevent the uptake of 
modified albumin, leading to increased urine excretion of modified albumin. 
Alternatively, an increase in glomerular filtration of modified albumin may 
overwhelm the capacity of the megalin pathway.
Eds: endosome, M: megalin, FcRn: neonatal Fc receptor
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7.3 Native albumin vs modified albumin 
An important finding in this thesis was the demonstration that commercial albumin probes 
prepared by covalent modification of purified albumin with fluorescent molecules had an altered 
secondary structure. In addition, these commercial fluorescent albumin probes displayed auto-
quenching since they exhibited a more intense fluorescent signal after enzymatic degradation. Both 
of these properties of the probes were directly related to the number of fluorophore molecules 
bound per albumin molecule, with the greater the degree of covalent modification the greater the 
extent of altered secondary structure and auto-quenching. Within the scope of this thesis, it was 
evident that both FITC-BSA and DQ-red BSA had substantially greater auto-quenching compared to 
A488-BSA. This difference between A488-BSA and FITC-BSA may explain some of the different 
results obtained with the 2 different probes which are considered below.  
 
An important aspect of the studies in this thesis is that it is the first direct comparison of a 
how proximal tubular epithelial cells bind and take-up native albumin compared to the standard 
modified albumin.   
7.4 Modified but not native albumin is taken up by cultured tubular 
epithelial cells.  
The results in Chapter 4 showed that the uptake of modified (fluorescent) albumin probes by 
OK KL cells was consistent with the described megalin-dependent endocytotic pathway in proximal 
tubular cells on the basis of: (i) uptake by OK KL cells, but no uptake by OK DNP cells which lack 
megalin, and; (ii) inhibition by Latrunculin A which blocks the cytoskeleton which is required for 
endocytosis.  
 
An interesting finding was the apparent greater uptake of FITC-BSA compared to A488-BSA 
by OK KL cells. This may have two separate, though linked, explanations due to the higher degree of 
modification of FITC-BSA versus A488-BSA. First, the greater degree of conjugation of fluorescent 
molecules in FITC-BSA provides a greater degree of auto-quenching, thereby causing an over-
estimate of the amount of probe taken up. Second, since megalin is a scavenger receptor, it may the 
case that it binds more efficiently to albumin which has a greater degree of covalent modification in 
the same way as scavenger receptors for advanced glycation end-products exhibit enhanced binding 
for molecules with greater degrees of covalent glycation [257-259]. This later point would be 
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consistent with the more efficient competition for modified albumin uptake by OK KL cells using DQ-
red BSA or FITC-BSA compared to that seen with unconjugated BSA which presumably has a much 
lower degree of modification.  
 
A major finding of this thesis was the lack of uptake of native albuminuria by OK KL cells. 
Clearly OK KL cells have the machinery to take up modified albumin, but are unable to take up native 
14C-rHA. Only a very small fraction of the added native albumin probe was taken up by OK KL or OK 
DP cells, and this very minor uptake was not affected by Latrunculin A. In addition, the uptake of 
native albumin could not be inhibited by competition with an excess of modified albumin probe or 
an excess of unlabelled albumin in either cell type. Furthermore, this very low level binding of 14C-
rHA was not saturable in a dose-response assay suggesting that this minor uptake did not occur via a 
receptor-based mechanism. Finally, the peptide A6 did not block the uptake of 14C-rHA, which also 
supports the conclusion that this low level binding of native albumin by both OK cell lines does not 
involve megalin. Therefore, it is reasonable to conclude this this minor binding of native albumin to 
both OK cell lines represents non-specific binding.  
 
The major unanswered question in the thesis is, “can tubular epithelial cells uptake native 
albumin?” The experiments using the OK cell lines argue that they cannot uptake native albumin. 
However, this negative result may be a limitation of the in vitro system employed in these studies. It 
may that tubular epithelial cells indeed uptake native albumin from the luminal space in the kidney, 
but that this mechanism is no longer intact in a simple 2-dimensional culture well. For example, 
expression of particular receptors or channels may require cells in a 3 dimensional tubular 
arrangement or contact with other cell types or particular matrix proteins. In addition, particular 
biophysical parameters may also be missing from the in vitro system such as a fluid flow rate and 
shear stress. For example, shear stress has been shown to activate different mechanisms of 
endocytosis in PT cells [260].    
7.5 Implications of studies for our understanding of urinary albumin 
excretion  
Native albumin is not taken up into tubular cells via megalin, the only well characterised 
albumin receptor. The implication of this finding is that megalin is truly a scavenger receptor in that 
it only recognises modified forms of albumin. Therefore, the loss of megalin expression in proximal 
tubular epithelial cells seen in various forms of kidney disease would be expected to result in 
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increased urinary excretion of modified albumin. This would be accentuated if there is also increased 
filtration of albumin by the damaged glomerulus (Fig 7.1). Unfortunately, current clinical assays for 
albuminuria are based on antibody recognition of amino acids and therefore cannot distinguish 
between native and modified forms of albumin.   
 
The finding that modified forms of albumin can exhibit an altered secondary structure 
argues that modified albumin may have a more elongated rather than globular form. This could lead 
to differences in glomerular filtration of native versus modified forms of albumin since several 
investigators have shown different glomerular sieving coefficients for neutral versus negatively 
charged Ficoll [131, 196], which is postulated to be due to a more elongated structure imposed by 
the negative charge [26, 131]. This is a question that I had hoped to address in mice in this thesis 
using radiolabelled native albumin with and without covalent modification. However, it remains 
unknown whether there is differential glomerular filtration of native versus modified albumin, and 
whether there is differential urinary excretion of native versus modified albumin in health and 
disease.   
 
It may well be the case that tubular epithelial cells can take up native albumin, but that this 
mechanism is not maintained by cultured cells in vitro as discussed above (Section 7.4). Three 
possible mechanisms can be postulated for the uptake of native albumin by proximal tubular 
epithelial cells: (i) via the neonatal Fc receptor (FcRn); (ii) via an unidentified cell surface receptor, 
and; (iii) via fluid phase uptake – although this would not be selective for native versus modified 
albumin, or even for albumin compared to other proteins (Fig 7.1). While there are no published 
studies to support the latter two options, the FcRn is expressed by tubular epithelial cells and it is 
known to play a role in preventing urinary albumin loss and hypoalbuminuria [261]. Indeed, a recent 
study has shown that FcRn expression by proximal tubular cells is involved in the transcytosis of 
glomerular filtered albumin back into the blood in an intact form [262]. An important question to 
address in this transcytosis mechanism is whether there is a difference in the binding of native 
versus modified albumin to the FcRn (see Fig 7.1). It could be argued that transcytosis would be 
expected to favour recovery of native albumin while modified albumin should be removed to reduce 
the potential for triggering inflammation via receptors of the innate immune system (e.g. RAGE). The 
native albumin probe developed in this thesis could be used to address this important question. 
Another relevant issue is whether the capacity of the transcytosis pathway can be overwhelmed by 
an increase in glomerular albumin filtration during disease, or whether the transcytosis mechanism 
is interrupted in disease leading to albuminuria?   
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My studies using OK cells showed that LPS stimulation could reduce the uptake of modified 
albumin – presumably through an effect on the megalin-mediated uptake mechanism. This operated 
via a JNK-dependent mechanism. These findings are consistent with in vivo studies in which LPS-
induced albuminuria is associated with reduced megalin expression [263, 264], and unpublished 
observations by my supervisor that LPS-induced albuminuria in mice operates via a JNK-dependent 
mechanism (Ho J, Ozols E, Ma FY, Bennett BL, Nikolic-Paterson DJ. JNK signalling is required for LPS-
induced albuminuria in mice. J Am Soc Nephrol 23:896A, 2012). In addition, a study of albumin 
overload in rats identified that cell-mediated processes involved in kidney handling of filtered 
albumin can be saturated leading to the development of proteinuria in the absence of any change in 
the fractional clearance of albumin [11]. 
7.6 Limitations of the studies 
I was unable to produce high specific activity 14C-rHA due to financial constraints as 
discussed above (Section 7.2).  The 14C-rHA which I produced had a low specific activity. This meant 
that while it was acceptable for use in cell culture experiments, it was unsuitable for in vivo work in 
mice since the radiolabel would have been diluted to the point of being undetectable. In addition, 
without a significant number of 14C atoms per albumin molecule, it would have been difficult to 
detect albumin degradation fragments in urine. Due to the limited amount of 14C-rHA produced, 
structural analysis was not performed on this actual material. However, the structural studies were 
performed on rHA prepared and purified by the same protocol.  
 
While we used the standard assay for albumin uptake by OK cells as described in the 
literature [31, 265], this assay has a number of potential limitations (as considered in Section 7.4). 
The cell uptake assay model did not account for shear stress of physiological fluid which is 
considered to be important in albumin uptake [260]. In addition, we did not assess FcRn expression 
by the two OK cell lines due to lack of suitable reagents for this species. Finally, I was unable to verify 
cubulin expression by OK KL cells due to the lack of a suitable commercial antibody.  
 
In the LPS studies, I was not able to identify the stage of the albumin uptake process that 
was inhibited. The important megalin interaction with fluorescent albumin was not investigated in 
LPS treated cells. While LPS did not reduce the expression of megalin, it may the case that LPS 
affected the cellular localisation of megalin or altered its binding to particular ligands and thus 
affected albuminuria uptake by OK cells.  
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7.7 Future studies  
7.1.1 Making better probes 
The most important issue for future studies is the exploration of alternative strategies for 
making native albumin with a high specific activity for use in vivo. If financial issues can be 
overcome, then my methodology can be utilised to make native albumin with high specific activity 
for in vivo studies of blood clearance rates, urine excretion of intact and fragmented albumin and 
calculation of fractional clearance of albumin.  
An alternative approach would be to use non-radioactive isotopic labelling with 13C/15N 
metabolic sources. While still an expensive exercise to make such a probe, it would have advantages 
over 14C-rHA in that it could be safely used in human subjects to study normal urinary albumin 
excretion and how this changes in kidney disease. However, the much lower sensitivity of detection 
of 13C/15N and issues of avoiding sample contamination are limitations of such an approach.  
7.1.2 Effect of albumin modifications 
A high specific activity 14C-rHA probe could be used to determine the importance of albumin 
modification on the handling of albumin by the kidney. This would involve comparing native 14C-rHA 
with 14C-rHA covalently modified by fluorescent molecules, AGE, CML or methyl groups. This would 
enable quantification of: (i) the glomerular sieving coefficient for modified versus native albumin; (ii) 
urinary excretion of intact and degraded forms of native and modified albumin in normal mice and in 
mice with proteinuric kidney disease, and; (iii) assessing the relative contribution of megalin to 
tubular albumin degradation and FcRn to tubular albumin transcytosis using mice lacking either 
megalin or FcRn expression in proximal tubular cells (with and without kidney disease). These 
experiments would define how the degree of covalent modification affects the way that albumin is 
handled by the kidney. It could also provide insights into whether developing a specific assay for 
urinary excretion of modified albumin might provide useful diagnostic or prognostic information in 
human patients.  
7.1.3 Determine the profile of albumin fragments in urine from normal mice. 
A high specific activity 14C-rHA probe in which the 14C atoms are uniformly distributed in the 
albumin molecule would allow comprehensive mapping of the pattern of albumin degradation 
fragments in mouse urine and how this changes in situations of mild albuminuria (diabetic 
nephropathy) and severe albuminuria (anti-GBM disease). It is feasible that a panel of urinary 
albumin fragments could be identified that could form the basis of an assay for the early detection 
 217 | P a g e  
and monitoring of urine albumin abnormalities, thereby enabling the earlier treatment of those 
patients likely to develop progressive kidney and cardiovascular disease. This approach could then 
be validated in patients using a 13C/15N-rHA probe.  
7.1.4 The importance of megalin and another receptors for albumin uptake 
The A6 peptide can be used to map the amino acid residues involved in albumin/megalin 
binding and determine whether the A6 peptide can block uptake of albumin by the proximal tubule 
in small animals. This could be done using mutagenesis of the individual amino acids of the A6 
sequence in albumin molecule to see if it affects the binding of albumin to megalin without changing 
albumin structure. The A6 peptide could also be investigated to determine if it affects other uptake 
pathways beside megalin, especially the FcRn, by using co-immunoprecipitation techniques.  
siRNA-based knock-down of megalin expression should be done with OK KL cells to give a 
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8 Appendix 
8.1 Abbreviations 
(NH4)2SO4 Ammonium sulfate 
10-FDF 10% fetal bovine serum DMEM/F12 
AGE Advanced glycation end-products  
AMN Amnionless 
AMN Amnionless 
ANZDATA Australia and New Zealand Dialysis and Transplant Registry  
Apo A-1 Apolipoprotein A-I 
ARPANSA Australian Radiation Protection and Nuclear Safety Agency 
ASP Ammonium sulfate precipitation 
ATCC American Type Culture Collection 
BSA Albumin [Bos taurus] 
CASK Calmodulin-dependent serine protein kinase 
CC16 Clara Cell Protein 
CD Circular dichroism 
CD2AP CD2-associated protein 
ClC-5 Chloride channel-5  
CML Carboxyl methylation of lysine residues 
CPM Count per minute 
CUB Clr/Cls, Uegf and bone 
CUBAM Cubilin and Amnionless complex 
CVD Cardiovascular disease 
DBP Vitamin D binding protein 
DDF DMSO DMEM/F12 medium 
DMEM Dulbecco's modified Eagle's medium 
DMSO Dimethyl sulfoxide  
DPM Disintegration per minute 
EDTA Ethylenediaminetetraacetic acid 
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EGF Epidermal growth factor 
ESRF End-stage renal failure 
FBS Fetal bovine serum 
GBM Glomerular basement membrane 
GFB Glomerular filtration barrier 
GRAS Generally Regarded As Safe 
GSC Glomerular sieving coefficient 
HDL High-density lipoprotein 
HSA Albumin [Homo sapiens] 




MAGI-1 Membrane-associated guanylate kinase 
MSA Albumin [Mus musculus] 
MWM Molecular weight markers 
NEB New England Biolab 
NHE3 Na- -H+ exchganger isoform 3 
OK or OK KL Opossum proximal tubular kidney cell 
OK DNP Opossum proximal tubular kidney cell without megalin 
PBS Phosphate buffered saline 
PMSF  Phenylmethanesulfonylfluoride or phenylmethylsulfonyl fluoride 
PT Proximal tubular cells 
PVDF Polyvinylidene difluoride 
RAP Receptor-associated protein 
RSA Albumin [Rattus norvegicus] 
SSA Serum albumin precursor [Ovis aries] 
TBS-T Tris buffered saline (0.01% Triton X100)  
TF Transferrin 
TGF Transforming growth factor 
TNF-alpha Tumour necrosis factor alpha 
TPP Three-phase partition precipitation  
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Figure A.1: Control of 14C-rHA, fluorescence albumin for uptake assay.  14C-rHA did not create 
fluorescent signal (A) as uptake of 14C-rHA did not have any fluorescent signal.  The standard curve of 
fluorescent intensity of A488-BSA (B). The 5 mg/ml A488-BSA was diluted in Hepes buffer pH 7.45 so 
each measurement has the same volume but different weight of A488-BSA 
8.3 Circular dichroism chromatograph compared BSA and other albumin  
 
Figure A2.1: The CD chromatograph of BSA compared to DQRed BSA. 
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Figure A2.2: The CD chromatograph of BSA compared to A488-BSA 
 
 
Figure A2.3: The CD chromatograph of BSA compared to A555-BSA 
 235 | P a g e  
 
Figure A2.4: The CD chromatograph of BSA compared to FITC-BSA 
 
 
Figure A2.5: The CD chromatograph of BSA compared to TR-rHA 
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Figure A2.7: The CD chromatograph of rHA compared to HSA  
 
The circular dichroism chromatograph compares the difference in secondary structure of 
different albumin molecules in HEPES buffer. The wavelength range is from 190 to 270nm with 1nm 
step. All the albumin molecules were measured at 1mg/ml in Hepes pH 7 buffers. All the background 
data was subtracted in these chromatographs. HT: high tension. V: voltage 
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8.4 Global alignment of protein sequences of albumin from human, cow, sheep, 
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Figure A.3. The graphic shows alignment of multiple species albumins using CLUSTALW 
Omega. Alignment Score is 31236. The symbol “*”indicates positions which have a single, fully 
conserved residue. The value is from 0 (un-conserved) to 9 for high conserved. The consensus 
symbol mean the protein always is found at this position. Both quality and conservation number 
suggests the conservation between group and the alignment. The residues have labelled colours 
according to their physicochemical properties such as red for (small+ hydrophobic (including 
aromatic -Y)), blue (acidic), magenta (basic) – H, Green (Hydroxyl + sulfhydryl + amine + G), others 
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Figure A.4 The alignment of mRNA sequence between albumin and other megalin ligands as 
in figure A.3. The black box indicates the similarity level between sequences. Sequence format is 
Pearson. The human albumin, DBP, TF, RatApoA1, CC16 has 1510 bp, 1720 bp, 2114 bp, 889 bp, 452 
bp.  
 












Table A.1 Aligning score between mRNA of albumin and other megalin ligands as in figure 
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8.6 Protein alignment of megalin ligands with albumin using CLUSTALW Omega 
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Figure A6: All megalin ligands (human albumin, DBP, TF, RatApoA1, CC16) were aligned using 
Clustalw omega. The black box indicates the similarity level between sequences.  
 
 
